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ABBREVIATIONS
Abbreviations used in this thesis are as laid down in the 
Biochemical Journal Instructions to Authors (Biochem. J. 169 
(1978) 1-27), with the following additions:-
POPOP
PPG
PolyA(+)RNA 
Polyribosomal RNA
1 A2go unit
1.4-Bis-(5-phenyloxazol"2-yl) benzene
2.5-Diphenyloxazole
PolyA-containing RNA
Total RNA extracted from the purified 
ribosome pellet.
The quantity of material contained in 
1 ml of a solution which has an
absorbance of 1 at 260 nm, when measured
in a cell with a 1 cm light path. This
is taken to be equivalent to 
100 yg of ribosomes
or 50 yg of ribosomal piA
Throughout this thesis, the centrifugal force, "g” , on a sample 
during centrifugation is calculated based on the average radius of 
rotation of the centrifuge tube.
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SUMMARY
The overall aim of the work described in this thesis was to examine 
the effects of diabetes and insulin on the metabolism of mRNA in rat 
skeletal muscle. The primary objective was to determine whether 
insulin stimulates protein synthesis in the skeletal muscle of diabetic 
rats by promoting the translation of pre-existing mRNA,
Initially the most suitable conditions for the isolation of skeletal 
muscle ribosomes, and the sedimentation of these on sucrose density 
gradients were determined, Ionic conditions of 50 mM Tris-HCl, 200 mM 
KCl, 5 mM MgCl2 (pH 7,6) in the sucrose density gradients were found 
to be best for decreasing the dimerization'of 80S ribosomes which 
hindered discrimination between monosomes and polysomes. Ribosomes 
extracted at high ionic strength (which gave superior yields) had 
similar sedimentation profiles to those isolated at low ionic strength, 
with about 60% of the total ribosomes in polysomes.
Skeletal muscle polysomes were found to be small in size compared to 
those from some other cells and tissues, with the most predominant 
species being those containing three, four and five ribosomes. This 
small size did not appear to be due to nicking of the mRNA by ribo­
nuclease, for ribosomes prepared under sterile conditions, in the 
presence of heparin (an inhibitor of ribonuclease) did not give larger 
polysomes. Neither did addition of cycloheximide, suggesting that 
the small size of the polysomes was not due to the ribosomes running 
off the mRNA during isolation. When skeletal muscle ribosomes were 
translated in a cell-free system from wheat germ, the major products 
were of molecular weight 15,500 - 17,500, although smaller amounts of 
species with molecular weights as high as 100,000 could be detected.
XVI1
Initially diabetes was induced with alloxan or streptozotocin and 
found to decrease the number of polysomes in rat skeletal muscle 
ribosomes, as judged by sucrose density gradient analysis. When 
insulin was administered to either alloxan- or streptozotocin- 
diabetic rats, and the ribosomes isolated at low ionic strength, 
the polysomes rapidly reassembled. However, when the ribosomes 
•were extracted at high ionic strength, reassembly of polysomes was 
only observed with the ribosomes from the rats that had been made 
diabetic with streptozotocin. These observations imply that alloxan 
induces a ribonuclease activity that is extracted from another sub- 
cellular fraction of skeletal muscle by the medium of high ionic 
strength during isolation, breaking down the polysomes which had 
reassembled in vivo after injection of insulin. Attempts to detect 
this putative nuclease activity directly using yeast RNA or radioactive 
HeLa cell ribosomal RNA as a substrate were unsuccessful. The con­
centration of RNA per gram of DNA in rat skeletal muscle was found to 
decrease by about 25% from that in normal rats, 3 days after the 
induction of either alloxan- or streptozotocin-diabetes, Thus the 
putative ribonuclease, referred to above, cannot be responsible for 
the decreased skeletal muscle RNA in diabetes,
RNA was prepared by phenol extraction of purified ribosomes (isolated
at low ionic strength) and estimated by its ultraviolet absorption.
The proportion of mRNA in this RNA was determined as polyA-containing
RNA, assayed by hybridization of the total RNA to ( H) polyU followed
by digestion with pancreatic ribonuclease and measurement of the amount 
3of ( H) polyU;polyA hybrid retained on glass fibre filters. Using this 
assay it was found that, on average, 0,108% of skeletal muscle polyribosomal
XVI11
RNA from normal rats consists of regions of polyA,
The size of polyA-containing RNA in RNA extracted from skeletal
muscle polyribosomes was estimated either from the sedimentation of 
3( H) polyU:polyA-containing RNA hybrids on sucrose density gradients,
3or by sedimenting the.RNA alone and assaying the hybridization of ( H) 
polyU to the polyA-containing RNA in the different fractions of the 
gradient. The size of the polyA-containing RNA was found to be 
small, with a range of sedimentation coefficients from 4-18S and a 
median value of about 9,5S. The size of the polyA sequences obtained 
by digestion of the total polyribosomal RNA with pancreatic and T^ 
ribonuclease was measured in an analogous way to that of the polyA- 
containing RNA and a sedimentation coefficient of about 4S was 
obtained. From these data it was concluded that the polyA region 
constituted about 20% of the length of skeletal muscle mRNA of adult 
rats, and that the proportion of mRNA in total polyribosomal RNA was 
0.54%
PolyA-containing RNA was isolated from the total RNA on a polyU-Sepharose 
column, and added to a cell-free translation system from wheat germ,
A small stimulation above the endogenous level of translation was obtained, 
but this was insufficient to establish that the polyA-containing RNA is 
functional mRNA,
Streptozotocin-diabetes decreased the polysome content of rat skeletal 
muscle ribosomes by about 50%, and the activity of the ribosomes in a 
cell-free system for protein synthesis by a comparable value. It did
XIX
not appear to affect the qualitative nature of the polypeptide chains 
synthesized in the cell-free system, as judged by analysis on poly­
acrylamide gels. Streptozotocin-diabetes did not affect the size of 
the polyA-containing RNA, nor that of its polyA tract, as judged by 
sucrose density gradient analysis.
Quantitative measurements of the polyA-containing RNA in the skeletal
3muscle of diabetic rats by hybridization with ( H) polyU showed that 
the polyA-containing RNA constituted a similar proportion of the total 
RNA in both normal and diabetic rats, whether the RNA was extracted 
from the unfractionated skeletal muscle or from the purified ribosomes. 
These results showed, for the first time, that in diabetes the amount of 
muscle mRNA decreases to the same extent as does the total RNA.
When measurements of polyA-containing RNA were made in diabetic rats 
treated with insulin, it was found that the proportion of polyA-containing 
RNA in the total polyribosomal RNA was similar to that in diabetic rats. 
This implies that insulin does not promote protein synthesis by stimulating 
the transcription of mRNA and therefore must regulate the translation of 
pre-existing mRNA, present in an inactive form.
Attempts were made to identify this inactive mRNA in sucrose density 
gradients of ribosomes prepared from the skeletal muscle of diabetic 
rats, but this RNA pelleted at the bottom of the gradient tube in 
association with aggregated ribosomes. All attempts to prevent this 
aggregation were unsuccessful and it was, therefore, not possible to 
determine in what form the inactive mRNA is stored during diabetes.
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CHAPTER 1
INTRODUCTION
- 1 -
1.1 GENERAL EFFECTS OF INSULIN ON METABOLISM
Diabetes is an ancient disease. In one of the Egyptian papyrus, 
written about 1550 B.C., the directions for the treatment of the 
disease begin with the words "A medicine to drive away the passing 
of too much urine". Nearly 2000 years ago, the Greek physician 
Aretaeus of Cappadocia called it a "mysterious disease". From 
that time until the early part of this century, the form of the disease 
which is now known as "juvenile-onset" diabetes mellitus was almost 
invariably fatal.
In 1889 Minkowski, together with von Mehring, contributed to the 
discovery of insulin when they observed that pancreatectomy led to 
the development of diabetes. But it was not until the historic day 
of July 30, 1921, that a substance extracted from the pancreas was 
able to reverse this. On that day Banting and Best recorded a steady 
decline in the blood glucose concentration of a depancreatized dog 
during the hours following the first injection of a pancreatic extract. 
The active substance, of the pancreas was called "insulin", the name 
already given to it in 1909 by the Belgian scientist Jean de Meyer, 
long before the substance itself had been discovered. The discovery 
of insulin represents one of the major scientific milestones of this 
century. Although much remains to be learnt about the biochemical 
action of insulin, considerable progress has been made since 1921, 
especially during the post-war period. In many of these later studies 
the 8-cytotoxins, alloxan (Lukens, 1948) and streptozotocin (Junod 
et al., 1969), have been used to induce in small experimental rodents
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a form of diabetes which bears some resemblance to the "juvenile- 
onset" diabetes of humans.
Insulin was the first naturally occurring protein to be completely 
analysed with respect to its amino acid sequence (Sanger, Thompson 
and Kitai, 1955; Sanger, 1959), Bovine insulin was shoim to be a 
polypeptide composed of 51 amino acids arranged in two chains (the "A" 
and the "B" chains) joined to one another by two disulphide bridges.
The three-dimensional structure of the insulin molecule has been 
determined by X-ray diffraction (Hodgkin, 1972). The two chains are 
compactly arranged with the "A" chain lying above a central helical 
region of the "B" chain.
Insulin is formed in the g-cells of the islets of Langerhans of the 
pancreas via the single chain precursor, proinsulin (Steiner et al,, 
1967), with the "A" and "B" chains linked by a connecting peptide, the 
"C-peptide", of variable length and amino acid composition in different 
species. Proinsulin is synthesized by the ribosomes attached to the 
rough endoplasmic reticulum, transferred to the cisternae of the Golgi 
apparatus in microvesicular structures derived from the rough endo­
plasmic reticulum, packaged into new secretory granules, and converted 
by proteolysis to mature insulin (Steiner et al,, 1967; Steiner et al,, 
1972). Inside the ^“granules insulin crystallizes with sequestered 
zinc ions, the secretory granules migrate to the cell membrane by a 
process known as exocytosis and, following fusion and dissolution of 
the two membranes at the point of contact, the contents of the granules 
are discharged to the outside of the cell (Lacy, 1967). At neutral
- 3 -
pH virtually complete dissociation of zinc-insulin tiexamers occurs 
(Pekar and Frank, 1972), and thus the physiologically active form of 
insulin in body fluids is considered to be mainly the monomer.
Insulin has profound anabolic effects on the metabolism of carbo­
hydrate, fat and protein, especially in liver, muscle and adipose 
tissue. In general, it promotes the synthesis of glycogen, protein 
and lipid while it inhibits the degradation of these substances.
Under physiological conditions, the secretion of insulin is stimulated 
by the metabolic substrates, glucose, amino acids and, perhaps, short- 
chain fatty acids (Williams and Ensinck, 1971). The major normal 
stimulus appears to be glucose. It has been proposed (Grodsky, 1972) 
that this acts by initiating the entry of calcium, which triggers a 
change in the physical conformation of the microtubules and displacement 
of the granules to the $-cell surface. Several gastrointestinal 
hormones (including secretin, pancreozymin and gastrin) stimulate the 
release of insulin from the pancreas by enhancing the sensitivity of 
the g-cells to glucose (Kipnis and Permutt, 1972),
Before describing the effects of insulin on metabolism it is important 
to emphasize that the molecular mechanism by which these effects are 
elicited is not known. Our present knowledge allows us to distinguish 
independent effects of the hormone on different metabolic processes 
and, in some cases, to describe the molecular changes in the target 
tissue that are responsible for these effects. However we know nothing 
of the molecular events which link the initial interaction of insulin 
with the cell (itself subject to some uncertainty) to these molecular 
changes.
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The first effect of insulin to be discovered was its stimulation of 
the entry of glucose into individual cells (Lundsgaard, 1939; Levine 
et al., 1949, 1950). Subsequent work has shown that insulin stimulates 
specific transport systems for sugars, and that these systems are 
present in muscle (Henderson, Morgan and Park, 1961) and adipose tissue 
(RenoId et al., 1965), but not in liver (Cahill et al., 1958), brain 
and other nervous tissue (Krahl, 1961). This suggested that the primary 
site of interaction of insulin with the cell is at the cell membrane.
It .is now well documented that insulin binds to specific receptor sites 
in the plasma membrane of its responsive cells, and that these receptor 
sites are proteins or glycoproteins which are able to recognize and 
bind insulin (Cuatrecasas, 1974). It is believed that the interaction 
of insulin with its receptor may result in changes in the reactivity of 
membrane proteins, such as enzyme and carrier systems; but it is not 
knoxfn whether the signal that leads to activation of transport is solely 
a membrane phenomenon or whether it involves intracellular loci.
Moreover, problems regarding a simple primary interaction were raised 
by the discovery of other intracellular metabolic effects of insulin, 
independent of its stimulation of trans-membrane sugar transport. These 
latter include the inhibition of glycogenolysis and gluconeogenesis 
in liver (Cahill et al., 1958; Vranic, 1972), lipolysis in adipose 
tissue (Ball and Jungas, 1964), and the stimulation of glycogenosis 
in muscle (Villar-Palasi and Lamer, 1968). Thus it is not clear 
whether one or multiple signals are generated, or whether insulin elicits 
all of its effects from the outside of the cells.
Insulin promotes glycogen synthesis in liver (Bishop et al., 1965) 
and muscle (Larner et al,, 1959) through its rapid increase in the
- 5 -
activity of the enzyme glycogen synthetaae(UDPG:glycogen a-1,4-
glucosyltransferase). Glycogen synthetase is present in two forms, 
phosphorylated (inactive) and dephosphorylated (active). In muscle 
insulin stimulates glycogen synthetase, apparently via cyclic AMP- 
independent pathways. Probably it either reduces the activity of 
the protein kinase which converts the active form of glycogen synthetase 
to the inactive enzyme, or increases the activity of the protein 
phosphatase to bring about conversion to the active form. Evidence 
has been presented in support of both possibilities (Nuttall, 1972), 
but it is not yet clear which is correct (see Nimmo and Cohen, 1977). 
Besides its rapid effects, insulin also exhibits long-term effects by 
stimulating enzyme synthesis. In liver, insulin stimulates the synthesis 
of glucokinase (Pilkis, 1970), thus stimulating glycolysis.
Insulin directly inhibits glucose output by the liver, in contrast to 
glucagon and adrenalin, which stimulate this process by promoting both 
glycogenolysis and gluconeogenesis (Mortiraore, 1972), These latter 
hormones increase the intracellular levels of cyclic AMP which is 
necessary for the activation of glycogen phosphorylase. Although 
insulin reduces the increased levels of cyclic AMP brought about by low 
concentrations of glucagon or adrenalin in perfused livers (Mortimore, 
1972; Exton and Park, 1972), its effect on hepatocyte glucose output 
can be dissociated from its effect on intracellular cyclic AMP levels 
(Davidson and Berliner, 1974). Thus the decrease in phosphorylation 
of glycogen phosphorylase which is responsible for its inactivation by 
insulin may be achieved by a more complex mechanism. Insulin stimulates 
glycolysis by increasing the activity of the key glycolytic enzymes and 
inhibits gluconeogenesis by suppressing the induction of the key gluco­
neogenic enzymes by glucocorticoid hormones (krahl, 1961; Weber, 1972).
— 6 —
Insulin promotes lipogenesis in liver and adipose tissue in a number 
of ways. The increased glucose entry and stimulation of glycolysis 
provides the a-glycerophosphate for the glycerol moiety of triglycerides; 
it provides acetyl-CoA for the synthesis of fatty acids; and through 
the partial oxidation of glucose in the pentose-phosphate pathway, it 
may be the source of reduced pyridine nucleotides (principally NADPH) 
needed for fatty acid synthesis. Insulin stimulates lipogenesis more 
directly by activating pyruvate dehydrogenase (Taylor et al., 1973) 
and possibly acetyl-CoA carboxylase (Halestrap and Denton, 1974); and, 
over a longer term, by increasing the synthesis of lipogenic enzymes 
(Nakanishi and Numa, 1970).
The increased insulin secretion that follows high carbohydrate intake, 
causes the excess formation of triglycerides and very low density lipo­
proteins in liver (Fredrickson et al., 1967). The enzyme responsible 
for the uptake of circulating triglycerides is lipoprotein lipase, which 
requires insulin for its activity in adipose tissue (Robinson and Wing,
19 71). This cleaves the triglycerides to yield glycerol and free fatty 
acids, the latter then being taken up by the adipose tissue and 
converted into triglycerides.
Insulin also has a direct antilipolytic action on the adipose tissue, 
by preventing activation of the hormone-sensitive lipase (Ball and 
Jungas, 1964), This enzyme is activated in adipose tissue through 
phosphorylation by a cyclic AMP-dependent protein kinase, and its 
activation is promoted by numerous hormones, including adrenalin, 
thyroid stimulating hormone, glucagon, adrenocorticotrophic hormone, 
growth hormone and the glucocorticoids (Robinson and Wing, 1971),
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Insulin has been reported to stimulate phosphodiesterase activity when 
added to intact adipose tissue (Loten and Sneyd, 1970) and this 
stimulation is dependent on the presence of extracellular calcium ions. 
Insulin may thus elicit a calcium-dependent activation of phospho­
diesterase activity in adipose tissue, which in turn would decrease 
cyclic AMP levels. As the hormone-sensitive lipase in adipose tissue 
is regulated by cyclic AMP, it was first suggested that insulin might 
affect the activity of this enzyme by altering the intracellular levels 
of this cyclic nucleotide. However, it was found subsequently that 
insulin had no effect on total cyclic AMP accumulation in fat cells 
under conditions in which it inhibited lipolysis (Pain et al., 1972), 
Moreover it appears that the antilipolytic effect of insulin is 
independent of calcium (Desai and Hollenberg, 1975).
In conditions characterized by insufficiency or lack of endogenous 
insulin, e.g. starvation or diabetes mellitus, the broad direction of 
metabolism changes from the deposition of dietary metabolites described 
above to the mobilization of tissue metabolic reserves. This is 
appropriate for starvation, but may have pathological consequences in the 
case of diabetes. Uptake of glucose by adipose tissue and muscle is 
suppressed and hepatic output of glucose rises; the latter effect being 
possibly due to glucagon (Marliss et al,, 1970) which stimulates 
glycogenolysis through its activation of glycogen phosphorylase. A 
second reason for the increased hepatic output of glucose during 
insulin deficiency is the stimulation of gluconeogenesis by glucagon 
and glucocorticoid hormones. Removal of the suppressive effect of 
insulin upon synthesis of the gluconeogenic enzymes leads to increased 
production of glucose from non-fat substrates, and increased
excretion of nitrogen in the urine. In adipose tissue, metabolism 
of glucose is reduced and insufficient a-glycerophosphate is generated 
for the estérification of free fatty acids. In the absence of insulin, 
the hormone-sensitive lipase activity increases and increased amounts 
of free fatty acids and glycerol are released into the blood. Some 
of these are transported to the liver, while others are metabolized 
by muscle, reducing the oxidation of glucose by this tissue. In the 
liver, the free fatty acids inhibit conversion of acetyl-CoA to 
malonyl-CoA by inhibiting acetyl-CoA carboxylase (Majerus and Vagelos,
1967), and so inhibit the synthesis of free fatty acids there. The 
intermediates involved in synthesis of free fatty acids are then converted 
to the ketone bodies, aceto-acetic acid and g-hydroxybutyric acid, which 
are released into the blood. In starvation ketone bodies are an 
important respiratory fuel for muscle and brain, but in diabetes they 
build up to pathological levels.
1.2 EFFECT OF INSULIN AND DIABETES ON PROTEIN METABOLISM 
IN SKELETAL MUSCLE
One effect of metabolic insulin insufficiency mentioned in the 
previous section was a stimulation of gluconeogenesis in the liver.
Under such circumstances the main substrate for this increased glucon­
eogenesis is amino acids derived from the breakdown of muscle protein 
(Exton et al., 1970). In the absence of insulin the rate of protein 
synthesis is depressed to allow a net breakdown of protein to amino 
acids, a process that is reversed by insulin. The latter stimulates 
the synthesis of protein and stems the net outflow of amino acids.
An understanding of the stimulation of net protein breakdown in 
starvation and diabetes has been hampered by our limited knowledge of 
the actual processes of protein degradation. Skeletal muscle, like 
many other tissues, contains soluble proteases, though at the moment 
these are poorly characterized. Some of these proteases have alkaline 
pH optima and may be involved in the turnover of myofibrils (Koszalka 
and Miller, 1960 a, b; Noguchi and Kandatsu, 1971; Dahlmann and 
Reinauer, 1978), while others are group specific and involved in apo- 
enzyme breakdown (Katunuma et al., 1975), An increase in the activity 
of an alkaline protease has been detected in the skeletal muscle of 
rats after treatment with glucocorticoids, in alloxan-diabetes, and in 
rats with hypoproteinaemia (Mayer, Amin and Shafrir, 1974). Treatment 
of diabetic rats with insulin depresses the increased alkaline proteolytic 
activity to normal level (RÜthig et al., 1978), Other soluble proteases
have optimum activity in the neutral pH range. An example of a protease
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of this type is the calcium-activated neutral protease that removes 
the Z bands from skeletal muscle (Kohn, 1969; Reddy et al., 1975).
However it is becoming increasingly evident that in many tissues the 
lysosomal proteases (generally characterized by acidic pH optima) are 
of major importance in protein catabolism. Recently studies have 
been directed towards determining the possible participation of lysosomes 
in the breakdown of intracellular muscle protein during normal protein 
turnover (Dean, 1975), as well as in conditions of physiological and 
pathological stress. A possible role for lysosomes in the mobilization 
of amino acids from skeletal muscle during starvation was suggested by 
an apparent increase in size of the lysosomes, together with a specific 
increase in the activity of the protease, cathepsin D, and certain other 
hydrolases (Canonico, and Bird, 1970). Other studies have implicated 
lysosomes in the loss of muscle protein in muscular dystrophies (Weinstock 
and lodice, 1969).
A special problem regarding protein degradation exists in skeletal muscle: 
this is the question of whether the different proteins of the myofibrils 
turn over as a unit. This is an attractive idea as it is difficult to 
envisage in muscle the independent turnover that operates in other cells 
(Dreyfus, Kruh and Schapira, 1960). Some studies have suggested that 
the myofibril has a definite life-span, supporting this idea (Zak, 
Ratkitzis and Rabinowitz, 1971). Other work, however, indicates that 
the different structural proteins of skeletal muscle turn over 
separately (MilTward, 1970; Koizumi, 1974; Zak et al., 1977),
The way in which insulin regulates protein turnover is of most
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relevance to the present work. It has been clearly shown that 
insulin decreases the release of some amino acids by the perfused rat 
hemicorpus (Jefferson et al., 1974) and by incubated rat diaphragm 
(Fulks et al., 1975). However, it is not clear whether the 
major effect of insulin on protein degradation is diiect, or if increased 
protein synthesis is mainly responsible for the diminished release of 
amino acids. Millward et al. (19 75) have emphasized the importance
of the rate of protein synthesis in determining the protein content of 
muscle. These investigators found that in rat skeletal muscle 
during rapid growth on a good diet, there is an increased rate of 
protein synthesis, associated with an increased rate of protein 
degradation. With age, however, the decline in the growth rate results 
from a fall in the rate of protein synthesis. This has been demonstrated 
in some experiments in vitro, where the activity of skeletal muscle 
ribosomes to synthesize protein was reduced with a concomitant decrease 
in the proportion of polysomes to total ribosomes (Srivastava and 
Chaudhary, 1969; Nakano and Sidransky, 1978). Starvation or induction 
of diabetes resulted in a rapid decrease in the rate of protein 
synthesis (Pain and Garlick, 1974). In these studies the turnover of 
heart proteins was more rapid than those of skeletal muscle and was 
affected less markedly by fasting or diabetes.
Other studies have suggested that lack of insulin increases protein 
degradation via lysosomal proteases. This has been shown most clearly 
in heart muscle (Morgan et al., 1974; Jefferson et al., 1974;
Rannels et al., 1975). Rat hearts that had been perfused for 3 hr 
in the absence of insulin, contained large membrane-limited vacuoles
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and showed increased rates of proteolysis. When the activity of the 
lysosomal enzyme, cathepsin D, was assayed in these studies, an increase 
in the extra-lysosomal activity was detected, although the total 
activity did not change (Rannels et al., 1975). This observation 
suggested that the lack of insulin stimulates the release of this enzyme 
from the lysosomes. Addition of insulin in physiological concentrations 
to the perfusate prevented or reversed these change s.,Proteolytic effects 
of insulin were also observed in both perfused rat skeletal muscle and 
incubated rat diaphragm preparations, although to a lesser extent than 
in heart muscle (Jefferson et al., 1974; Fulks et al., 1975),
One possible way in which insulin might prevent protein degradation is 
through an effect on the transport of amino acids into muscle, for it 
has been reported that the concentration of amino acids - in particular 
the branched chain amino acids - may regulate protein turnover. Thus, 
addition to rat diaphragms of branched-chain amino acids, at concentrations 
five times greater than in plasma^stimulated protein synthesis and 
reduced protein degradation (Fulks et al., 1975; Buse and Reid, 1975).
The mechanism by which the branched-chain amino acids regulate protein 
turnover is not clear and there is not yet evidence that this type of 
regulation occurs in vivo.
In the absence of insulin, the net breakdown of muscle protein may be 
due to the increased influence of other hormones. Thus glucocorticoid 
hormones have long been known to have net catabolic effects upon 
protein metabolism (Long et al., 1940), and increases in the levels of 
free amino acids in the muscle and plasma of animals receiving gluco­
corticoids have been reported (Friedberg and Greenberg, 1947;
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Betheil et al., 1965). Thyroid hormones may play an important role in 
the regulation of the basal protein turnover in skeletal muscle.
Although these hormones have well known effects in promoting protein 
synthesis in skeletal muscle, it is now clear that under certain 
circumstances they can also stimulate protein degradation, and may be 
responsible for the mobilization of body protein during starvation 
(Goldberg et al., 1977). It was found that thyroidectomy or hypo- 
physectomy decreased protein degradation in rat skeletal muscle.
Moreover, treatment of hypophysectomized rats with physiological doses 
of triiodothyronine or tetraiodothyronine increased protein degradation 
(Goldberg and Griffin, 1977). Other studies described an increase in 
the total cellular content of the lysosomal proteases, cathepsin D and 
cathepsin B, in liver and skeletal muscle of hypophysectomized rats 
upon treatment with thyroid hormones (De Martino and Goldberg, 1978). 
Finally it should be mentioned that glucagon may possibly play some part 
in protein degradation during starvation and diabetes. This hormone 
has been reported to increase protein degradation in liver (Deter, 1971). 
but it is not clear whether it has any similar effects on muscle.
The effects of insulin and lack of insulin on protein biosynthesis have 
so far been discussed with respect to their role in net protein break­
down in muscle, especially in relationship to the overall control of 
carbohydrate metabolism. However, the effect of insulin on muscle 
protein synthesis is important both to the overall protein metabolism of 
the animal and to the question of the mode of action of insulin on a 
process, the molecular details of which are much better understood 
than protein degradation (for reviews, see Lengyel, 1974; Weissbach 
and Pestka, 1977).
- 14 -
The effect of insulin on muscle protein synthesis is well documented. 
Sinex, MacMullen and Hastings (1952) were the first to demonstrate an 
effect of insulin upon the synthesis of protein; addition of the 
hormone to incubation media increasing the incorporation of (^^C)- 
labelled amino.acids into the proteins of the isolated rat diaphragm. 
Similar observations have been reported by other investigators (Krahl, 
1953; Manchester and Young, 1958; Wool and Krahl, 1959). This effect 
of insulin on protein synthesis in vivo and in vitro may be general, 
for it has been reported to affect - to an equal extent - all the 
proteins of rat heraidiaphragm which were resolved by discontinuous 
electrophoresis on non-denaturing polyacrylamide gels (Kurihara and 
Wool, 1968).
The effect of insulin on protein synthesis in skeletal muscle is 
independent of its action in facilitating the entry of glucose into 
the cell, for incorporation of labelled amino acids into muscle proteins 
is stimulated by insulin in the absence of glucose (Manchester and Young, 
1958; Wool and Krahl, 1959). However, insulin also stimulates the 
entry of amino acids into skeletal muscle; a process which is not 
secondary to an effect on protein synthesis, for it occurs with non­
utilizable amino acids and when protein synthesis is inhibited (Kipnis 
and Noall, 1958; Manchester and Young, 1960; Wool, Castles and Moyer, 
1965). This has led to considerable, and still unresolved, debate 
whether the effect of insulin on protein synthesis is an indirect 
consequence of its effect on amino acid transport (see e.g. Wool,
1968). Evidence against the effect of insulin on protein synthesis 
being secondary to that on amino acid transport was obtained by 
Manchester and Krahl (1959). They incubated rat diaphragm with a
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variety of -labelled carboxylic acids and bicarbonate in the
presence and absence of insulin, and observed that in each case insulin 
stimulated the incorporation of radioactivity from the several amino 
acid precursors into protein. As the labelled amino acids in this 
work would be synthesized intracellularly, the authors concluded that 
the stimulatory effect of insulin on protein synthesis is independent 
of its stimulation of the uptake of amino acids. Further evidence in 
favour of this viewpoint was provided by Kostyo (1964), who used 
sodium-free medium for his experiments, as this had been found to 
prevent the effect of insulin on amino acid uptake. He found that 
insulin stimulated glycine incorporation into protein, even in the absence 
of sodium ions. Although the evidence seems very strong, Hider, Fern 
and London (1971) have still argued against the viewpoint that the effect 
of insulin on protein synthesis is indirect.
The development of cell-free systems for performing protein synthesis 
in vitro was the impetus for attempts to anaylse the effect of insulin 
on protein synthesis at the molecular level. The first muscle cell- 
free systems used were from heart muscle, because of the relative ease 
of homogenization of this tissue (Rampersad and Wool, 1965). However 
the effect of diabetes on heart muscle protein synthesis is less marked 
than its effect on skeletal muscle protein synthesis (Wool, Rampersad 
and Moyer, 1966; Rannels et al., 1970), suggesting that the regulation 
of protein synthesis in these two types of muscle is different. Indeed 
there are detailed differences between the results obtained by Wool and 
co-workers in their experiments with cell-free protein synthesis by 
heart muscle and skeletal muscle ribosomes. Little further work was 
done on heart muscle, however, and it has been decided to concentrate
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here on reviewing the results obtained with skeletal muscle.
When ribosomes isolated from the skeletal muscle of alloxan-diabetic 
rats were assayed for their ability to catalyse protein synthesis 
in vitro, they incorporated about 50% less radioactive amino acids into 
protein than ribosomes derived from normal rats, or from diabetic rats 
after treatment with insulin (Wool and Cavicchi, 1967). The effect 
of insulin was seen when it was injected into the animals in vivo or 
added in vitro to intact muscle tissue, but insulin did not affect 
ribosome function when added directly to ribosomes in vitro.
These results suggested that the ribosomes from the muscle of normal 
rats contain more mRNA than those from diabetic rats. Further evidence 
consistent with this idea came from studies of polysomes. Analysis on 
sucrose density gradients of ribosomes extracted from the skeletal 
muscle of normal and diabetic rats revealed that the muscle of diabetic 
rats contains a smaller proportion of fast sedimenting species (polysomes), 
and greater proportion of light species (monomers and dimers), compared 
to the muscle of normal rats (Stirewalt, Wool and Cavicchi, 1967).
It is possible to envisage the difference in polysomes of ribosomes 
obtained from normal and diabetic rats in two different ways (Fig,1.2.1).
The ribosomes in the muscle of diabetic rats could either contain fewer 
polysomes (.and hence less mRNA) than those in normal rats, but with these 
polysomes being of a similar size to those of the normal (Model (i)); 
or could contain smaller sized polysomes in which fewer ribosomes are 
attached to the same number of mRNA molecules as in the normal (Model(ii)),It 
is not clear which, if any, of these alternatives is correct; although
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the observation of an increase in the number of ribosomal subunits 
in the skeletal muscle of diabetic rats (Rannels et al., 1970) tends 
to favour Model (ii), as this is consistent with a block in initiation 
which would be expected to lead to smaller polysomes (Lodish, 1971).
Model (ii) entails an equal amount of mRNA in the skeletal muscle of - 
normal and diabetic rats, implying that the effect of insulin on protein 
synthesis is modulated via translational rather than transcriptional 
control. Although insulin does increase transcription in skeletal 
muscle (Wool and Munro, 1963), and diabetes does reduce the total RNA 
content of muscle (Wool, Stirewalt and Moyer, 1968; Pain and Garlick, 
1974) and the number of ribosomes therein, there is indirect evidence 
that translational control is involved in the effect of insulin on the 
polysome profiles. Thus, administration of insulin to diabetic rats 
that had been pretreated with actinomycin D, in a concentration 
sufficient to block RNA transcription (Wool and Moyer, 1964), caused 
rapid reformation of polysomes and restoration of the activity of cell- 
free systems for protein synthesis (Stirewalt, Wool and Cavicchi, 1967). 
The speed with which insulin caused reformation of polysomes and 
restoration of the activity of cell-free systems for protein synthesis 
/(5 min with or without actinomycin D) was, in itself, strong circum­
stantial evidence for translational control. It should be pointed out 
that model (i) can also accommodate such translational control if 
there is non-polysomal mRNA sequestered somewhere in the cell.
The point at which the translational control was thought to operate 
was suggested by further cell-free experiments using added polyuridylic 
acid (polyU) as tenplate. When polyU was added in vitro to skeletal
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muscle ribosomes obtained from either normal or diabetic rats, it 
stimulated protein synthesis above that directed by the endogenous mRNA 
on the ribosomes. In the presence of excess polyU, the relative 
ability of ribosomes from normal and diabetic rats to synthesize poly­
phenylalanine was critically dependent on the magnesium concentration.
At lower magnesium concentrations (below an effective concentration of 
about 10 mM) ribosomes from the skeletal muscle of diabetic rats 
incorporated less (^^C) phenylalanine than those of normal rats; 
whereas at higher magnesium concentrations they incorporated more 
radioactivity than ribosomes from normal rats (Wool et al., 1968).
The relative translation of polyU by the ribosomes at high magnesium 
concentration was consistent with the idea (previously mentioned) that 
the ribosomes from diabetic rats contain less mRNA, and hence can bind 
more polyU, than those from normal rats. However the superiority of 
the ribosomes from normal rats at low (and presumably more physiological) 
magnesium concentration was taken to indicate that there was a defect 
in the ribosomes from diabetic rats, and it was suggested that this 
defect was responsible for the difference in content of mRNA of the 
ribosomes, as its reversal by insulin was also rapid and not prevented 
by actinomycin D (Wool and Cavicchi, 1966).
Wool and co-workers performed a series of experiments to try to 
elucidate the nature of this defect in ribosomes from diabetic rats 
for translating polyU at low magnesium concentration. They showed 
that the defect resided in the 60S subunit. Reconstituted 80S ribo­
somes or those containing 60S subunits from the skeletal muscle of
3diabetic rats incorporated less ( H) phenylalanine in the presence of
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polyU than reconstituted ribosomes from the skeletal muscle of normal 
rats at low magnesium concentration (Martin and Wool, 1968), They 
then proceeded to examine the activity of normal and diabetic ribosomes 
in the various partial reactions of protein synthesis. They found no 
difference in the activity of peptidyl transferase (which is located 
on the 60S subunit) in either 60S or 80S ribosomes from normal and 
diabetic rats (Stirewalt and Wool, 1970). Nor was there any difference 
in GTP hydrolysis catalysed by elongation factor-2 (Leader, Wool and 
Leader, 1970), nor in the non-enzymic binding of turnip-yellow-mosaic 
virus to the ribosomes (Rolleston, Wool and Martin, 1970).
3Further studies examined the polyU-dependent binding of ( H) phenyl-
alanyl-tRNA to reconstituted ribosomes from the 40S and 60S subunits of
. the
normal and diabetic rats, both in/absence (Wool and Rolleston, 1971; 
Castles, Rolleston and Wool, 1971), and in the presence of elongation 
factor-1 (Leader, Wool and Castles, 1971). In both of these studies 
it was found that at low magnesium concentration ribosomes from diabetic
3
rats bound less ( H) phe-tRNA than those from normal rats,and in the
latter study the difference persisted even in the presence of saturating
amounts of elongation factor-1. At high magnesium concentration, on
3the other hand, the binding of ( H) phe-tRNA was greater in the ribosomes
from diabetic rats. However these same studies showed that the superior
3ability of normal ribosomes to bind C H) phe-tRNA at low magnesium
concentration was not due to an intrinsic difference in ribosomes, but
merely to a difference in the amount of pre-existing peptidy1-tRNA
on the 60S ribosomal subunits. This emerged from analysis of the
3products after alkaline hydrolysis of the ( H) species bound to the 
ribosomes. At the high magnesium concentration the product was, as
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3expected, mainly ( H) phenylalanine; but at the low magnesium con­
centration the product was a peptide derived from unlabelled peptidyl- 
tRNA linked to a C-terminal radioactive phenylalanine residue (Castles, 
Rolleston and Wool, 1971; Leader, Wool and Castles, 1971), From 
these studies it appeared that, at low concentrations of magnesium, 
phe-tRNA binds only to the acceptor site of ribosomes carrying peptidyl- 
tRNA in the P site, with the subsequent formation of a peptide bond 
between the two species. This would be because at low magnesium con­
centrations little or no initiation of the synthesis of peptide chains 
is possible either non-enzymically or with elongation factor-1, These 
conclusions were supported by other data. Thus, in these same studies, 
it was found that puromycin treatment of the ribosomes (to remove the
endogenous peptidyl-tRNA) caused a vast reduction in their ability to 
3bind ( H) phe-tRNA and abolished the difference between the binding to
ribosomes from normal and diabetic rats. Moreover Stirewalt, Castles
and Wool (1971) showed that some peptidyl-tRNA does remain on dissociated
60S ribosomal subunits (consistent with the location of the apparent
defect); and a difference in the amount of residual peptidyl-tRNA on
ribosomes from the muscle of normal and diabetic rats was also consistent
with previous experiments in which ribosomes showed a different capacity 
3to react with ( H) puromycin (Wool and Kurihara, 1967),
3These studies, then, showed that the decrease in binding of ( H) phe-tRNA to 
ribosomes extracted from the skeletal muscle of diabetic rats, at low magnesium 
concentrations, results from a decreased amount of endogenous peptidy1-tRNA 
on the ribosomeso The latter obviously reflects the decreased protein 
synthetic activity occurring on skeletal muscle ribosomes of diabetic rats 
in vivo. Thus the problem of the mechanism of the apparent
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translational control of protein synthesis in the skeletal muscle of 
normal and diabetic rats in vivo, still remained. All that had 
been achieved was the finding of no intrinsic difference in the activity 
of ribosomes from normal and diabetic rats, consistent with comparison 
of their RNAs (Wool, Stirewalt and Moyer, 1968) and proteins (Low, Wool 
and Martin, 1969; Leader, Coia and Fahmy, 1978).
It must, however, be mentioned that, subsequent to the work described 
above, there have been renewed claims of an intrinsic functional 
difference in normal and diabetic ribosomes, even when these had been 
treated with puromycin-. It was claimed that ribosomes containing
60S subunits from the muscle of diabetic rats translated mRNA from
encephalomyocarditis virus at a slower rate than ribosomes containing 
60S subunits from the muscle of normal rats (Wool, 1972). Furthermore
60S subunits from the muscle of diabetic rats were less effective in
forming 80S couples, and the 80S ribosomes more susceptible to 
dissociation by initiation factor-3, than subunits or 80S ribosomes from 
normal rats (Wettenhall, Nakaya and Wool, 1974; Nakaya, Ranu and Wool, 
1974).
In view of the artifactual nature of the previously claimed diabetic 
ribosomal 'defect’, these results should be treated with some caution, 
especially as they were published in short communications which have 
not been followed up. Thus, although puromycin releases the peptide 
from peptidyl-tRNA, it is still possible that deacylated tRNA remains 
on the ribosomes (Wettenhall, Wool and Sherton, 1973); and this might 
influence certain of their activities. It is also worth pointing out 
that in none of these studies was it demonstrated that the supposed
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defect was reversed by treatment with insulin.
Whether or not the ribosomes of the skeletal muscle of diabetic rats 
are modified, the results described earlier in this section provide 
fairly strong evidence that the, undisputed, alteration in protein 
synthesis may be modulated by translational control. However, because 
of the indirect nature of this evidence it seemed important to try to 
examine the question more directly; and this was the principal 
objective of the work described in this thesis. The approach adopted 
was to characterize the mRNA in the skeletal muscle of normal and 
diabetic rats and diabetic rats treated with insulin. As a background 
to this, some features of eukaryotic mRNA and the control of its trans­
lation are considered in the following sections of this Introduction.
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1.3 EUKARYOTIC MESSENGER RNA
In living cells the genetic information encoded in the sequence of bases 
in the double helix of DNA is transcribed into a complementary sequence 
of RNA bases to form the molecule known as messenger RNA (mRNA), which 
is subsequently translated into protein.
The initial discovery of mRNA was made in bacterial cells. Hershey,
Dixon and Chase(1953) observed that when E .coli cells were infected with 
T-even bacteriophages, bacterial DNA transcription stopped and new DNA 
molecules were formed. Hall and Spiegelman (1961) concluded from 
hybridization reactions that the RNA synthesized after infection was a 
T-even specific RNA, The concept that this newly synthesized RNA con­
stituted a messenger between the DNA and the sites of protein synthesis 
was postulated by Jacob and Monod in 1961. These and other investigators 
showed that the viral-induced RNA became attached to pre-existing ribo­
somes but was metabolically much less stable than 16S and 23S rRNA,
The presence or absence of certain inducer molecules in rapidly growing 
bacteria, causes rapid alterations in the rate of synthesis of certain 
proteins. This rapid response to environmental changes has been shown 
to reflect rapid turnover of bacterial mRNAs which have been found to 
have half-lives of a few seconds to several minutes. In prokaryotic 
organisms, transcription is tightly coupled to translation, for association 
of mRNA with ribosomes, synthesis of polypeptide chains and degradation 
of mRNA may all begin before mRNA synthesis is completed (Adesnik and 
Levinthal, 1970).
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Early attempts to identify mRNA in eukaryotes centred mainly on the 
nucleus and employed various criteria, none of which was totally satis­
factory, For example, rapidity of labelling and relative instability 
compared to other types of RNA (Penman et al. 1963), heterogeneous 
sedimentation pattern (Henshaw et al., 19.65) and possession of a "DNA- 
like" base composition (Davidson, 1969), were all taken to be characteristics 
of mRNA. Progress came when investigations shifted from looking for mRNAs 
in the nucleus to the polysomes (Warner, Knopf and Rich, 19.63) in the cyto­
plasm, where mRNA directs the incorporation of amino acids into proteins. 
Although RNA active in stimulating the incorporation of amino acids into 
protein was found within polysomes (Singer and Leder, 1966; Noll, 1969), 
unequivocal evidence for a functional mRNA required the translation of 
the RNA into a specific protein product. This required a heterologous 
cell-free system for the translation of the mRNA and satisfactory subsequent 
characterization of the protein product. Perhaps the first such unambiguous 
translation of a specific eukaryotic mRNA was by Lockard and Lingrel (1969). 
They translated mouse globin mRNA in a crude lysate from rabbit reticulocytes 
The synthesis of mouse globin g-chains was demonstrated by carboxymethyl 
cellulose chromatography of the cell-free product to distinguish the mouse 
globin from endogenous rabbit globin.
The reticulocyte lysate was subsequently used for translation of a wide 
variety of eukaryotic mRNAs such as immunoglobulin light chain (Stavnezer 
and Huang, 1971), myosin (Rourke and Heywood, 1972) and ovalbumin 
(Comstock et al., 1972) mRNAs. Although this cell-free system translates 
exogenous mRNA at a rapid rate, it suffers the presence of large quantities 
of endogenous (mainly globin) mRNA which compete with exogenous mRNA for
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translation and dominate the products obtained.
Several other cell-free systems were therefore developed, the first being 
the Krebs II ascites tumour cell-free system (Mathews and Korner, 1970). 
Several m M A s  have been faithfully translated in ascites cell-free systems, 
e.g. lens crystallin mRNAs (Mathews et al., 1972) and his'tone mRNAs 
(Jacobs-Lorena, Baglioni and Borun, 1972). Although this system has a 
low endogenous activity, and allows high levels of incorporation of radio­
activity, it is low in translational efficiency relative to the reticulo­
cyte lysate (Osborn and Mathews, 1974). Furthermore, a major disadvantage 
of this system is the production of incomplete polypeptide chains either by 
premature termination or by nuclease cleavage of the itiENA (see, for 
example, Swan, Aviv and Leder, 1972).
Another cell-free system, which has some advantages over the ascites system, 
is the wheat germ cell-free system (Marcus, 1972; Roberts and Paterson, 
1973)., A wide variety of viral and eukaryotic mRNAs have been translated 
with fidelity in the wheat germ system, and high molecular weight products, 
such as the rat preproinsulin CChan, Keim and Steiner, 19 76), have been 
obtained. Unfortunately, the wheat germ system may also suffer from 
premature termination of translation, especially with longer mRNAs (see, 
for example, Burstein et al,, 1976), and different batches of germ show 
considerable variation in activity (Marcu and Dudock, 1974).
The use of an intact whole cell, the oocyte of Xenopus laevis for 
translation of exogenous mRNA was pioneered by Gurdon and co-workers
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(Lane, Marbaix and Gurdon, 19.71), In this system amounts of purified 
mRNA as low as 1 ng can be injected and efficiently translated, sometimes 
for several days. Although there is much greater stability of mRNA in 
this system, it requires considerable technical proficiency to perform 
the injection, thus limiting its general use.
Recently Pelham and Jackson (1976) described a modification of the 
reticulocyte lysate system, which eliminates its high endogenous activity 
allowing easy detection of exogenous mRNA, This involves preincubation 
of the lysate with micrococcal nuclease Ca calcium-requiring enzyme), 
followed by addition of an excess of a calcium^chelating agent to inactivate 
the nuclease and allow subsequent translation of exogenous mRNA,
The use of the cell-free systems, described above, to identify eukaryotic 
mRNAs was the first step in the characterization of the latter, and now 
much is known of the structure of eukaryotic mRNAs, In contrast to 
bacterial mRNAs which are polycistronic, eukaryotic mRNAs appear to be 
monocistronic containing no multiple initiation sites and coding for only 
one polypeptide. In addition to the coding sequence, eukaryotic mRNAs 
generally contain extra nucleotides at both the 5’-^and 3’-ends of the 
molecules. Most eukaryotic mRNAs possess at their 3*-end a sequence of 
50-200 polyadenylate residues (Brawerman, 1974),. Exceptions identified 
to date include histone mRNAs CSchochetman and Perry, 1972b),about 30% of 
HeLa cell mRNAs (Milcarek et al,, 1974) and certain sea urchin embryo mRNAs 
(Nemer et al,, 1974), In polyAC+lRNAs the polyA region does not have a 
discrete size, but a range of different sizes are found to exist for a given 
mRNA, Moreover, no correlation appears to exist between the mRNA size and
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the average size of its polyA region.' Thus, Mondai et al. (1974) found 
no relationship between the size of polyA sequences in different sized 
mRNAs from different size-classes of chick embryonic muscle polysomes.
Sequence analysis has shown that rabbit g-globin mRNA consists of a 
coding region of 438 nucleotides, flanked by a 5'-non-coding region of 
56 nucleotides and by a 3'-non-coding region of 95 nucleotides (Efstratiadis 
et al,, 1977), in addition to the 3'-terminal polyA region. Chicken 
ovalbumin mRNA is 1,860 residues long, excluding the polyA region; and 
while the coding sequence is close to the 5*-end, it is 637 nucleotides 
from the 3'-end (McReynolds et al,, 1978), Sequence analysis of nucleotides
adjacent to the 3'-terminal polyA regions in six mRNAs (rabbit and human 
a- and 3-globins, mouse immunoglobulin light-chain, and chicken ovalbumin) 
revealed regions of sequence homology, the most rigidly preserved one being 
the hexanucleotide AAUAAA at between 14 and 20 nucleotides from the start 
of the polyA region. The function of this sequence is unknown, but has been 
suggested to serve as a signal for termination of transcription (Proudfoot, 
Cheng and Brownlee, 1976),
Most eukaryotic mRNAs possess at their 5*-end a modified 'cap' structure, 
having the general form m^GC5')pppC5*)Xp (Fig, 1,3,1), the terminal 
7-methylguanosine (m^G) and the penultimate nucleotide being joined by 
their 5^-OH groups through a triphosphate bridge (for review, see 
Shatkin, 1976), Three types of cap structure have been identified: 
type 0 (m^G(5’)ppp(5')X), type 1 (m^G(5*)ppp(5’)XmY) and type 2 (m^G(5') 
ppp(5’)XmYmZ), differing in the number of 2'-0-methylated penultimate 
nucleotides. Cap structure type 2 probably arises by a secondary
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méthylation of the mRNA in the cytoplasm (Perry and Kelley, 1976), whereas 
types 0 (found in some viruses and lower eukaryotes such as yeast and 
slime mould) and 1 are thought to arise in the nucleus (see below). In 
addition to the 5 ^methylated nucleotides, internal methyl^adenine 
residues (m^Ap) and smaller amounts of methyl^cytosine (m^Cp) have been 
demonstrated in mRNAs of some eukaryotes (see, for example, Desrosiers, 
Friderici and Rottman, 1974).
There is some evidence that eukaryotic mRNAs contain a large degree of 
secondary structure. Thus globin mRNA normally migrates on poly­
acrylamide gels as a diffuse band but in the presence of formamide it 
migrates as a sharp band (hanyon et al., 1972); and ovalbumin mRNA 
sediments at about 15S, but migrates on polyacrylamide gels more slowly » 
than 18S rRNA (Palacios et al., 1973).
It is thought that the mRNA in eukaryotes is derived by post-transcriptional 
modification of larger RNA precursor molecules, known as heterogeneous 
nuclear RNA, HnRNA, (see, for example. Lewin, 1975). HnRNA molecules are 
generally larger than cytoplasmic mRNA molecules (between 5,000 and 50,000 
nucleotides), with sedimentation values ranging from 10 to 90S (Penman 
et al., 1968), and constitute about 1% of total cellular RNA in HeLa cells 
(Darnell, 1968). They are characterized by rapid labelling kinetics, and 
the majority of these molecules (up to 90%) never enters the cytoplasm.
This implies a rapid rate of turnover, and half-lives of 5-60 min have been 
estimated for HnRNA in the nucleus. Due to the rapid decay rate of HnRNA, 
and to difficulties with radioactive pulse-chase experiments, it has not 
been possible to establish a direct precursor-product relationship between
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HnRNA and mRNA, However, both types of molecules share some common
characteristics which suggest that cytoplasmic mRNA is derived from the
nuclear HnRNA. These characteristics include insensitivity of synthesis
to low concentrations of actinomycin D, and the presence of a polyA
sequence about 200 bases long at the 3'-end of the molecule (Edmonds et al.,
1971). Perry et al. (1975a) reported a sequence homology of 20-30%
between HnRNA and mRNA in mouse L cells. Melli and Pemberton (1972)
have used complementary to purified globin mRNA (prepared in vitro
polymerase
using the enzyme jytLcrococcus lysodeiktious RNA- / ) to demonstrate that
globin messenger sequences are present in duck reticulocyte HnRNA. Also 
studies of HnRNA of mouse L cells indicate that these molecules contain 
5’-caps (Type 1) and internal N^ methylated adenine residues (Perry et al., 
1975b).
The presence of the 5'-cap structure and the 3'-polyA region in both HnRNA 
and mRNA posed the problem of how the larger HnRNA molecules could possibly 
be precursors of the smaller mRNA molecules. An answer to this problem 
was suggested when it became apparent that non-coding 'intervening sequences' 
interrupt the coding regions in the genes for several mRNAs (Jeffreys and 
Flavell, 1977; Brack and Tonegawa, 1977; and Tilghman et al., 1978a).
It would clearly be possible to explain the characteristics of the HnRNA, 
mentioned above, if these intervening sequences were transcribed and only 
later cleaved from the RNA, which would be re-spliced giving the mRNA.
Such a mechanism has recently gained support from the hybridization of the 
15S RNA precursor of mouse 6-globin mRNA to a mouse 6-globin gene containing 
an intervening sequence of 550 base pairs (Tilghman et al., 1978b).
Only 20-40% of HnRNA molecules contain a polyA segment, and nuclear polyA 
is not quantitatively converted to cytoplasmic polyA, for some of this
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polyA is degraded in the nucleus (Jelinek et al., 1973). In the nucleus 
polyA synthesis occurs post-transcriptionally by stepwise addition of 
adenylate residues to HnRNA. Thus, actinomycin D does not inhibit the 
synthesis of polyA (Darnell et al., 1971), and there is no polydT tract 
in the DNA sequence of the mouse g-globin gene (Konkel, Tilghman and 
Leder, 1978). PolyA synthesis can also occur in the cytoplasm by 
addition of adenylate residues to pre-existing polyA in mRNA. This has 
been demonstrated in sea urchin embryos immediately after fertilization 
(Slater et al., 1973).
Heterogeneous nuclear RNA has been found to be complexed with proteins 
(for review see Van Venrooij and Janssen, 1978). While the exact function 
of these proteins is not yet clear, it is possible that they may be involved 
in the protection, stabilization and processing of the RNA during its 
transport from the nucleus to the cytosplasm. Messenger RNA in the cyto­
plasm has also been found complexed with proteins in messenger ribonucleo- 
protein particles, mRNPs (for review see Williamson, 1973) and these are 
presumed to derive from the complexes of HnRNA and protein. The mRNA in 
polysomes is also complexed to non-ribosomal proteins, and polysomal mRNP 
particles can be released by treatment of polysomes with magnesium chelating 
agents such as EDTA (Huez et al., 1967). Although the role of the protein 
associated with polysomal mRNA is not yet known, it is possible that it 
protects the polyA region from ribonuclease digestion (Blobel, 1973).
In contrast to prokaryotic mRNA, eukaryotic mRNA is relatively stable.
This can be deduced from the prolonged synthesis of globin in reticulocytes 
where no functional nucleus exists (Marks et al., 1962), the prolonged
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translation of mRNA injected into frog oocytes {Gurdon, 19731 and from 
the early development of sea urchin embryos where protein synthesis utilizes 
preformed maternal mRNA CGross and Cousineau, 1964), The half-life of 
reticulocyte globin mRNA in the anaemic mouse was estimated to be approx. 
15-17 hr (Hunt, 1974), and in HeLa cells two separate classes of mRNAs 
with half-lives of 7 and 24 hr have been reported {Singer and Penman,
1973), although another study reported a half-life of several days (Murphy 
and Attardi, 1973).
The functional significance of polyA has not yet been established. It 
has been suggested that polyA is required for the transport of mRNA from 
the nucleus to the cytoplasm, for studies with cordycepin showed that 
inhibition of polyA synthesis also prevents the appearance of mRNA in the 
cytoplasm (Weinberg, 1973), Clearly the existence of some mRNAs which 
lack polyA, would argue against this idea unless there were a separate 
mechanism for the transport of these mRNA molecules from the nucleus to the 
cytoplasm. Some evidence for such a distinct transport mechanism emerges 
from the observations that polyA(+)RNA molecules enter into the cytoplasm 
after a delay of 15-20 min, whereas histone mRNA, which lacks polyA,is 
rapidly transported to the cytoplasm (Adesnik and Darnell, 1972).
PolyA does not appear necessary for translation of mRNA in cell-free systems,
for histone mRNAs are actively translated in Krebs ascites systems {Gross
et al,, 1973), and deadenylated rabbit globin mRNA is translated in several 
a
cell-free systems with the same efficiency as intact globin mRNA (Sippel 
et al., 1974). However, polyA may act to stabilize the mRNA molecule by 
protecting the 3'^terminus from ribonucleolytic attack. Deadenylated globin
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mRNA appears to be much less stable than adenylated globin mRNA for 
translation in Xenopus oocytes (Huez et al., 1974), and reinitiation of 
translation of deadenylated ovalbumin mRNA was also found to be much less 
efficient than that of polyadenylated ovalbumin mRNA (Doel and Carey,
1976). In HeLa cells the polyA sequence that initially appears in the 
cytoplasmic mRNA appears to have the same size (200 nucleotides) as the 
polyA in HnRNA (Greenberg and Perry, 1972). However, in the cytoplasm 
the polyA sequence becomes progressively shorter as the mRNA ages 
(Sheiness and Darnell, 1973). In view of the shortening of the size 
of polyA with time, it has been suggested that there is a minimum length 
of polyA that is critical for mRNA stability, and the eventual loss of 
this would leave the RNA chain vulnerable to exonucleases (Brawerman, 1973). 
However, it is not yet clear whether the degradation of mRNA proceeds by 
progressive exonucleolytic attack, or by multiple endonucleolytic cleavage 
at specific internal sites. Moreover, it has been pointed out that mRNA 
decays in an exponential fashion, which would imply that every molecule 
(young and old) is equally susceptible to inactivation (Perry and Kelley, 
1973).
The function of the 5 ’-cap structure is also not completely clear. There 
is some evidence indicating that it is involved in the formation of mRNA-
ribosome complexes and consequently in the initiation of protein synthesis.
7 7 7Cap analogues such as m Gp, m GTP and m GpppXm have been shown to inhibit 
ribosomal binding and translation, of several viral and cellular capped 
mRNAs in eukaryotic cell-free systems in vitro (.see, for example, Canaani, 
Revel and Groner, 1976; Suzuki, 1976). Shafritz et al. (1976) have 
reported that m^Gp inhibits directly the interaction of eukaryotic initiation
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factor eIF-4B with capped vesicular stomatitis virus mRNA and HeLa histone 
mRNA, but not with encqjhalomyocarditis virus RNA which lacks the 5’-cap 
structure. On the other hand, it was found that decapping of some viral 
mRNAs (e.g. vesicular stomatitis virus) and cellular mRNAs (e.g. globin 
mRNA) did not preclude their translation in cell-free systems (Rose and 
Lodish, 1976; Held, West and Gallagher, 1977). This - together with the 
absence of 'cap’ from encephalomyocarditis RNA - argues against the necessity 
of cap for translation. The 5'-cap structure may contribute to the stability 
of those mRNAs in which it occurs, by protecting the 5 '-end of the mRNA 
from exonucleolytic attack. Thus reovirus mRNAs with blocked 5'-termini 
were found more stable than unblocked mRNAs when injected into oocytes or 
when translated in cell-free systems (Furuichi et al., 1977),
The functional significance of the modified methyl^adenosine and methyl^cytidine 
residues that are found in some eukaryotic mRNAs is much less clear than that 
of the polyA region and the 5'-cap. It has been suggested that such residues 
constitute recognition sites for RNA processing and/or splicing enzymes, or 
that they have a function in translation (Derman and Darnell, 1974); but 
there is no evidence to support these ideas.
In the last ten years there has been a vast increase in work on mammalian 
mRNAs. It is therefore worthwhile considering the different preparation 
methods that have made this possible. A mRNA-rich preparation is usually 
derived from the RNA extracted from polysomes with phenol, chloroform and a 
buffer containing sodium dodecyl sulphateo It has been observed that 
during phenol extraction of polysomes at neutral pH or a relatively high 
concentration of mono- or divalent cations, the polyA sequences tend to
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aggregate non-specifically with the denatured proteins at the interphase 
layer between the organic and the aqueous phases (Brawerman et al., 1972), 
Inclusion of chloroform in the extraction medium prevents this aggregation 
(Perry et al., 1972).
Several procedures have been established for purification of mRNA. One 
of the earliest involved the sedimentation of the RNA through a sucrose 
density gradient to separate the mRNA from the rRNA, This technique 
proved to be useful in isolation of mRNAs from differentiated cell types 
synthesizing predominantly one protein and having a mRNA with a different 
S value from the rRNA (e.g. immunoglobulin light chains in myeloma cells, 
a- and 3-haemoglobins in reticulocytes, and ct-crystallins in the lens of the 
eye). Messenger ribonucleoprotein particles (usually released from poly­
somes by EDTA treatment) often sediment in a sucrose gradient'at regions 
that are distinct from the other RNA species, and have therefore been used 
as a source of mRNA (see, for example, Lingrel et al. , 1971; Bems and 
Bloemendal, 1974).
Electrophoresis of RNA in gels containing polyacrylamide or agarose has 
been used to separate RNA species and estimate their molecular weights 
(Bishop et al., 1967). More recently electrophoresis in gels containing 
formamide has been used to separate and recover a- and 3-globin mRNAs 
(Gould and Hamlyn, 1973).
The existence of the polyA sequence at the 3’-end of most eukaryotic mRNAs, 
however, has provided the most useful and generally applicable tool for the 
isolation of mRNA from other RNA species. PolyA and polyA-containing mRNA
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can be adsorbed on nitrocellulose filters at high ionic strength, and 
eluted in salt-free buffer (Brawerman et al., 1972), The length of the 
polyA sequence must be at least 50-60 nucleotides to be adsorbed to the 
nitrocellulose filters. PolyA can also be adsorbed on glass-fibre filters 
to which polyU has been coupled by ultraviolet irradiation (Sheldon et al., 
1972). However, affinity chromatography on columns prepared by cross- 
linking synthetic homopolymers to a supporting matrix (e.g. oligo dT- 
cellulose; polyU-sepharose), has been the most widely used method of 
isolating polyA-containing mRNAs (see, for example, Aviv and Leder, 19 72; 
Adesnik et al., 1972).
Immunoprécipitation is useful in separating specific mRNAs from a mixture 
of other mRNAs. Purified antibodies to the protein whose mRNA is to be 
extracted are added to the isolated polysomes, leading to a specific antigen- 
antibody reaction and consequent precipitation of the desired polysomes.
This method has been adopted in the isolation of catalase - and serum 
albumin - synthesizing liver polysomes (Uenoyama and Ono, 1972),
Other methods of obtaining preparations which are rich in specific mRNAs 
are available under certain circumstances. For example, histone mRNAs 
can be obtained from cultured mammalian cells during the period of DNA 
synthesis, or from sea urchin embryos in the early embryonic stages where 
a class of small polysomes engaged in histone synthesis predominates 
(Robbins and Borun, 1967; Kedes and Gross, 1969). Moreover, the synthesis 
of some mRNAs can be induced by specific hormones, for example, the 
synthesis of avidin mRNA in hen oviduct is induced by progesterone (O’Malley 
et al., 1972), and the synthesis of ovalbumin mRNA in chick oviduct is
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induced by oestrogen (Rhoads, McKnight and Schimke, 1971).
The concern of the work described in this thesis is with mRNA from adult 
skeletal muscle. It is therefore of relevance to consider what is known 
of muscle mRNAs, Most of the work to date concerned with muscle mRNAs has 
been conducted on embryonic muscle, particularly chicken, and on embryonic 
muscle cell cultures. Although the muscle contractile proteins myosin, 
actin, tropomyosin and troponin are now well characterized, only the mRNA 
of myosin heavy chain and that of actin have been extensively studied. The 
successful isolation of myosin heavy chain mRNA relied strongly on its 
large size, which enabled its separation from the bulk of cellular messengers 
Heywood and Nwagwu (1968, 1969) isolated from polysomes of embryonic chick 
muscle a fraction of RNA sedimenting at 26S, which when added to cell-free 
systems directed the synthesis of the large subunit of myosin. When this 
RNA fraction had been separated from rRNA, its migration on gel electro­
phoresis indicated a sedimentation coefficient of 32S (Morris et al., 1972). 
Similar results were obtained by Sarkar et al. (1973) and Mondai et al. 
(1974), who also found that the polyA region of myosin heavy chain mRNA 
consists of about 170 nucleotides. Later studies (Heywood, Kennedy and 
Bester, 1975; Bag and Sarkar, 1976) reported the isolation of myosin mRNA 
from cytoplasmic 'free' ribonucleoprotein particles (not derived from 
polysomes). The criterion of size could not be exploited to isolate 
actin mRNA, and so work on this has not involved such pure material as for 
studies on myosin mRNA. Bag and Sarkar (1975) have found actin mRNA in 
cytoplasmic non-polysomal mRNP particles in chicken embryonic muscle. Other 
studies showed that an 8-12S fraction obtained from small polysomes of 19- 
day embryonic chick red muscle was able to direct the synthesis of myoglobin
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in a homologous cell-free system (Thompson, Buzash and Heywood, 1973). 
Several experiments suggest that in muscle cells the majority of messengers
q
contain polyA. Kaufman and Gross (1974), using hybridization with ( H) 
polydT, estimated that most mRNA in the polysomes of fused myotubes contains 
polyA. Whalen and Gros (1978) have reported that the great majority of 
mRNA from either prefusion or postfusion cultures of foetal calf myoblasts 
was polyA(+)RNA; quantitative determinations showing that about 70-90% 
of the actin mRNA is polyA(+)RNA. It is of interest in this respect to 
mention that multiple genes have been found for actin (Elzinga et al.,1976), 
and Whalen, Butler-Browne and Gros (1976) found that calf embryo muscle 
cells contain a-(muscle specific), and 6- and y-actins (also found in non­
muscle cells). It appears that a- and y-actin mRNA molecules are poly­
adenylated, whereas g-actin mRNA possesses a continuous spectrum of polyA 
lengths, some of which are very short (Hunter and Garrels, 1977).
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1.4 TRANSLATIONAL CONTROL OF EUKARYOTIC PROTEIN SYNTHESIS
In prokaryotes/ control of the rate of protein synthesis generally 
occurs at the stage of transcription, and indeed transcription and 
translation are tightly coupled. In eukaryotes, however, the messenger 
RNA is much longer lived (Singer and Penman, 19 73) and the sites of 
transcription and translation are separated by the nuclear membrane.
It might therefore be advantageous for the eukaryotic cell to be able to 
control directly the rate of protein synthesis, and indeed there is 
evidence for several types of translational control.
There are a number of metabolic circumstances which cause a decrease in 
the rate of protein synthesis, disaggregation of polysomes and con­
comitant appearance of inactive monosomes in the cytoplasm. When the 
cells are returned to normal conditions, the cytoplasmic monosomes re­
enter polysomes and protein synthesis resumes.. This occurs rapidly, 
and in the presence of actinomycin D, suggesting that pre-existing mRNA 
is being used, and that control is being exerted at the translational 
stage.
The first example of this type of control is when mammalian cells are 
deprived of one of the essential amino acids, leading to a block in the 
initiation of protein synthesis (Vaughan et al., 1971), and a breakdown 
of polysomes (Lee et al., 1971). It has been suggested that amino acid 
starvation might affect the charging of tRNA which in turn blocks the 
initiation of protein synthesis. Other examples of this type of control 
include serum deprivation of cultured cells (Hassell and Engelhardt, 1973), 
the arrest of protein synthesis at mitosis (Fan and Penman, 1970), the
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control of globin synthesis by haerain (Zucker and Schulman, 1968), and 
the inhibition of the initiation of globin synthesis in reticulocyte 
lysates by double-stranded RNA (Ehrenfeld and Hunt, 1971) or by oxidized 
glutathione (Kosower et al., 1972).
Apart from the case of insulin and skeletal muscle, discussed in detail 
in section 1.2, above, there is some evidence that other hormones may 
also exert translational control of protein synthesis. Examples are 
the effects of adrenocorticotrophic hormone on adrenal protein synthesis 
(Garren et al., 1965); thyroid stimulating hormone on thyroid protein 
synthesis (Lecocq and Dumont, 1972) and growth hormone on liver protein 
synthesis (Barden and Korner, 1972).
A common mechanism of controlling protein synthesis has recently been 
elucidated for some of the above examples. In reticulocyte lysates, 
incubated without addition of haemin, protein synthesis proceeds for few 
minutes and then suddenly stops. Fractionation of the reticulocyte 
supernatant led to the isolation of a protein that is responsible for 
the inhibition of protein synthesis in the absence of haemin. This is 
a cyclic AMP-independent protein kinase, the substrate of which is the 
smallest subunit (mol.wt, 35,000) of the initiation factor, eIF-2 
(Farrell et al., 1977; Farrell et al,, 1978). The inhibitor is formed 
from a proinhibitor by an unknown mechanism (Maxwell et al., 1971) and 
it catalyses the incorporation of one to two phosphate groups into each 
molecule of eIF-2, In crude systems, it has been shown that the cyclic 
AMP-independent repressor inhibits the formation of the {eIF-2 . met-tRNA^ 
GTP . 403} ribosomal complex in the presence of ATP. Despite extensive
- 42 -
circumstantial evidence that the phosphorylation of eIF-2 was responsible 
for the inhibition of protein synthesis', phosphorylated eIF-2 was as 
active as unphosphorylated eIF-2 in cell-free assays for the formation 
of the 40S initiation complex. Recently, however, another factor has 
been isolated that stimulates the activity of elF-r2, Phosphorylation 
of eIF-2 abolishes the effect of the stimulating factor (Ranu et al.,
19 78; De Haro and Ochoa, 1978), suggesting a molecular explanation for 
the inhibition of protein synthesis in vivo. A similar mechanism for 
inhibiting protein synthesis appears to operate in reticulocyte lysates 
following the addition of double-stranded RNA (Farrell et al., 1977), 
or oxidized glutathione (Clemens et al., 1975), although distinct protein 
kinases are involved. This type of control is not restricted to reticu­
locytes, as it also appears to occur in other cells (Clemens et al., 1975)
There are some other examples of translational control which fall outside 
the general scheme outlined above. One such example entails an aspect 
of the antiviral state induced by interferon treatment. Exposure of 
viral-infected cells to interferon prevents the translation of viral mRNA 
while the translation of host mRNA is not affected (Yakobson et al., 1977) 
The mechanism by which interferon exerts this effect has not yet been 
clarified. There are a number of different effects on the protein 
synthetic machinery but none of them can easily explain the specificity 
of interferon against viral protein synthesis. These effects include 
the déacylation of leu-tRNAs (Sen et al,, 1976), the inhibition of mRNA 
méthylation and capping (Sen et al,, 1977), the activation of an eIF-2 
protein kinase - enhanced by preincubation of the cells with double­
stranded RNA - and the phosphorylation of a ribosome-associated protein
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of 67,000 mol, wt. (Revel et al,, 19771. A heat-stable small molecular 
weight inhibitor of. translation has recently been isolated from the cell 
sap of interferon-treated cells. This has been identified as an oligo­
nucleotide, pppAC2’)p(5’lA(2^)pC5')A, (Kerr and Brown, 1978) which is 
synthesized from ATP by a large thermolabile enzyme requiring double­
stranded RNA, This small oligonucleotide activates a ribonuclease 
(Ratner et al,, 1977; Schmidt et al,, 19781, but this is active against 
host mRNAs as well as viral mRNAs, Moreover it has been observed that 
when interferon is given to cells infected with SV40 virus, the translation 
of the viral mRNA stops and no degradation of the untranslated mRNA 
occurs (Yakobson et al., 1977). Because attempts, so far, have failed to 
reveal an interferon-induced inhibitor that is specific for viral protein 
synthesis in vitro, it has been suggested that there is no such inhibitor, 
but the very features (whatever these may be) that give viral protein 
synthesis a selective advantage in vivo also make this more vulnerable 
than host protein synthesis to the action of the inhibitor(s) induced by 
interferon (Metz, 1975).
Clearly the inhibitory effects of different viruses on host cell protein 
synthesis need not, and probably do not, operate by a common mechanism. 
Attempts to elucidate the mechanism of inhibition in encephalomyocarditis 
virus infection have had some success. It has been found that the 
encephalomyocarditis viral RNA out-competes host mRNA for initiation 
factor eIF-4B in vitro (Golini et al,, 1976), and this has been suggested 
as the mechanism operating in vivo. An alternative mechanism has, 
however, been proposed. This entails an effect of the virus on the 
permeability of the host cell membrane to monovalent cations,' and a
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greater efficiency of translation of viral mRNA under the resulting 
altered ionic conditions (Carrasco and Smith, 1976). These investigators 
found that addition of sodium chloride inhibited the translation of 
globin mRNA or mouse polyA-containing RNA in a cell-free system from 
ascites cells, while it stimulated the translation of encephalomyocarditis 
viral mRNA under the same conditions. Moreover, they found that at the
onset of viral protein synthesis, the ability of the cell to take up
^^Rb^, a potassium ion analogue, becomes drastically impaired, suggesting 
a disruption of the normal Na*/K* gradient. The mechanism proposed 
by Carrasco and Smith is consistent with a previous observation that 
poliovirus capsid protein is required to produce the inhibition of host 
protein synthesis (Steiner-Pryor and Cooper, 1973). Egberts et al. 
(1977), however, have found that the change in ionic permeability in 
mengovirus-infected cells did not occur until after host protein synthesis 
had stopped. Moreover, the differential translation of viral and host
mRNAs at high ionic strength has not been found with other viruses
(Stevely and McGrath, 1978). Thus the generality of the mechanism 
proposed by Carrasco and Smith is in doubt.
An interesting case of the control of protein synthesis during the 
S phase of the cell cycle involves the synthesis of histones. Inhibition 
of DNA synthesis causes rapid disaggregation of polysomes and degradation 
of histone mRNAs in HeLa cells (Borun et al., 1975); although hybrid­
ization studies showed that histone mRNA is still synthesized in the 
absence of DNA synthesis. This suggests that a regulatory mechanism 
may exist to degrade histone mRNAs in the cytoplasm in the absence of
DNA synthesis (Melli et al., 1977).
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Control of protein synthesis also appears to operate in muscle cells 
during myogenesis. Thus, Buckingham et al. (1974, 1976) found that 
mRNA for myosin heavy chain was present in prefusion myoblasts from 
primary cultures of foetal calf muscle but was not translated until 
after fusion. The untranslated prefusion mRNA had a much shorter half- 
life than the translated postfusion mRNA, but the change in half-life 
appeared to precede the utilization of the mRNA.
There are a number of examples of translational control involving the
utilization of pre-existing mRNA following the fertilization of eggs or
during activation of dormant cells. In sea urchin eggs following
fertilization, there is an increase in the rate of translation of the
stored (maternal) histone mRNAs (Gross et al., 1973). A similar
b
phenomenon occurs following hydration of Artemia salina cysts. In 
this latter case there is activation and synthesis of initiation factor 
eIF-2 (Lee-Huang et al,, 1977), but this may merely be associated with, 
rather than responsible for, the utilization of the mRNA,
It appears that the untranslated mRNA is often stored during translational 
inhibition of protein synthesis in the form of non-polysomal mRNP 
particles, which appear to be distinct from the mRNP particles that can 
be generated by treatment of polysomes with EDTA, and from the mRNP 
particles transporting the mRNA from the nucleus to the cytoplasm.
These storage mRNP particles accumulate in many conditions where there 
is translational inhibition of protein synthesis, and disappear when 
the rate of protein synthesis is restored (Lee, Krsmanovic and Brawerman, 
1971; Schochetman and Perry, 1972a; Terada et al,, 1972; Christman 
et al., 1973; Rudland, 1974; Sonenshein and Brawerman, 1977). It
— 46 —
also appears that mRNA, stored in a dormant form in the cytoplasm of 
unfertilized eggs, exists as mRNP particles. Thus, maternal 20-40S 
mRNP particles from unfertilized sea urchin eggs directed the synthesis 
of histones in a heterologous cell-free system (Gross et al., 1973),
3j
Such ’masked' mRNAs were also found in wheat embryos (Marcus, 1969), 
cotton seedlings(Ihle and Dure, 1972), myoblasts (Heywood, Kennedy and 
Bester, 1975; Buckingham et al., 1976) and in immature erythroid cells 
(Marks and Rifkind, 1972).
Although the protein components of mRNP particles might be responsible 
for keeping the mRNAs in their inactive form, it has been suggested 
that an RNA species, translational control RNA (tcRNA), has this role. 
Bester, Kennedy and Heywood (1975) described a tcRNA molecule, obtained 
from the dialysate of mRNP particles from embryonic chick muscle. This 
tcRNA molecule contains oligoU sequences sufficient to form small hybrids 
to synthetic polyA. It has been suggested that this oligoU-rich tcRNA 
base pairs with the polyA sequence of mRNA in the mRNP particle, thereby 
inhibiting its translation. More recently, it has been shown that 
purified tcRNA isolated from myosin mRNP particles from embryonic chick 
muscle exhibited translational inhibition of myosin as well as globin 
mRNAs in,wheat germ cell-free systems, although the inhibition of globin 
mRNA translation was less marked (Kennedy, Siegel and Heywood, 1978),
A tcRNA molecule of about 20 nucleotides, rich in U and C, has also been 
described in Artemia salina cysts and has been suggested as a factor 
in maintaining their dormancy (Lee-Huang et al,, 1977), In contrast, a 
class of small RNA molecules was isolated from a reticulocyte ribosomal 
wash (Bogdanovsky, Hermann and Schapira, 1973), and from polysomal mRNP 
particles of embryonic chick muscle (Bester, Kennedy and Heywood, 1975)
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that has an apparent stimulatory effect on translation.
It is possible that a mechanism operates within individual cells to 
produce differential translation of different mRNAs because of different 
affinities or requirements of these for the various initiation factors.
It has already been mentioned that, in extracts from mouse Krebs ascites 
cells, encephalomyocarditis virus RNA is translated more efficiently 
than host mRNA, because of a greater affinity for initiation factor elF- 
4B, Furthermore, Wigle and Smith (1973) isolated a factor (Ie m c ) f:tom 
Krebs ascites cytosol which stimulated the translation of encephalo­
myocarditis virus RNA but appeared to have no effect on the translation 
of globin mRNA. This factor, however, is not specific for encephalo­
myocarditis virus RNA, but is in fact initiation factor eIF-4A, which 
is also required for the translation of globin mRNA (Staehelin et al., 
1975). The apparent specificity was due to the greater requirement of 
encephalomyocarditis virus RNA for this factor. Such different 
requirements for initiation factors seem also to occur between different 
cellular mRNAs. Thus, in rabbit reticulocytes, the synthesis of a- 
and 3-globin chains is maintained at a ratio of 1:1 by different rates 
of initiation, to compensate for the fact that the amount of a-globin 
mRNA exceeds that of 3-globin mRNA (Lodish, 1971), The observation 
that initiation factor eIF-4B, and to a lesser extent eIF-4A, relieves 
the competition between a- and 3-globin mRNAs in a purified ribosomal 
system from reticulocytes (Kabat and Chappell, 1977) suggests that 
3-globin mRNA has a higher affinity or a lower requirement for the 
initiation factors than does a-globin mRNA,
In the light of these observations, it is perhaps possible to resolve the
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controversy over the claims that specific initiation factors are 
required for the translation of different mRNAs. In reticulocyte 
lysate or wheat germ cell-free systems, it has been reported that the 
translation of myosin heavy chain mRNA from embryonic chick muscle 
requires the addition of initiation factor eIF-3 prepared from muscle; 
that from reticulocytes being ineffective. An analogous situation has 
been found for the translation of globin mRNA, where reticulocyte 
initiation factor eIF-3 is specifically required (Heywood, 1969 ;
Rourke and Heywood, 1972; Kennedy and Heywood, 1976). However, 
Przybyla and Strohman (1974), and Mondai et al. (1974), by apparently 
translating chick myosin heavy chain mRNA in a rabbit reticulocyte 
lysate, have demonstrated that no tissue-specific initiation factor is 
required to translate this mRNA. It is possible, however, that the 
observations of Heywood and co-workers may have been due to their eIF-3 
preparations being impure and containing different amounts of other 
contaminating initiation factors, if optimal translation of myosin mRNA 
requires a different concentration of a given initiation factor than 
globin mRNA. The cruder but more active cell-free systems used by 
other workers may have contained sufficient initiation factors to have 
obscured such differences. It should, however, be pointed out that 
pure initiation factor eIF-3 comprises about nine polypeptide chains 
(Schreier et al., 1977). Thus it is possible that this factor has a 
different complement of subunits in different tissues and that this 
might modify the affinity of initiation factor eIF-3 towards different 
mRNAs.
CHAPTER 2
EXPERIMENTAL
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2.1 MATERIALS
2.1.1 Biological
The rats used in this study were male albinos of the Wistar strain,
weighing approximately 130-150 g. They were boused and bred in the
Animal Unit of the Department of Biochemistry and fed on diet 41B (Oxoid Ltd).
2.1.2 Chemical
2-mercaptoethanol, 2,5-diphenyloxazole (PPO), l,4-bis-(5-phenyloxazol-2- 
yl)benzene (POPOP), 2,5-bis-{2-(5-tert-Butylbenzoxazolyl))-Thiophene (BBOT), 
and aery1amide were from Koch-Light Laboratories Ltd., Colnbrook, Bucks; 
toluene, methoxyethanol, sodium deoxycholate, dithiothreitol, diethyl- 
pyrocarbonate, and formamide were from British Drug Houses Chemicals, Poole, 
Dorset; bovine pancreatic deoxyribonuclease (EC 2.1.4.5 - electro- 
phoretically purified) was purchased from Worthington Biochemical Corporation, 
Freehold, N.J., USA; cycloheximide, calf thymus DNA, yeast RNA, ribonuclease- 
free sucrose, dimethylsulphoxide, crystalline bovine pancreatic ribonuclease 
(EC 2.7.7.16), and alloxan monohydrate (Batch No. A-8128) were from 
Sigma Chemical Co., St. Louis, Mo., USA; lubrol WX and N-ethylmaleimide 
were obtained from Grand Island Biological Company N.Y., USA; crystalline 
bovine plasma albumin was purchased from Armour Pharmaceutical Company, 
Eastbourne, England; and sodium dodecyl sulphate was from Bio-Rad Laboratories 
Richmond, California, USA. Glucagon-free insulin (porcine zinc insulin 
crystals, lot 615-D63-10), assaying 24 units/mg and containing less than 
0.003% glucagon, was a gift of Dr. Otto Behrens, Eli Lilly Research 
Laboratories. Dextrostix and Clinistex reagent strips were purchased 
from the Ames Company; reagent kits for quantitative determination of
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blood glucose and creatine phosphokinase (EC 2.7.3.2) were from 
Boehringer Mannheim Company; N,N’-methylene bisacrylamide, N,N,N*,N’, 
tetramethylethylenediamine (TEMED), ammonium persulphate, bromophenol 
blue and X-ray film (Kodak X-Omat R) were obtained from Eastman-Kodak 
Co,, Rochester, N,Y,, USA; and streptozotocin {2-deoxy-2(3-methyl-3- 
nitroso ureido)-D-glucopyranose} was kindly donated by the Upjohn Inter­
national Incorporated , Kalamazoo, Mich., USA, Poly (^H) uridylic acid 
(specific activity 61.9 pCi/pmole P), in 50% ethanol solution and poly- 
adenylic acid (K^ salt) were purchased from Miles Laboratories Inc.,
3
Elkhardt, Ind., USA; ( H) phenylalanine (specific activity 5 Ci/mmole)
35and ( S) methionine (specific activity at the time of use, 1080 Ci/mmole) 
were obtained from the Radiochemical Centre, Amersham, UK; and Poly 
U-Sepharose 4B was obtained from Pharmacia, Uppsala, Sweden. All other 
chemicals were purchased from British Drug Houses Ltd. and were, where 
possible, ’Analar’ grade. Solutions were made in glass-distilled,
deionized, sterile water. All glassware was acid-washed and baked at
180°C for 12 hr. to destroy any adsorbed ribonuclease.
2.2. CHARACTERIZATION OF EXPERIMENTAL DIABETES
2.2.1 Induction of diabetes
In some experiments diabetes was induced by rapid intravenous injection 
(o.2 ml) of alloxan monohydrate (60 rag/kg body weight) into rats that 
had been starved overnight, the drug being dissolved in sterile saline 
just prior to use. The animals were killed 2 or 3 days later.
Diabetes was also induced by intravenous injection (0.2 ml) of strepto­
zotocin (50 mg/kg body weight) into rats that had been starved overnight.
Fig. 2 .2 .1 .1 .
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and the animals were killed 2 or 3 days later, Streptozotocin was 
dissolved in freshly prepared 100 mM trisodium citrate buffer (pH 4.45) 
and injected within 15 min of dissolution.
When treated with insulin, each rat was injected intraperitoneally with 
5 units of insulin (0.2 mg). For each experiment insulin was freshly 
dissolved in 0.003 N HCl (1 mg/ml).
For comparison of rats in different physiological conditions (normal, 
diabetic, and diabetic treated with insulin), processing of their tissues 
was performed on the same day, and the ribosomes or RNA derived from these 
were subsequently analysed at the same time.
2,2.2 Enzymatic determination of the concentration of blood glucose 
The glucose levels in the urine and blood of diabetic rats and diabetic 
rats which had been treated with insulin were routinely checked using 
Clinistix and Dextrostix reagent strips.
For quantitative measurement of the concentration of blood glucose, the 
method described by Werner et al.(1970) was followed, using reagent kits 
supplied by Boehringer Mannheim Company. Immediately after decapitation 
of the rats, blood samples were collected in tubes containing heparin.
The blood (0.1 ml) was added to 1 ml of a solution of uranyl acetate in 
saline (1.6 mg/ml), mixed, and centrifuged for 10 min at 2,400 rpm (500 g). 
The deproteinized supernatant (0.05 ml) was used for glucose estimation 
and mixed with 5 ml of reagent containing 100 mM phosphate buffer (pH 7.0); 
20 pg (>0.8 U) peroxidase/ml; 180 pg ( è 10 U) glucose oxidase/ml; 
and 1 mg/ml of the chromogen, ABTS {2,2’ diazo-bis(3-ethylbenzothiazoline- 
6-sulphonate)}. Blank and standard solutions were prepared at the same
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time. The samples were kept at room temperature for 35 min avoiding 
exposure to direct sunlight, and the absorbances of samples (A sample) 
and standards (A standard) were measured at 420 nm against the blank.
Fig. 2,2,2.1 shows a standard curve for the assay.
Repeated assays with Dextrostix showed that normal rats had blood glucose 
concentrations in the range 70-110 mg/100 ml, whereas alloxan-diabetic rats 
had glucose concentrations >250 mg/100 ml. However, 60 min after injection 
of insulin the blood glucose concentration was still elevated, at >250 mg/
100 ml. These results were substantiated quantitatively in a single assay 
(Table 2,2.2.1) by the glucose oxidase-peroxidase method described above, 
and are similar to those previously reported by Wool and Cavicchi (1966).
In contrast to the results with alloxan-diabetic rats, the Dextrostix 
measurements showed that insulin injection reversed the elevated blood 
glucose levels (>250 mg/100 ml) to the normal range (70-110 mg/100 ml) in 
the case of streptozotocin-diabetic rats. This result was substantiated 
when more extensive quantitative determinations were performed using the 
glucose oxidase-peroxidase method (Table 2.2,2.1).
2.2.3 Effect of dose of streptozotocin on the induction of diabetes in rats 
Rats were starved for 16 hr, injected (intravenously) with various doses of 
streptozotocin, killed 2 days later and the blood glucose concentration was 
determined in each case by the glucose oxidase-peroxidase method described 
above (section 2.2,2). It is evident from Fig. 2,2.3.1 that 50 mg 
streptozotocin/kg body weight is the minimal diabetogenic dose and this was 
used in most of the work described in this thesis.
Fig. 2.2.2.1 Standard curve for estimation of blood glucose 
by the glucose oxidase-peroxidase method
The assay was performed as described in section 2.2.2, using 
a standard glucose solution of 0.505 mM. The concentration 
of glucose (c) in blood was calculated from the following 
formula:
A sample
C = 100 X --------  (mg/100 ml)
A standard
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Table 2.2.2.1 Concentration of glucose in blood of rats 
under different physiological conditions
Rats were starved overnight, injected (intravenously) with 
alloxan-monohydrate (60 mg/kg body weight) or with streptozotocin 
(65 mg/kg body weight), and killed 3 days later. Some rats 
were intraperitoneally injected with 5 units of insulin, 60 min 
before death. The blood glucose concentrations were determined 
by the glucose oxidase-peroxidase method as described in 
section 2.2.2.
Values are : Mean + S.E.M. of No. of Determinations.
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Table 2.2.2.1
Physiological status 
of rats
Blood glucose 
concentration 
(mg/100 ml)
No, of 
Determinations
Normal 125 1
Alloxan-Diabetic 442 1
Alloxan-Diabetic + 
Insulin 366 1
Streptozotocin-Diabetic 404 ±14.4 7
Streptozotocin-Diabetic 
+ Insulin 63 ± 11.6 . 7
Fig. 2.2.3.1 Effect of streptozotocin on the concentration 
of glucose in rat blood
Rats were starved overnight, injected (intravenously) with 
various doses of streptozotocin, killed 2 days later, ai^ d the 
blood glucose concentrations determined by the glucose oxidase- 
peroxidase method as described in section 2.2.2.
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2.3 PREPARATION OF RIBOSOMES FROM RAT SKELETAL MUSCLE
2.3.1 Preparation of ribosomes at low ionic strength
This method is that of Florini and Breuer (1966), as modified by Martin et al. 
(1969).
Ribosomes were prepared from thigh, gastrocnemius, and abdominal muscles 
of male rats. The physical and functional characteristics of ribosomes 
from these different muscles have been shown to be identical (Wool et al., 
1968). All operations after removal of the legs from the rats were con­
ducted in a cold room at 4°C. Rats were decapitated quickly; the 
carcasses were separated from the head to prevent flooding of the tissues 
with hormones from the pituitary. The rear legs were skinned and removed 
by cutting through the pelvic joint, the abdominal muscle was then removed 
in one sheet. The muscle was immediately placed in ice and stored until 
all animals involved in the experiment had been killed. Muscle was then 
cut away from the bones and tendons, freed of adipose tissue and minced 
with scissors in small amounts of homogenization buffer. Medium A , con­
taining 50 mM Tris-ECl (.pH 7.6), SO mM KCl, 12.5 mM MgCl^ and 250 mM 
sucrose. It was then weighed by displacement and homogenized in 2.5 
volumes of Medium A for 1 min at the 'high speed' setting of a Virtis "23" 
homogenizer. The homogenate was centrifuged for 15 min at 12,500 rpm 
(13,000 g) in the 8 x 50 ML rotor of an MSE 18 centrifuge at 4^0, sedimenting 
unfractured cells, mitochondria, nuclei, myofibrils and debris in the 
'mitochondrial pellet' fraction. The 'post-mitochondrial supernatant' was 
filtered through glass wool to remove fat and the filtrate was then 
centrifuged for 2 hr at 30,000 rpm (.78,000 g) in the Type 30 rotor of a 
Beckman ultracentrifuge at 4^0. This yielded a 'post-microsomal
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supernatant' which was discarded, and a 'microsome pellet'. For further 
purification, the microsome pellet was resuspended by 12 up-and-down 
strokes in a homogenizer equipped with a loose-fitting teflon pestle in 
30 ml of a mixture of Medium A and the detergents, Lubrol WX (0.5% w/v) 
and sodium deoxycholate (.1% w/v) (This was made up by mixing 25.5 ml of 
Medium A with 1.5 ml of 10% (w/v) Lubrol WX in 10 mM MgCl2> and 3 ml of 
freshly prepared 10% (w/v) sodium deoxycholate in distilled water). This 
was centrifuged for 15 min at 12,500 rpm (13,000 g) in the 8 x 50 ML rotor 
of an MSE 18 centrifuge at 4^C, and the supernatant was diluted with 
Medium A to augment its volume by 15%. The diluted supernatant was 
layered in 7 ml aliquots over 5 ml portions of Medium B (composition 
similar to Medium A but with 500 mM sucrose instead of 250 mM sucrose) and 
centrifuged for 3 hr at 50,000 rpm (165,000 g) in the 50 Ti rotor of a 
Beckman ultracentrifuge at 4°C. The 'post-ribosomal supernatant' was then 
aspirated off; care being taken to avoid contamination of the ribosome 
pellets with the upper layer, and the tubes were drained and wiped dry.
The ribosome pellets were stored at -20°C. This preparation is illustrated 
in outline in Fig, 2.3.1.1.
2.3.2 Preparation of ribosomes at high ionic strength 
This method (Stirewalt, Castles and Wool, 1971) was similar to that 
described in section 2,3.1 above (low ionic strength method) except 
that: (i) the initial homogenization of tissue was carried out in Medium C, 
containing 50 mM Tris-HCl (pH 7.6), 250 mM KCl, 12,5 mM MgCL^and 250 mM 
sucrose; and (.ii) the 'mitochondrial pellet' was reextracted with 
Medium C before centrifugation at 30,000 rpm (78,000 g). The reason for 
the higher concentration of KCl (250 mM) was to solubilize myosin, which 
otherwise precipitates in the 'mitochondrial pellet' fraction, trapping
Fig. 2.3.1.1 Summary of different fractions obtained 
during preparation of skeletal muscle 
ribosomes
Rat skeletal muscle was homogenized and fractionated as 
described in section 2,3.1.
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Fig. 2 .3 .1 .1 .
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with it a large number of ribosomes (Heywood, Dowben and Rich, 1967) .
2.3.3 Preparation of 'post-mitochrondrial supernatant' by the method 
of Chen and Young Ç1968)
The muscle from the rear legs of rats was immersed in chilled Medium D ,
of the composition: 10 mM Tris-HCl (pH 7.6), 250 mM KCl, and 10 mM MgCl^.
The muscle CIO g) was finely minced with scissors at 4°C and homogenized
in 2 volumes of Medium D for 1 min at the "high speed" setting of a Virtis
"23" homogenizer. The homogenate was centrifuged for 15 min at 12,500 rpm
(13,000 g) in the 8 x 50 ML rotor of an MSE 18 centrifuge at 4°C, to
sediment the cell debris, mitochondria and nuclei. This 'post-mitochondrial
supernatant' was filtered through glass wool and the filtrate was then
treated with 10% (w/v) Lubrol WX dissolved in Medium D and an aqueous
10% (w/v) solution of sodium deoxycholate to achieve a final concentration
of 0.5% (w/v) Lubrol WX, and 1% (w/v) sodium deoxycholate.
2,4 EXTRACTION OF RNA FROM RAT SKELETAL MUSCLE
2.4.1 Extraction of total RNA
The RNA was extracted according to the method described by Perry et al.(1972)
which had been found to preserve the integrity of polyA(+)RNA.
RNA was extracted from the unfractionated muscle by quickly freezing about 
0.3 g of tissue in liquid nitrogen and pulverizing it in a chilled metallic 
mortar with a pestle. The powdered tissue was suspended in 10 ml of 
Medium E containing: 10 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA and 
0.5% sodium dodecyl sulphate in a motor-driven teflon-glass homogenizer at 
room temperature. One volume of phenol-chloroform (1:1 by volume) was
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added to the suspension and the mixture was shaken for lOmin.at room 
temperature in stoppered glass centrifuge tubes. (The phenol was saturated 
with Medium F , containing 10 mM sodium acetate, 100 mM NaCl, 1 mM EDTA 
(pH 6,0), just before use). The samples were then centrifuged for 10 min 
at 2,400 rpm (500 g) at 20°C, and the upper, aqueous, phase was transferred 
carefully to another centrifuge tube. The lower, phenol, phase and the 
interphase layers were extracted with 2 volumes of Medium E - chloroform 
(1:1 by volume) for 5 min, centrifuged as previously, and the upper, aqueous, 
layer was combined with the previous one. The combined aqueous layers was 
reextracted with 1 volume of phenol-chloroform (1:1 by volume) for 5 min, 
centrifuged and the upper, aqueous, phase was removed. RNA and DNA were 
precipitated from the aqueous phase with 2.5 volumes of 95% ethanol at -20^C 
for 16 hr, centrifuged for 15 min at 12,500 rpm (13,000 g) at 4°C. The 
precipitate was then dissolved in 2 ml of DNA-digestion buffer containing 
10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 5 mM MgClg and 5 mM N-ethylmaleimide.
To this solution, 10 pi of deoxyribonuclease solution (2 mg/ml in 150 mM 
NaCl) was added and the mixture was incubated for 15 min at 37°C. The 
RNA was precipitated with 2.5 volumes of 95% ethanol at -20°C for 16 hr, 
centrifuged and dissolved in Medium E and reextracted with phenol and 
chloroform to denature the deoxyribonuclease, as described previously. To 
remove any residual phenol, the extracted RNA was precipitated with 2.5 
volumes of 95% ethanol at -20°C, centrifuged for 15 min at 12.500 rpm 
(13,000 g) and ethanol was removed by draining from the inverted tubes for 
30 min at 4°C. The RNA was dissolved in 2 ml of Medium F, reprecipitated 
with ethanol, centrifuged, and dried for 1 hr at 4°C, and finally dissolved 
in a known volume of Medium H , containing 30 mM trisodium citrate,
300 mM NaCl. After extraction with phenol and chloroform the ^260^^280 
ratio of RNA solution was usually in the range 1.95 - 2.05.
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2.4.2 Extraction of RNA from purified ribosomes
To extract RNA from the purified ribosomes of rat skeletal muscle, the 
ribosome pellet was gently suspended by hand using a small teflon-glass 
homogenizer in 2 ml of Medium E at room temperature, and the RNA was 
extracted as previously described for unfractionated muscle Csection 
2,4.1), except that the DNA digestion step was omitted.
2.4.3 Isolation of , polyAC+lRNA by poly U-gephafose Affinity 
Chromatography
The method used is described in the booklet "Affinity Chromatography, 
Principles and Methods", published by Pharmacia Fine Chemicals, Uppsala, 
Sweden. The polyU-Sepharose CO.3 g) was swollen in a solution of 100 mM 
NaCl (pH 7.5) for 30 min, washed on a glass filter with the same solution 
(100 ml per gram dry powder) and poured into a column made from a 5 ml 
plastic syringe. The column was washed once with 15 ml of buffer con­
taining 100 mM NaCl, 10 mM EDTA, 10 mM Tris-HCl (pH. 7.5), 0.2% sodium 
dodecyl sulphate, then with 5 x 1 ml portions of NETS buffer containing 
400 mM NaCl, 10 mM EDTA, 10 mM Tris-HCl (pH 7.5), 0.2% sodium dodecyl 
sulphate; finally equilibrated with 5 x 1 ml portions of a concentrated 
salt buffer, CSB, prepared in 25% formamide in 700 mM NaCl, 50 mM Tris- 
HCl (pH 7«5) and 10 mM EDTA. (The formamide had been deionized by stirring 
with Bio-Rad mixed-bed ion exchange resin AG 501-X8 (D), 20-50 mesh). The 
RNA extracted from purified rat skeletal muscle ribosomes was dissolved 
in 1 ml of CSB and heated in a 55°C water bath for 3 min, cooled on ice and 
applied to the column {2 ml bed volume), the eluate being recycled through 
the column and retained. The"unbound"RNA was washed off the column by 
2 X 1 ml portions and 2 x 2 ml portions of CSB and the washings were combined 
with the initial eluate. This fraction contained the "unbound" RNA
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(predominantly rRNA) . The ■ polyA(.+)RNA was eluted from the column with
2 X 1 ml portions and 2 x 2 ml portions of elution buffer prepared in
90% formamide (deionized), 10 mM PO^, 10 mM Na^ EDTA, 0,2% sodium 
dodecyl sulphate (pH 7.5). The eluate was. diluted to 25% formamide with 
NETS buffer and applied to the column which has been reequilibrated with 
CSB (20 ml). The 'flow-through' was discarded and the bound polyA(+)RNA 
was eluted with 5 x 1 ml portions of the elution buffer described above.
The RNA was precipitated with 2.5 volumes of 95% ethanol in the presence of 
150 mM NaCl, To remove any contaminating formamide, the RNA was suspended 
in sterile water and applied to a Sephadex G50 'desalting' column. The
eluate was collected in I ml fractions and the RNA detected by its ultra­
violet-absorbance at 260 nm; the peak fractions being collected, lyophilized 
and kept at -70°C until use.
The amount of RNA eluted as polyA(+)RNA was, on average, 4% of the total
applied.
2.5 SUCROSE DENSITY GRADIENT ANALYSIS OF RIBOSOMES AND RNA
2.5.1 Sucrose density gradient analysis of ribosomes 
The ribosomes were suspended in the required medium (50 mM Tris-HCl
(pH 7.6), 200 mM KCl and 5 mM MgCl^, in most experiments) by gentle manual
homogenization in a small teflon-glass homogenizer at 4°C. A portion 
(0.2 ml) containing approximately 2 A^^Q units of ribosomes, was then 
layered onto 5.2 ml of a linear 15-45% (w/v) sucrose density gradient made 
in the same medium in which the ribosomes were suspended. The gradients 
were centrifuged for 35 min at 50,000 rpm (234,000 g) in the SW 50.1 rotor
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of a Beckman ultracentrifuge at 4°C. After centrifugation, the gradients 
were analysed for ultraviolet-absorbance at 254 nm using the density- 
gradient scanner attachment of a Gilford 240 recording spectrophotometer, 
by upwards displacement with 50% (or 75%) sucrose solution at a rate of 
1 ml per min,
2.5.2 Sucrose density gradient analysis of rat skeletal muscle 
'post-mitochondrial supernatant'
The'post-mitochondrial supernatant' from rat skeletal muscle was analysed 
by layering 1.5 ml on a linear 15-40% (w/v) sucrose gradient (37 ml) 
prepared in Medium D. The gradient was centrifuged for 3 hr at 27,000 
rpm (94,500 g) in the SW 27 rotor of a Beckman ultracentrifuge at 4°C.
The ultraviolet-absorbance profiles were measured at 260 nm using a flow­
cell with a 5 mm light-path in a Gilford model 240 recording spectrophoto­
meter, The gradients were pumped at a rate of 3 ml per min from the 
bottom of the tube.
2.5.3 Sucrose density gradient analysis of RNA
Linear, 7-25% (w/v). sucrose density gradients were prepared at 20°C in 
Medium G consisting of: 50 mM Tris-ECl (pH 7.6), 150 mM NaCl, 1 mM EDTA and
0.5% sodium dodecyl sulphate. About 50 pg of RNA dissolved in 0.2 ml of 
Medium G was layered onto a 5 ml sucrose gradient. The gradients were 
centrifuged for 4 hr at 45,000 rpm (189,000 g) in the SW 50.1 rotor of a 
Beckman ultracentrifuge at 20°C. Gradients were continuously monitored 
for ultraviolet-absorbance at 254 nm using the density-gradient scanner 
attachment of a Gilford 240 recording spectrophotometer, as described in 
section 2.5.1.
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When radioactive samples were analysed, fractions of 0,2 ml were collected
from the gradients, mixed with 0,3 ml of a solution containing 0.5 M
NH^OH and 0.5 mM EDTA and dried overnight at 60°C in glass scintillation
vials. Water (0.3 ml) and 7 ml scintillation liquid (0.4% (w/v) PPO,
0.02% (w/v) POPOP, 40% Cv7v).2-methoxyethanol, 60% (v/v) toluene) were added
and the radioactivity was determined in a Beckman scintillation spectro-
3meter with an efficiency of about 15% for H. In some experiments
E.coli tRNA (4S) and skeletal muscle ribosomal RNA (18S and 28S) were used
3as markers on a parallel gradient. A gradient containing ( H) polyU 
only was similarly analysed in certain cases.
2.6 ASSAY OF POLYA(j-lRNA BY HYBRIDIZATION WITH (\) POLYU
The method described by Rudland, Weil, and Hunter (1975) was followed. 
Hybridization of polyAC+)RNA to ( H) polyU was accomplished in standard 
annealing mixtures (0.5 ml) containing Medium H (composed of 30 mM tri­
sodium citrate and 300 mM NaCl), 0.04 yCi (0.25 pg) of (^H) polyU (Miles 
Laboratories, specific activity; 61.9 pCi/pmol P), varying amounts of non­
radioactive synthetic polyA or varying amounts of polyribosomal RNA. 
Reactants were incubated at 50^C for 14 hr, allowed to cool to 20°C for 
2 hr before digestion with 20 pg pancreatic ribonuclease for 2 hr at 20^C. 
Samples were then precipitated with 1 ml ice-cold 10% (w/v) trichloro­
acetic acid after addition of 200 pg of carrier RNA (Yeast RNA dissolved in 
200 mM sodium acetate (2 mg/ml)). Variations from these standard conditions 
are indicated in the figure legends.
After being allowed to stand for 1 hr at 4°C, the precipitates were collected 
on Whatman GF/C glass fibre discs, washed several times with 5% trichloro­
acetic acid, transferred into glass scintillation vials, dried at 100°C for 
1 hr and cooled. To the vials was added 10 ml of a scintillation fluid
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containing 4 g PPO, 0.2 g POPOP per litre of toluene, and the radio-
3activity was estimated with an efficiency of about 15% for H.
2.7 ASSAYS FOR CELL-FREE PROTEIN SYNTHESIS
2.7.1 Assay of protein synthesis with rat skeletal muscle ribosomes 
in vitro
The assay was carried out in a final volume of 100 pi at 37°C. The assay
mixture contained: 20 mM Tris-HCl (pH 7.6), 125 mM KCl, 7.5 mM MgClg,
5 mM p-mercaptoethanol, 1 mM ATP (neutralized), 0.1 mM GTP (neutralized),
5 mM creatine phosphate (0.18 mg), 20 pg of creatine phosphokinase, 40 pg
3of E.coli tRNA (Schwartz-Mann) aminoacykted with ( H) phenylalanine 
(5 Ci/mmole, Radiochemical Centre, Amersham) and 19 non-radioactive amino 
acids (Wool and Cavicchi, 1967), and 0.7 mg of rat liver supernatant pro­
tein (Rampersad and Wool, 1965). The ribosome fraction was added to start 
the reaction, and reaction mixtures were incubated on a water bath for 
30 min. At the end of incubation period, the proteins were precipitated 
by adding 5 ml of ice-cold 5% (w/v) trichloroacetic acid, and the reaction 
mixtures were kept at 0°C for 30 min. The mixtures were then heated at 
90-95°C for 20 min. After the samples had been chilled at 0°C for 15 min, 
protein was collected on glass fibre discs (Whatman GF/C -filters, 24 ram 
diameter), washed with four 10-ml portions of 5% trichloroacetic acid con­
taining 10 mg/ml of non-radioactive phenylalanine. The filter discs were 
then put into glass vials containing 0.7 ml of 90% formic acid to solubilize 
the protein on the filters and the radioactivity was measured in 10 ml of 
scintillation fluid containing, per litre, 500 ml toluene, 500 ml 2-methoxy-
ethanol, and 5 g 2,5-bis-{ 2 -(5-tert-butylbenzoxazolyl)}-thiophene, (BBOT),
3with an efficiency of about 30% for H. Correction was made for a control 
lacking ribosomes.
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2.7.2. Translation of rat skeletal muscle ribosomes and polyA(+)RNA 
in a cell-free system from wheat germ
The method described by Marcu and Dudock (1974) was adopted.
Standard protein synthesis assay
The assay contained in a final volume of 50 pi: 15 pi of wheat germ S-30
fraction (kindly provided by Mrs. H. Singer), 20 iriM N-2-Hydroxyethyl-
piperazine-N'-2-ethanesulphonic acid (HEPES), pH 7.6, 2 mM dithiothreitol,
1 mM ATP (neutralized), 20 pM GTP, 8 mM creatine phosphate, 0.5 pg
creatine phosphokinase, 0.4 mM spermidine, KCl and Mg acetate as indicated, 
35
25 yCi of ( S) methionine (1080 Ci/mmole), ribosomes or polyA(+)RNA and/or
water to 50 pi. The wheat germ extract contained sufficient endogenous
amino acids and tRNAs to support protein synthesis. Assays were incubated
at 25°C for 2 hr. At the end of the incubation 5 pi aliquots were removed
for determination of radioactivity incorporated into protein. The aliquots
were pipetted onto 2.5 cm discs of Whatman No.l paper, dried, placed into
“510% trichloroacetic acid containing 10 M non-radioactive methionine for 
10 min, washed for 10 min in 5% ice-cold trichloroacetic acid, then boiled 
in 5% trichloroacetic acid at 90^0 for 10 min, rinsed with cold 5% tri­
chloroacetic acid, and dried by sequential rinsing in ethanol, ethanol- 
diethyl ether (3:1 v/v), and diethyl ether. The filters were then dried 
in air and then under a heat lamp for 5 min prior to estimation of radio­
activity in 10 ml of toluene-based scintillation fluid containing 5% (w/v) 
PPO with an efficiency of about 85% for
2.7,3 Identification of cell-free translation products by polyacrylamide 
gel electrophoresis in sodium dodecyl sulphate
Sodium dodecyl sulphate gels were prepared by the following modification
of the method of Laemmli (1970) and samples were in 4 mm tracks on slab
of 20 X 25 X 0.15 cm. The separation gel (22 cm deep) contained 10% (w/v)
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acrylamide, 0.26% (w/v) bisacrylamide, 0.1% (w/v) sodium dodecyl sulphate, 
375 mM Tris-HCl (pH 8.8), 0,03% (v/v) N,N,N’,N', tetramethylethylenediamine 
(TEMED), and 0.1% (w/v) ammonium persulphate.
Stacking gels (3 cm deep) contained 5% (w/v) acrylamide, 0.03% (w/v) 
bisacrylamide, 0.1% (w/v) sodium dodecyl sulphate, 65 mM Tris-HCl (pH 6.8), 
0.1% (v/v) N,N,N',N* tetramethylethylenediamine (TEMED) and 0.1% (w/v) 
ammonium persulphate.
Prior to electrophoresis, protein precipitates (10 pi of the cell-free 
assay was precipitated with 5 volumes of acetone) were dissolved each in 
50 pi of a reducing mixture containing 100 mM dithiothreitol, 2% (w/v) 
sodium dodecyl sulphate, 65 mM Tris-HCl (pH 6.8), 10% (v/v) glycerol and 
0,001% bromophenol blue tracker. The running buffer contained 25 mM Tris- 
HCl pH (8.3), 192 mM glycine and 0.1% (w/v) sodium dodecyl sulphate. The 
gel was electrophoresed overnight at 4°C at 15-20 mA per gel constant 
current.
Processing of slab gel for fluorography
The method of Bonner and Laskey (1974) was adopted. After electrophoresis, 
the gel was immersed in three successive baths of dimethyl sulphoxide 
(500 ml each, for successively 30 min, 30 min, and 45 min) with constant 
shaking. The gel was then impregnated with PPO by immersion in 200 ml of 
20% (w/v) PPO in dimethyl sulphoxide. It was shaken gently for 45 min at 
room temperature after which the PPO was precipitated in the gel and the 
dimethyl sulphoxide removed by constant washing with water for a minimum 
period of 45 min. The gel was then dried onto Whatman 3MM chromatography 
paper, under vacuum. Exposure of film (Kodak X-Omat R) was at -70°C for 
7-28 days.
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The molecular weights of the cell-free products were estimated by comparison 
with parallel samples of proteins of known molecular weight which were 
immunoglobulin G heavy chain (molecular weight 55,000) and immunoglobulin k 
light chain (molecular weight 23,500), The molecular weights of translated 
proteins were then estimated by the method of Weber and Osborn (1969) as 
shown in Fig. 2. 7. 3.1.
2.8 ASSAY OF RIBONUCLEASE ACTIVITY
The ribonuclease activity was determined as described by Barrett (1972).
In principle mononucleotides and.oligonucleotides are released from RNA by 
ribonuclease action, the undegraded substrate and large fragments are then 
precipitated by perchloric acid containing uranyl acetate, and the yield 
of low molecular weight digestion products is determined in the supernatant, 
either by measurement of ultraviolet-absorbance at 260 nm, or by estimation 
of radioactivity.
2.8.1 Assay of ribonuclease activity using yeast RNA as substrate 
The rat skeletal muscle was homogenized in 3 volumes of either low ionic 
strength Medium A or high ionic strength Medium C at 4°C. The homogenate 
was centrifuged for 15 min at 12,500 rpm (13,000 g) in 8 x 50 ML rotor of 
an MSE 18 centrifuge at 4°C, filtered through glass wool and the 'post- 
mitochondrial supernatant' was used as the source of ribonuclease. To 
0.5 ml of the 'post-mitochondrial supernatant', 0.25 ml of buffered substrate 
(Yeast RNA in 200 mM sodium acetate-acetic acid buffer, pH 7,6, 2 mg/ml) 
was added to start the reaction and the final volume adjusted to 2 ml in 
200 mM sodium acetate (pH 7.6). The mixture was incubated at 37°C for 
2 hr, and the reaction was stopped by adding 2 ml of ice-cold perchloric
Fig. 2.7.3.I Standard curve for determination of molecular 
weights of proteins in gels containing sodium 
dodecyl sulphate
Mouse immunoglobulin (kappa) light chain and immunoglobulin G 
heavy chain were electrophoresed on a sodium dodecyl sulphate 
gel as described in section 2.7.3.
values derived from this curve aré only approximate 
because of there only being two molecular weight standards. This 
is especially true in the regions of extrapolation.
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acid - uranyl acetate reagent (10 g perchloric acid and 0.25 g nrany1 
acetate per 100 ml water). After being allowed to stand at 4°C for 60 min,
the samples were centrifuged for 10 min at 2,400 rpm (500 g) at 4°C, the 
ultraviolet-absorbance of the supernatant was measured,and the ribonuclease 
activity expressed as «(^'^260n/mg protein. Control samples were 
incubated: (i) without added ^post-mitochondrial supernatant’, and 
(ii) without substrate, and the sum of these were subtracted from the 
experimental values.
In other experiments, the skeletal muscle was homogenized in 3 volumes 
of Medium C (high ionic strength) at 4°C and the homogenate was used as 
the source of ribonuclease. The substrate yeast RNA in this case was 
dissolved in 200 mM sodium acetate-acetic acid (pH 5) at a concentration 
of 2 mg/ml.
32
2.8,2 Assay of ribonuclease activity using ( P) rRNA as substrate
The method used was as described in section 2.8.1, except that the substrate 
32
was ( P) rRNA from HeLa cells, diluted with yeast RNA to a final con­
centration of 2 mg/ml in 200 mM sodium acetate - acetic acid buffer (pH 7.6). 
Control incubation was carried out to determine the non-enzyraic hydrolysis 
of RNA, After conducting and terminating the reaction, as before, the 
post-acidification supernatant (1 ml) was added to 10 ml of Bray's solution: 
0.2 g POPOP, 4 g PPO, 60 g naphthalene, 100 ml methanol, 20 ml ethylene 
glycol, per 1000 ml dioxane (Bray, 1960); and the radioactivity was
determined in a Beckman liquid scintillation counter with an efficiency of 
32
about 80% for P. The ribonuclea 
hydrolysed (counts/min/mg protein).
 . . . 32se activity was measured as ( P) rRNA
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2.9 DETERMINATION OF PROTEIN
Rat skeletal muscle (0.5 g) was minced and homogenized in 10 ml of 10%
trichloroacetic acid in a Virtis "23" homogenizer at the "high speed" 
setting at 4°C and centrifuged for 10 min at 2,400 rpm (500 g) at 4°C.
The precipitate was washed twice with 10 ml ice-cold 0,5 N perchloric 
acid, centrifuged and the supernatant was discarded. The precipitate 
(compact volume 0.5 ml) was suspended in 10 ml of IN NaOH, using a glass 
rod, and incubated at 37°C for 16 hr. A control containing only 1 N 
NaOH was similarly incubated. The samples were shaken and an aliquot 
(10 pi) from each sample was used for protein determination as described 
by Lowry et al. (1951) using bovine plasma albumin (500yg/ml in distilled 
water) as a standard.
To standards and samples, adjusted to a final volume of 0.5 ml and a final 
concentration of 0.1 N NaOH, was added 2 ml of a freshly prepared mixture 
of 50 parts 2% Na2C0  ^ in 0,1 N NaOH and 1 part 2% Na citrate, 0,4% KI and 
1% Cu SO^ ” 5 HgO. These were well mixed and allowed to stand at room 
temperature for 10 min. To each reaction mixture 0.2 ml of 2-fold
diluted Folin phenol reagent (Folin and Ciocalteu, 1927) was added very
rapidly and mixed immediately. After 45 min, the absorbance of the 
samples was determined at 750 nm against a blank in a spectrophotometer.
A standard curve for the assay is shown in Fig. 2.9.1.
2.10 DETERMINATION ' OF RNA AND DNA
The skeletal muscle (250 mg) was homogenized in 20 ml of ice-cold 10% 
trichloroacetic acid for 2 min in a Virtis model "23" homogenizer at the
Fig. 2.9.1 Standard curve for estimation of protein by
the method of Lowry
The assay was performed as described in section 2.9 using a 
standard bovine plasma albumin solution (500 yg/ml). All 
determinations were carried out in duplicates.
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"high speed" setting. Homogenization and subsequent steps were carried 
out at 4°C. The homogenate was centrifuged for 10 min at 2,400 rpm 
(500 g) and the precipitate was washed 4 times with 12 ml of ice-cold 
0.2 N perchloric acid.
The skeletal muscle RNA was determined by the method of Fleck and Munro 
(1962), as modified by Wool, Stirewalt and Moyer (1968). The perchloric 
acid precipitate was carefully drained of the acid and suspended in 1 ml 
of 0.3 N NaOH for each 50 mg of muscle, and shaken for 75 min at 37°C to 
hydrolyse the RNA. A control sample containing 0.3 N NaOH was included. 
The samples were cooled, neutralized, acidified with 1 volume of cold 1 N 
perchloric acid, allowed to stand at 0°C for 10 min to precipitate the DNA, 
and then centrifuged. The supernatant was decanted and kept aside, the 
precipitate was washed twice with 4 ml of ice-cold 0.5 N perchloric acid 
then the supernatant and washings were combined together, diluted with 
water to make the sample 0.25 N in perchloric acid and the absorbance at 
260 and 275 nm was determined using a Beckman spectrophotometer. RNA 
concentration was calculated according to the formula (Wool, Stirewalt 
and Moyer, 1968); RNA (jig/ml) = 125 A26O “ 109.5 A275.
A portion of the diluted supernatant was also used for determination of 
RNA content by the orcinol method (Mejbaum, 1939), with yeast RNA in 
5% trichloroacetic acid (200 pg/ml),as a standard. To samples (1.5 ml 
in 0.25 N perchloric acid) and standards (1.5 ml in 5% trichloroacetic 
acid), 1.5 ml of freshly prepared orcinol solution at a concentration of 
0,01 g/ml of FeClg CO.5 gm/100 ml conc. HCl) was added. Reaction mixtures 
were placed in a boiling water bath for 20 min (each tube was covered 
with a marble to prevent evaporation), allowed to cool to room temperature
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and the intensity of the green colour was measured at 660 nm against a 
blank.in a spectrophotometer, A standard curve for the assay is shown 
in Fig. 2.10.1.
The DNA precipitates Cabove) were heated for 25 rain at 70°C in 0.5 N 
perchloric acid (4 ml), centrifuged for 10 min at 2,400 rpm (500 g) and an 
aliquot from the supernatant was used for estimation of DNA by the diphenyl'­
aminé method (Burton, 1956), using calf thymus DNA in 0.5 N perchloric 
acid (250 yg/ml) as a standard.
The diphenylamine, which was stored in the dark, contained 1.5 g diphenyl'­
aminé dissolved in 100 ml of glacial acetic acid, to which 1,5 ml of 
concentrated sulphuric acid was added; and the aqueous acetaldehyde solution 
contained 0.62 ml of acetaldehyde per 40 ml distilled water (stored at 4°C). 
The samples and standards (1 ml) in 0.5 N perchloric acid were mixed with 
2 ml of freshly prepared diphenylamine reagent (prepared by mixing 20 ml 
of stock diphenylamine reagent and 0.1 ml of aqueous acetaldehyde) and 
incubated at 37°C for 16 hr with a control containing 0.5 N perchloric acid 
only. After incubation, the absorbance was measured at 600 nm against a 
blank in a spectrophotometer. A standard curve for the assay is shown in 
Fig. 2.10.2.
2.11 COMPOSITION OF STANDARD BUFFER SOLUTIONS
Medium A : 50 mM Tris-HCl (pH 7.6), 80 mM KCl, 12.5 mM MgCl2
and 250 mM sucrose.
Medium B; 50 mM Tris-HCl (pH 7.6), 80 mM KCl, 12.5 mM MgCl^
and 500 mM sucrose.
Medium C ; 50 mM Tris-HCl (pH 7.6), 250 mM KCl, 12.5 mM MgCl^
and 250 mM sucrose.
Fig. 2,10.1 Standard curve for estimation of RNA
by the orcinol method
The assay was performed as described in section 2,10 using 
yeast RNA in 5% trichloroacetic acid (200 yg/ml) as a 
standard. All determinations were carried out in duplicates,
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Fig. 2,10.2 Standard curve for estimation of DNA by the
diphenylamine method
The assay was performed as described in section 2.10 using 
calf thymus DNA in 0.5 N perchloric acid (250 yg/ml) as a 
standard. All determinations were carried out in duplicates
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Medium D: 10 mM Tris-HCl (pH 7.6), 250 mM KCl, and 10 mM MgCL,
Medium E ; 10 mM Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA and
0.5% SDS.
Medium F: 10 mM Na Acetate, 100 mM NaCl, 1 mM EDTA (pH 6).
Medium Gi 50 mM Tris-HCl (pH 7,6), 150 mM NaCl, 1 mM EDTA and 
0,5% SDS.
Medium H: 30 mM trisodium citrate, 300 mM NaCl,
CHAPTER 3
RESULTS
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3.1 INITIAL CHARACTERIZATION OF RAT SKELETAL MUSCLE RIBOSOMES
Before studying skeletal muscle mRNA it was necessary to determine the best 
conditions for extraction and fractionation of the polysomes from which this 
mRNA was to be obtained.
3.1.1 Comparison of different methods of extraction of ribosomes
In the original studies of Wool and co-workers on the effect of diabetes 
on the activity of skeletal muscle ribosomes (Stirewalt, Wool and Cavicchi, 
1967), the ribosomes were isolated using a modification of the method 
described by Florini and Breuer (1966), in which the initial homogenization 
of the tissue was in a medium of low ionic strength (80 mM KCl). However, 
in their later studies (Stirewalt, Castles and Wool, 1971) they used a 
medium of higher ionic strength (250 mM KCl), as this had been shown to 
give a greater yield of ribosomes (Heywood, Dowben and Rich, 1967; Earl 
and Morgan, 1968). However these workers had not published a comparison 
of the polysomes isolated by the two methods, and it was felt necessary to 
make such a comparison before proceeding with the study described in this 
thesis.
Fig. 3.1.1.1 shows that there was a similar proportion of polysomes in the 
ribosomes extracted at either low or high ionic strength (Experimental; 
sections 2.3.1 and 2.3.2), As the extraction at high ionic strength 
resulted in an approximate doubling of the yield of ribosomes (Table 3.1.1.1), 
it was decided to use this method in subsequent studies.
Fig. 3.1.1.1 Comparison of the sedimentation characteristics 
of ribosomes extracted from skeletal muscle in 
media of different ionic strengths
Ribosomes (2 units/0.2 ml), extracted at low ionic strength
(80 mM KCl), as described in section 2.3.1 (a), or at high 
ionic strength (250 mM KCl), as described in section 2.3.2 (b) , 
were suspended in medium containing 50 mM Tris-HCl (pH 7.6),
200 mM KCl, 5 mM MgClg, and applied to a 5.2 ml linear gradient 
of 15-45% (w/v) sucrose in the same medium. They were centrifuged 
for 35 rain at 50,000 rpm (234,000 g) in a Beckman SW 50.1 rotor 
at 4°C and analysed as described in section 2.5.1.
— 80 -
Fig. 3 .1 .1 .1 .
"c^
Q
ÜIs
BottomTop Direction of centrifugation
Table 3.1.1.1 Effect of ionic strength of extraction 
medium on the yield of skeletal muscle 
ribosomes
Rats were killed, their skeletal muscle quickly weighed 
and ribosomes were prepared at low ionic strength (80 mM KCl; 
section 2.3.1) or at high ionic strength (250 mM KCl; 
section 2.3,2), Diabetic rats had received streptozotocin 
(50 mg/kg body weight) 2 days before death, and - where 
indicated - insulin (5 units) 60 min before death. The yields 
of ribosomes were determined from the ultraviolet-absorbance 
of the resuspended pellets using the formula:
1 A.260 = 100 pg ribosomes
Values are: Mean ± S.D, (No. of determinations)
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3,1.2 Optimization of the separation of polysomes and raonosomes by 
sucrose density gradient centrifugation
In their studies on the sedimentation on sucrose density gradients of
normal skeletal muscle ribosomes extracted at low ionic strength, Stirewalt,
Wool and Cavicchi (1967) observed major peaks at 80S, 114S, 145S, 175S and
200S (These assignments were made from parallel measurements in the
Beckman Model E analytical ultracentrifuge). The 80S peak was clearly
the classical monomeric species and it was concluded that the Î458, 175?
and 2008 species were polysomes comprising three, four and five ribosomes,
respectively. However there was some ambiguity about the ’114S' species
because, unlike the higher molecular weight species,it was not removed by
incubation of the ribosomes with ribonuclease. It was concluded that this
was a dimer of the 80S species, stabilized by magnesium ions, and this
conclusion is supported by the subsequent finding that reassociated ribo-
somal subunits can also form such ’1148* species (Martin et al.,1969).
In the present work skeletal muscle ribosomes, extracted at high ionic 
strength, shpwed a similar peak to the ’114S' peak found by Stirewalt et al. 
(1967) in ribosomes isolated at low ionic strength. This peak was 
similarly resistant to ribonuclease (Fig. 3.1.2.1). It was still possible, 
however, that the original ’114S’ peak (D in b and c) contained dimeric 
polysomes containing mRNA (disomes), as well as dimers of 80S monomers, 
lacking mRNA, but stabilized by magnesium ions. It was thought desirable 
therefore, to try to find conditions to dissociate the dimers.
When muscle ribosomes extracted at low ionic strength (50 mM Tris-HCl,
80 mM KCl, 12,5 mM MgCl2) were analysed on sucrose density gradients at 
50 mM Tris-HCl, 200 mM KCl, 5 mM MgCl^ (Experimental; section 2.5.1), it 
had been found (Fig. 3.1.2.2) that there was a reduction in the proportion
Fig. 3.1.2.1 Effect of ribonuclease on the sedimentation of 
ribosomes on sucrose density gradients
Ribosomes (2 units/0.2 ml), extracted from rat skeletal
muscle at high ionic strength (250 mM KCl), were suspended in 
medium containing 50 mM Tris-HCl (pH 7,6), 200 mM KCl, 5 mM MgCl^
and incubated (a) with pancreatic ribonuclease (1 yg/ml) or
(b) without pancreatic ribonuclease for 15 min at 37°C; or
(c) without pancreatic ribonuclease for 15 min at 0°C. They
were then layered onto a 5.2 ml linear gradient of 15-45% (w/v) 
sucrose in the same medium, centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C and analysed as 
described in section 2.5.1.
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Fig.3.1.2.2 Analysis of ribosomes extracted at low ionic
strength on sucrose density gradients of different 
ionic composition
Ribosomes(2 ^260 un^ts/0.2 ml), extracted from rat skeletal 
muscle at low ionic strength (80 mM KCl; section 2.3.1) were 
suspended and centrifuged in medium containing (a) 50 mM Tris- 
HCl (pH 7.6), 80 mM KCl, 10 mM MgCl^; or (b) 50 mM Tris-HCl 
(pH 7.6), 200 mM KCl, 5 mM MgClg. The 5.4 ml linear gradients 
of 15-45% (w/v) sucrose were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C, and analysed as 
described in section 2.5.1,
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of the ’114S' peak (as well as a greater recovery of ribosomes on the 
gradients). It thus appeared that an increase in the ratio of potassium 
to magnesium ions might be reducing the formation of dimers of the 80S 
species. Ribosomes prepared at high ionic strength were therefore analysed 
on sucrose density gradients at increasing concentration of KCl.
Fig. 3.1.2,3 shows that the relative size of the '1148' peak was reduced 
on gradients containing 200 mM KCl, compared with those containing 80 mM KCl, 
but that at 350 mM KCl breakdown of polysomes appeared to occur with the 
simultaneous formation of a peak sedimenting more slowly than 80S, probably 
representing ribosomal subunits.
In the experiment to determine the effect of ribonuclease on the sedimentation 
of muscle ribosomes it was observed that the control, incubated at 37°C 
without ribonuclease, had incidentally increased the resolution of the 
different polysome species (Fig. 3.1,2,1, cf. b and c), It was thought 
possible that further disaggregation of the '114S' peak might be achieved 
by increasing the temperature of centrifugation. However when the 
centrifugation was performed in medium containing 200 mM KCl at 20^C, the 
polysome profiles appeared disturbed, and although a reduction of the '114S' 
peak did occur, there was an increase in species (presumably ribosomal 
subunits) sedimenting slower than monomers (Fig, 3,1.2,3 d), It was 
therefore decided to avoid the use of elevated temperature. In subsequent 
studies a medium containing 50 mM Tris-HCl (pH 7,6), 200 mM KCl and 5 mM 
MgCl2 was used for fractionating polysomes on sucrose density gradients and 
the '114S' peak was always combined with the monomer peak in subsequent 
fractionation of sucrose density gradients for analysis of messenger RNA,
Fig. 3.1,2,3 Effect of ionic strength and temperature on 
rat skeletal muscle ribosomes analysed on 
sucrose density gradients
Ribosomes (2 units), extracted from rat skeletal muscle at
high ionic strength (250 mM KCl; section 2,3.2), were sus­
pended in 0,2 ml of medium containing (a) 50 mM Tris-HCl 
(pH 7.6), 80 mM KCl, and 5 mM MgCl^; (b) and (d) 50 mM Tris-
HCl (pH 7.6), 200 mM KCl, and 5 mM MgCl^; (c) 50 mM Tris- 
HCl (pH 7.6), 350 mM KCl, and 5 mM MgCl^; and layered over
5.2 ml linear gradients of 15-45% (w/v) sucrose in the same 
medium. These were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50,1 rotor at 4°C (a, b and c), 
or for 25 min at 20°C (d), and analysed as described in 
section 2.5.1.
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3,1.3 Attempts to optimize the, yield and size of polysomes 
The proportion of polysomes relative to monosomes in the ribosomes obtained 
in this work was similar to that reported by others working with adult 
skeletal muscle CStirewalt, Wool and Cavicchi, 19.67; Chen and Young, 1968;
Von Der Decken, 1970; Nihei, 1971; Jefferson, Koehler and Morgan, 1972; 
Manchester, 1974). However this proportion was much less than that 
obtained from other sources, e.g. cultured cells (Jchochetman and Perry,
1972a) or embryonic muscle (lleywood, Dowben and Rich, 1967), where large 
polysomes predominate under physiological conditions. Although this 
might reflect a lower protein synthetic activity in adult muscle and, on 
average, smaller proteins being made; it was also possible that this might 
not represent the true distribution of polysomes in the cell. It might 
have resulted from ”run-offof  ribosomes (elongation and termination 
without reinitiation) or from ribonuclease contamination during the pre­
paration of the ribosomes.
One means of preventing ribosome "run-off" is with cycloheximide which, 
at suitable concentration, inhibits the elongation of protein synthesis 
(Baliga, Cohen and Munro, 1970). However, Fig. 3.1.3.1 shows that when 
skeletal muscle ribosomes were prepared using solutions to which cycloheximide 
had been added there was no change in the proportion of polysomes compared 
with Fig. 3.1.1.1.
One possible reason for this result might have been that the skeletal muscle 
was too thick to allow the cycloheximide to penetrate sufficiently quickly 
into the majority of the tissue. One type of muscle in which this problem 
could be overcome was diaphragm, the extreme thinness of which should permit 
rapid diffusion of the cycloheximide through the tissue. However it had 
not been shown whether the ribosomes of this type of muscle responded to
Fig. 3.1.3.1 Sucrose density gradient sedimentation of
ribosomes isolated from rat skeletal muscle 
in the presence of cycloheximide
Ribosomes were extracted from rat skeletal muscle at high 
ionic strength (250 mM KOI; section 2.3.2) in the presence 
of cycloheximide (added to all solutions to a concentration of 
100 yg/ml). The ribosomes (2 units) were suspended in
0.2 ml of medium containing 50 mM Tris-HCl (pH 7.6), 200 mM KOI, 
5 mM MgCl^ and applied to a 5.2 ml linear gradient of 15-45% 
(w/v) sucrose in the same medium. They were centrifuged for 
35 min at 50,000 rpm (234,000 g) in a Beckman SW 50.1 rotor at 
4°C and analysed as described in section 2.5.1.
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diabetes in the same way as those of skeletal muscle; and there was real 
doubt on this matter, in view of the report that heart muscle does not 
respond to diabetes with a reduction in the proportion of polysomes 
(Rannels et al., 1970). In fact, Fig. 3.1.3.2 shows that, in diabetes, 
diaphragm suffers a decline in polysomes, similar to that of thigh and 
gastrocnemius muscles. When diaphragm ribosomes were isolated in the 
presence of cycloheximide there was, however, no increase in the pro­
portion of polysomes (Fig. 3.1.3.3). Thus it did not appear that "run-off" 
of ribosomes was responsible for the relatively low proportion of poly­
somes ,
The second possibility was that limited cleavage of mRNA by ribonuclease 
was reducing the proportion of polysomes. To try to eliminate ribonuclease, 
ribosomes were prepared using sterilized glassware and with heparin added 
to all solutions to inhibit ribonuclease. However this did not increase 
the proportion of polysomes (Fig. 3.1.3.4). Thus while it was felt prudent 
to continue to use sterilized glassware for preparation of ribosomes, neither 
heparin nor cycloheximide were used in subsequent preparations.
Fig. 3.1.3.2 Sucrose density gradient centrifugation of 
ribosomes isolated from the diaphragm of 
normal and alloxan-diabetic rats
Ribosomes (2 units) were extracted from the diaphragms
of (a) normal rats, or (b) rats, 3 days after induction of 
diabetes with alloxan, at high ionic strength (250 mM KCl; 
section 2.3.2), suspended in 0.2 ml of medium containing 50 mM 
Tris-HCl (pH 7.6), 200 mM KCl, 5 mM MgCl2> and applied to a
5.2 ml linear gradient of 15-45% (w/v) sucrose in the same 
medium. They were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C and analysed as 
described in section 2.5.1.
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Fig. 3.1.3.3 Sucrose density gradient sedimentation of
ribosomes isolated from rat diaphragm in the 
presence of cycloheximide
Ribosomes were extracted from rat diaphragm at high ionic 
strength (250 mM KCl; section 2.3.2) in the presence of 
cycloheximide (added to all solutions to a concentration of 
100 ug/ml). The ribosomes (2 units) were suspended in
0.2 ml of medium containing 50 mM Tris-HCl (pH 7.6), 200 mM 
KCl, 5 mM MgCl^, and applied to a 5.2 ml linear gradient of 
15-45% (w/v) sucrose in the same medium. They were 'centrifuged 
for 35 min at 50,000 rpm (234,000 g) in a Beckman SW 50.1 rotor 
at 4°C and analysed as described in section 2.5.1.
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Fig. 3.1.3.4 Sucrose density gradient centrifugation of 
ribosomes isolated from rat skeletal muscle 
under conditions designed to reduce possible 
ribonuclease activity
Ribosomes were extracted from rat skeletal muscle at high ionic 
strength (250 mM KCl; section 2.3.2) in the presence of heparin 
(added to all solutions to a concentration of 1 mg/ml). The 
ribosomes units) were suspended in 0.2 ml of medium
containing 50 mM Tris-HCl (pH 7.6), 200 mM KCl, 5 mM MgCl^and 
applied to a 5.2 ml linear gradient of 15-45% (w/v) sucrose in 
the same medium. They were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C and analysed as 
described in section 2.5.1.
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3.2 THE EFFECT OF DIABETES AND INSULIN ON RAT SKELETAL 
MUSCLE POLYSOMES
3.2.1 Effect of diabetes and insulin on the sedimentation profiles 
of ribosomes
Having decided on suitable conditions to isolate ribosomes from rat 
skeletal muscle^the effect of diabetes and insulin was examined, to 
determine whether this was similar to that described previously (Stirewalt, 
Wool and Cavicchi, 196 7).
Fig. 3.2.1.1 (a and e) shows that alloxan reduced the proportion of poly­
somes and increased the proportion of monosomes and other low molecular 
weight species in skeletal muscle ribosomes extracted at low ionic strength. 
The effect of diabetes was in agreement with that found by others (Stirewalt, 
Wool and Cavicchi, 1967). The ribosomes isolated at high ionic strength 
from the skeletal muscle of rats made diabetic by alloxan also showed a 
decreased proportion of polysomes and increased proportion of low molecular 
weight species (c). The detailed shape in (c) is different from that in 
(e), but this difference was not seen on every occasion.
When insulin was injected into alloxan-diabetic rats, 60 min before death, 
and ribosomes extracted at high ionic strength, the anticipated reformation 
of polysomes did not occur (d). This result was most surprising. However, 
numerous attempts to obtain reformation of polysomes in alloxan-diabetic rats 
after injection of insulin failed, even though experiments were performed 
in which the period of diabetes was reduced or younger animals were used.
It was decided, however, to examine ribosomes extracted at low ionic strength.
Fig. 3.2.1.1. Analysis of ribosomes from rat skeletal 
muscle on sucrose density gradients
Ribosomes (1.5 A^^^ units) were suspended in 0.2 ml of medium 
containing 50 mM Tris-HCl (pH 7,6), 200 mM KCl, 5 mM MgCl^ and 
applied to a 5.2 ml linear gradient of 15-45% (w/v) sucrose 
in the same medium. They were centrifuged for 35 min at 
50,000 rpm (234,000 g) in a Beckman SW 50.1 rotor at 4°C, and 
analysed as described in section 2,5,1.
(a
(b
(c
(d
(e
(f
(g
(h
Normal rat; low ionic strength 
Normal rat; high ionic strength 
Alloxan-diabetic rat; high ionic strength
Alloxan-diabetic rat + insulin; high ionic strength
Alloxan-diabetic rat; low ionic strength
Alloxan-diabetic rat + insulin; low ionic strength
Streptozotocin-diabetic rat; high ionic strength 
Streptozotocin-diabetic rat + insulin; high ionic strength
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and in this case the injection of insulin did cause the polysomes to 
reform (f). Thus the effect of insulin on polysome reformation could be 
obtained only if the ribosomes were isolated at low ionic strength, but 
not if they were isolated at high ionic strength. It therefore appeared 
that the high ionic strength method for extraction of ribosomes produced 
some artifact which obscured the effect of insulin.
When the other diabetogenic drug, streptozotocin, was used, it was found 
that insulin caused reformation of the polysomes even when the ribosomes 
were extracted at high ionic strength (g and h). This effect of insulin 
was rapid as can be seen from Fig. 3.2.1.2, where a partial effect is 
evident 10 min after administration of insulin. These results were similar 
to those of Stirewalt et al. (1967), although those workers found more 
extensive reformation of polysomes by 5 min. Thus it seems that the arti­
fact associated with ribosomes extracted at high ionic strength from diabetic 
rats is specific for alloxan.
In the light of these observations, it was decided to select streptozotocin 
as the diabetogenic drug and this was used at the lowest effective con­
centration of 50 mg/kg body weight (see Experimental; section 2,2.3), In 
addition, low ionic strength medium was chosen for extracting the skeletal 
muscle ribosomes. Though the low ionic strength extraction gives a lower yield 
of ribosomes than extraction at high ionic strength (Table 3,1.1,1), it 
seemed prudent to avoid the latter condition. The effects of strepto­
zotocin diabetes and insulin on the sedimentation profiles of ribosomes 
extracted at low ionic strength are shown in Fig, 3.2,1.3 and were similar 
to their effects on ribosomes extracted at high ionic strength (Fig. 3.2,1.1).
Fig. 3.2.1.2 Effect of insulin on the sedimentation of
ribosomes isolated from the skeletal muscle 
of streptozotocin-diabetic rats
Ribosomes (1.5 units) were extracted at high ionic strength
(250 mM KCl; section 2.3.2) from the skeletal muscle of rats 
3 days after they had received streptozotocin. They were 
suspended in 0.2 ml of medium containing 50 mM Tris-HCl (pH 7,6), 
200 mM KCl, 5 mM MgCl^» and applied to a 5.2 ml linear gradient 
of 15-45% (w/v) sucrose in the same medium. Ribosomes were 
centrifuged for 35 min at 50,000 rpm (234,000 g) in a Beckman 
SW 50.1 rotor at 4°C, and analysed as described in section 2.5.1. 
(a) Ribosomes from rats receiving no insulin. (b) Ribosomes 
from rats receiving 5 units of insulin 10 min before death.
(c) Ribosomes from rats receiving 5 units of insulin 60 min before 
death.
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Fig. 3.2.1.3 Effect of streptozotocin-diabetes and insulin 
on rat skeletal muscle ribosomes isolated at 
low ionic strength
Ribosomes (1.5 units) were extracted from rat skeletal
muscle at low ionic strength (80 mM KCl; section 2,3.1), 
suspended in 0,2 ml of medium containing 50 mM Tris-HCl (pH 7.6), 
200 mM KCl, 5 mM MgCl2> and applied to a 5.2 ml linear gradient 
of 15-45% (w/v) sucrose in the same medium. They were centri­
fuged for 35 min at 50,000 rpm (234,000 g) in a Beckman 
SW 50.1 rotor at 4^C and analysed as described in section 2.5.1. 
(a) Ribosomes from normal rats. (b) Ribosomes from rats 
killed 2 days after having been injected with streptozotocin 
(50 mg/kg body weight). (c) Ribosomes from streptozotocin- 
diabetic rats given 5 units of insulin 60 min before death.
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To quantitate the effect of diabetes on the proportion of polysomes in 
the total ribosome population , the areas under the monosome + '114S* and 
polysome peaks were measured by tracing these out and weighing them. It 
was found that the proportion of polysomes was about 60% in muscle ribo­
somes from normal rats but was only 30% in muscle ribosomes from diabetic 
rats (Table 3,2.1.1). Thus the proportion of polysomes in the ribosomes 
from the diabetic rats was only about 50% of that in the ribosomes from 
normal rats. This difference in proportion of polysomes was quite similar 
to the difference in the activity of skeletal muscle ribosomes in cell- 
free protein synthesis in vitro, where the ribosomes from diabetic rats 
were 40% as active as those from the normal (Fig. 3.2.1.4 and Table 3.2.1.2). 
When insulin was administered to diabetic rats, the protein synthetic 
activity of ribosomes was restored to 80% of that of the normal (Fig. 3.2,1.4). 
These results were in good agreement with those of Wool and Cavicchi (1967). 
When the products synthesized in vitro were analysed by sodium dodecyl 
sulphate - polyacrylamide gel electrophoresis, the products were predominantly 
of small molecular weight (15,500 and 17,500), although some species of 
higher molecular weight were seen on prolonged exposure of the X-ray film 
(Fig. 3.2.1,5). This is consistent with the small size of the polysomes
detected on sucrose density gradients. The polypeptides synthesized by 
the ribosomes from diabetic rats were in general similar to those synthesized 
by normal rats, consistent with previous findings using discontinuous 
electrophoresis on polyacrylamide gels (Kurihara and Wool, 1968). Although 
some high molecular weight bands (112,000, 104,000, 98,000) can be seen in
the products of ribosomes from normal - but not diabetic - rats (Fig. 3.2,1.5), 
this difference was not always found.
Table 3.2,1.1 Proportion of polysomes in ribosomes from the 
skeletal muscle of normal and diabetic rats
The rats were made diabetic with streptozotocin (50 mg/kg body 
weight) and killed 2 days later. The areas under the monomers + 
’114 S’, and under the polysome peaks (of the sucrose gradient 
profiles) were measured by tracing these out and weighing them.
Figures in parentheses indicate comparison with the normal 
value of polysomes, set at 100% in each case*
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Fig. 3.2.1.4 Effect of diabetes and insulin on the protein 
synthetic activity of ribosomes from rat 
skeletal muscle assayed in a cell-free system 
from rat liver
The assay mixture (100 yl) contained: 20 mM Tris-HCl (pH 7.6),
125 mM KCl, 7.5 mM MgCl^, 5 mM 3-mercaptoethanol, 1 mM ATP
(neutralized), 0.1 mM GTP (neutralized), 5 mM creatine phosphate
(0.18 mg), 20 ug of creatine phosphokinase, 40 yg of E .coli tRNA 
3charged with ( H) phenylalanine (specific activity 5 Ci/mmole) 
and 19 non-radioactive amino acids, 0.7 mg of rat liver super­
natant protein; and various amounts of ribosomes as indicated. 
Incubation was for 30 min at 37?C, thereafter the radioactivity 
incorporated into protein was measured as described in section 
2.7.1. Diabetic rats had received streptozotocin (50 mg/kg 
body weight) 2 days before death and, where indicated, 5 units 
of insulin 60 min before death. Each 100 cpm of radioactivity 
in protein was the result of incorporation of 0.03 praole of 
phenylalanine.
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Table 3.2,1.2 Effect of diabetes on the protein synthetic 
activity of ribosomes from rat skeletal 
muscle assayed in a cell-free system from 
wheat germ
The assay mixture (50 yl) contained: 15 y1 of wheat germ
S-30 fraction, 20 mM HEPES (pH 7.6), 2 mM dithiothreitol,
1 tnM ATP (neutralized), 0.02 mM GTP, 8 mM creatine phosphate,
0.5 yg creatine phosphokinase, 0.4 mM spermidine, 180 mM KCl,
35
2.5 mM Mg acetate, 25 yCi of ( S) methionine (1080 Ci/mmole),
17 yg of ribosomes and/or water to 50 yl. Reaction mixtures 
were incubated at 25°C for 2 hr, then 5 yl aliquots were removed 
for determination of radioactivity incorporated into protein as 
described in section 2,7.2, Diabetic rats had received 
streptozotocin (50 mg/kg body weight) 2 days before death.
(Values were corrected for a background of 23,000 cpm).
Table 3.2.1.2
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Source of 
ribosomes tested
35( S) incorporation 
(cpm)
% of 
Normal
Normal rats 148,000 100%
Streptozotocin- 
diabetic rats 64,000 43%
Fig. 3.2.1.5 Sodium dodecyl sulphate gel electrophoresis 
of the translation products of rat skeletal 
muscle ribosomes
The products of translation of skeletal muscle ribosomes in a 
cell-free system from wheat germ (cf. Table 3.2.1.2) were processed 
for sodium dodecyl sulphate gel electrophoresis as described in 
section 2.7.3. Dried gels were subjected to fluorography for 
(a) 7 days or (b) 28 days,
(i) No added ribosomes 
(ii) Ribosomes (17 yg) from normal rats 
(iii) Ribosomes (17 yg) from streptozotocin-diabetic rats
The molecular weights indicated were calculated from Fig. 2.7.3.1 
and are x 10*"^  • Their accuracy is subject to the limitations noted 
in the legend to Fig. 2.7*3*1"
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3.2.2 Ribonuclease activity of rat skeletal muscle
It was desirable to account more precisely for the inability of insulin 
to reverse the effect of alloxan-diabetes (Fig. 3.2.1.1 c and d) on the 
polysomes isolated from rat skeletal muscle at high ionic strength. The 
most obvious explanation was that alloxan causes the induction or 
activation, in rat skeletal muscle, of a ribonuclease which is only 
extracted into the 'post-mitochondrial fraction* in a medium of high 
ionic strength. If this ribonuclease were not inactivated within 60 min 
of insulin injection, it would then, during extraction of the ribosomes, 
cause the degradation of polysomes that had reassembled in vivo in response 
to insulin injection. It is assumed that streptozotocin does not cause 
the appearance of this putative nuclease, presumably because of its less 
severe side effects compared with alloxan (Mansford and Opie, 1968) .
Attempts were made to detect this putative ribonuclease directly by assaying
the ability of 'post-mitochondrial supernatant' to liberate acid-soluble
products from added RNA. Initially yeast RNA was used as a substrate,
and the liberated nucleotides were detected by their ultraviolet absorbance
(Experimental; section 2.8.1). It can be seen from Table 3.2.2.1 that in
no case was the ribonuclease activity of the 'post-mitochondrial supernatant'
from the muscle of alloxan - or streptozotocin - diabetic rats higher than
that from the normal, whether the homogenization of tissue had been made in
medium of high or low ionic strength. Because the sensitivity of this
method for measurement of ribonuclease activity was relatively low, a second
32
approach was adopted in which a ( P)-labelled rRNA from HeLa cells was
used as a substrate (Experimental; section 2.8.2). However, there was
»
also no increase in ribonuclease activity in the post-mitochondrial
Table 3.2.2.1 Ribonuclease activity of rat skeletal muscle
'post-mitochondrial supernatants' assayed
with non-radioactive yeast RNA as substrate
The 'post-mitochondrial supernatant' (0.5 ml) prepared at low 
ionic strength (80 mM KCl; section 2.3.1) or at high ionic 
strength (250 mM KCl; section 2.3.2) together with 0.5 mg 
of yeast RNA in 200 mM sodium acetate-acetic acid (2 mg/ml), 
pH 7.6, were adjusted to a final volume of 2 ml in 200 mM 
sodium acetate (pH 7.6), and incubated at 37°C for 2 hr. Control 
samples lacking the supernatant or the substrate were similarly 
incubated. The ribonuclease activity was determined by 
measuring the ultraviolet-absorbance of the acid-soluble 
digestion products at 260 nm and expressed as A A2gQ/min/mg 
protein, as described in section 2.8.1.
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supernatant*from the muscle of alloxan-diabetic rats when the conversion
32
of ( P)-labelled rRNA into acid-soluble fragments was followed (Table 3,2.2.2); 
even though in this case the ribonuclease activity was somewhat higher in 
the extracts prepared at high ionic strength.
No further attempts were made to pursue this problem as it did not appear 
to be relevant to the catabolism of skeletal muscle RNA in diabetes. This 
is evident from measurements of skeletal muscle RNA under various conditions 
(Table 3.2.2.3), where the reduction in RNA content of muscle (expressed 
on a DNA basis^was found to be similar in both types of diabetes (74 and 
75% of normal for alloxan - and streptozotocin - diabetic rats respectively). 
It should be noted that this reduction in RNA content of skeletal muscle in 
diabetes is a separate effect from the reduction in activity of the ribosomes 
described in section 3.3.2, where equal amounts of ribosomes were always 
compared. Thus, diabetes reduced the rate of protein synthesis by 60%
(Fig. 3.2,1.4), over and above the reduction that would be caused by the 25% 
decrease in (ribosomal) RNA (Table 3.2.2.3). Moreover insulin causes the 
reformation of polysomes (Fig. 3.2.1.3) and the restoration in the rate of 
cell-free protein synthesis (Fig. 3.2.1.4) in less than 60 min, but does not 
restore the normal ratio of RNA to DNA in this time (Table 3.2.2.3).
It was of interest to see whether the reduction in skeletal muscle RÎ^ A in 
both types of diabetes (Table 3,2.2.3) was associated with an increase in 
the lysosomal acid ribonuclease, similar to that seen in dystrophic muscle 
(Abdullah and Pennington, 1968), Theretoie horaogenates of the skeletal muscle 
of normal and diabetic rats were assayed for ribonuclease activity with 
yeast RNA at pH 5 (Table 3.2.2.4). In this case an appreciable release 
of acid-soluble material was seen (cf. Table 3.2.2.1), but there was no 
greater ribonuclease activity in the homogenate from the diabetic animal.
Table 3.2,2.2 Ribonuclease activity of rat skeletal muscle
'post-mitochondrial supernatants' assayed
with (^^P) rRNA as substrate
Reaction conditions were similar to those in Table 3.2,2.1
32except that the buffered substrate was ( P) rRNA from HeLa 
cells. The radioactivity in the post-acidification super­
natant was determined as described in section 2.8.2. The
32ribonuclease activity was measured as ( P) rRNA hydrolysed 
(counts/min/mg protein).
Table 3.2.2.2
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Conditions of 
homogenization
rRNA hvdrolvsed 
(counts/min/ma nrotein)
Normal Alloxan-
diabetic
S treptozotocin- 
diabetic
Low ionic 
strength
453 330 226
High ionic 
strength 602 581 533
Table 3.2.2.3 Effect of diabetes and insulin on the amount of 
RNA, DNA and protein in rat skeletal muscle
The assays were performed as described in sections 2,9 and 2.10 
Rats were made diabetic by intravenous injection of alloxan 
(60 mg/kg body weight) or streptozotocin (65 mg/kg body weight) 
after having been starved overnight, and killed 3 days later. 
ïsThen treated with insulin, each rat was intraperitoneally 
injected with 5 units of insulin 60 min before death. Figures 
in parentheses are the percent change of diabetic or diabetic 
plus insulin compared with normal.
Each figure is the mean of 3 or 4 determinations.
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Table 3.2.2.4 Ribonuclease activity of rat skeletal muscle
homogenates assayed with non-radioactive
yeast RNA as substrate
Rat skeletal muscle homogenate (0.5 ml) prepared at high ionic 
strength (250 mM KCl, section 2.3.2) together with 0.25 ml 
(2 mg/ml) of yeast RNA in 200 mM sodium acetate-acetic acid 
(pH 7.6), were adjusted to a final volume of 2 ml in 200 mM 
sodium acetate (pH 5), and incubated at 37^0 for 2 hr. Control 
samples lacking the supernatant or the substrate were similarly 
incubated. The ribonuclease activity was determined by measuring 
the ultraviolet-absorbance of the acid-soluble digestion products 
at 260 nm and expressed as ^ A^^^/min/mg protein, as described in 
section 2.8.1
Table 3.2.2,4
108
Condition of rats Ribonuclease activity 
C A A^g^/min/mg protein)
Normal 0.045
Alloxan-diabetic 0.043
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3.3 QUANTITATIVE COMPARISON OF POLYA(+)RNA FROM THE SKELETAL 
MUSCLE OF NORMAL AND DIABETIC RATS
Having established suitable conditions for the isolation of skeletal muscle 
ribosomes from normal and diabetic rats, it was possible to proceed to an 
analysis of the mRNA in these ribosomes. The amounts of mRNA in cells are 
small compared with those of other RNA species, and especially compared 
with rRNA. Thus, although the sedimentation coefficients of mRNAs,generally 
differ from those of rRNAs, it.is difficult to detect mRNA by its ultra­
violet absorption when total or polysomal RNA is fractionated by sucrose 
density gradient centrifugation. For this reason mRNA is often detected 
by labelling with a short pulse of radioactive RNA-precursor, under con­
ditions where little labelling of rRNA occurs. This is possible in cultured 
cells and in rapidly metabolizing tissues such as the liver; however in 
skeletal muscle it is not possible to obtain sufficient incorporation of 
radioactive precursor into RNA (Wool and Cavicchi, 1966; Florini, 1970).
It was therefore necessary to use other means to detect and quantitate the
mRNA from this tissue. One way in which this may be done is by hybridizing 
3 .( H) polyU with the unlabelled muscle RNA under conditions favouring binding
of the homopolynucleotide to the polyA sequence at the 3’-end of the mRNA.
3The amount of bound ( H) polyU may be determined by digesting the unhybridized 
species with ribonuclease, and collecting the hybrids on glass fibre filters. 
The amount of hybrid may then be used as a measure of the amount of mRNA 
present (Rudland, Weil and Hunter, 1975). Before applying this method to 
the quantitation of skeletal muscle mRNA, its validity was first confirmed 
in the experiments described in the following section.
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33,3.1 Characterization of the ( H) polyTJ hybridization assay for 
polyA(+)RNA
. 3The hybridization assay with ( H) polyU (conducted as described in
Experimental; section 2,6) was first characterized with synthetic polyA,
3When mixtures of polyA and ( H) polyU were incubated for various times 
(Fig. 3.3.1.1) it was found that there was fairly rapid initial formation 
of hybrid and a slower increase thereafter. For the convenience of 
allowing the hybridization to proceed overnight, an incubation time of 
14 hr was adopted. It can be seen from Fig. 3.3,1.2 that the amount of
3
( H) polyU bound was linearly dependent on the amount of polyA in the 
assay, up to about 0.1 pg polyA, The ratio of polyU to polyA was 2:1, 
implying hybrids of 2 polyU:l polyA were formed under these conditions. 
Such triplexes had been found previously by other workers (Michelson 
et al., 1967). Thus, it appears from Fig, 3.3.1.1 that hybrids in the 
ratio 1 polyU;l polyA were formed in the initial 2 hr hybridization phase.
The specificity of the hybridization reaction was shown by the fact that 
tRNA from E.coli did not form hybrids with (^H) polyU (Fig. 3.3,1.3),
As the results of the hybridization assay with synthetic polyA appeared 
satisfactory, the assay was used to determine the polyA(+)RNA in the total 
RNA extracted from purified skeletal muscle ribosomes. This total RNA 
extracted from the purified ribosome pellet (Experimental; section 2,4.2) 
is predominantly ribosomal RNA (28S, IBS and 5S species), but it also con­
tains the mRNA which is, of course, associated with the polysomes (and, as 
will be seen later, with other smaller ribosomal species, to a certain
extent). For convenience this extracted RNA will be referred to as 
’polyribosomal RNA’. It can be seen from Fig, 3.3,1.4 that the amount of
Fig. 3.3.1.1 Effect of incubation time on hybridization 
of (^H) polyU and polyA
Each incubation mixture contained 0.042 pg polyA and 0.25 pg 
3( H) polyU in 0.5 ml of solution containing 30 mM trisodium 
citrate and 300 mM NaCl. Mixtures were incubated at 50°C for 
different periods, cooled and digested with pancreatic ribo­
nuclease (20 pg). The hybrids resistant to ribonuclease 
digestion were precipitated with ice-cold 10% trichloroacetic 
acid and 200 pg of carrier yeast RNA, collected and the radio­
activity was measured as described in section 2,6.
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Fig. 3.3.1.2 Hybridization of C^H) polyU with different 
amounts of polyA
3Each incubation mixture contained 0.25 yg ( H) polyU and different 
amounts of synthetic polyA in 0.5 ml of solution containing 30 mM 
trisodium citrate and 300 mM NaCl. Mixtures were incubated 
at 50°C for 14 hr, cooled and digested with pancreatic ribo­
nuclease (20 yg). The hybrids resistant to ribonuclease digestion 
were precipitated with ice-cold 10% trichloroacetic acid and 
200 yg of carrier yeast RNA, collected and the radioactivity was 
determined as described in section 2.6.
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Fig, 3.3.1.3 Specificity of C^H) polyU; polyA 
hybridization assay
3Each incubation mixture contained 0.25 yg C H) polyU and different 
amounts of E.coli tRNA or synthetic polyA in 0.5 ml of solution 
containing 30 mM trisodium citrate and 300 mM NaCl, Mixtures 
were incubated at 50°C for 4 hr, cooled and digested with pan­
creatic ribonuclease (20 yg), The hybrids resistant to ribo­
nuclease digestion were precipitated with ice-cold 10% trichloro­
acetic acid and 200 yg of carrier yeast RNA, collected and the 
radioactivity was measured as described in section 2.6.
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3Fig. 3.3.1.4 Hybridization of Ç H) polyU with polyribosomal 
RNA from normal rat skeletal muscle
3Each incubation mixture contained 0.25 yg C H) polyU and 
different amounts of polyribosomal RNA in 0.5 ml of solution con­
taining 30 mM trisodium citrate and 300 mM NaCl. Mixtures were 
incubated at 50°C for 14 hr, cooled and digested with pancreatic 
ribonuclease (20 yg). The hybrids resistant to ribonuclease 
digestion were precipitated with ice-cold 10% trichloroacetic 
acid and 200 yg of carrier yeast RNA, collected and the radio­
activity was measured as described in section 2.6,
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hybrid formed was linearly dependent on the amount of this polyribosomal
RNA added. The results of this experiment showed that 50 pg polyribosomal
3RNA bound approximately 0.1 pg ( H) polyU. As the hybrids formed are tri­
plexes composed of 2 polyUtl polyA, 50 pg polyribosomal RNA contains 
approximately 0.05 pg polyA, Thus about 0.1% of the muscle polyribosomal 
RNA consists of regions of polyA - seven experiments giving an average value 
of 0,108% (Table 3,3,1,1). This compared with a value of 0,3% for the 
polyA content of total cytoplasmic RNA from mouse fibroblasts (Rudland,
Weil and Hunter, 1975), suggesting that the values for muscle mRNA given 
by the hybridization reaction were not unreasonable. From detailed con­
siderations to be described in Discussion (section 4,1), this implies that 
about 1% of the total polyribosomal RNA is polyA(+)RNA,
3.3,2 Determination of the relative proportions of polyA(+)RNA in 
various fractions of rat skeletal muscle
As mentioned in the Introduction, one objective of this work was to
investigate the possibility of translational control in rat skeletal
muscle by examining the relative amounts and locations of mRNA in the
muscle of diabetic rats before and after injection of insulin. If there
is translational control, one would expect a similar proportion of polyA(+)RNA
to total RNA in both of these condidions. However, such anticipated
similarity between the muscle RNA in diabetic rats and in diabetic rats
treated with insulin could occur irrespective of differences or similarities
between the proportion of polyA(+)RNA in the normal and diabetic rats.
Thus, even if there were a reduction in the proportion of mRNA to total RNA
in the muscle of rats following induction of diabetes, there might be
sufficient non-polysomal mRNA to account for all the mRNA in the polysomes
that reform upon injection of insulin (Fig, 3,2,1,3).
Table 3.3.1.1 PôlyA content of purified ribosomes from 
normal rat skeletal muscle
In each experiment the amount of polyribosomal RNA (extracted 
from the purified ribosomes) was determined by its ultraviolet- 
absorbance at 260 nm, and its polyA content was measured by
3
hybridization with ( H) polyU as described in sections 2.4.2 
and 2.6.
Table 3.3.1.1
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Expt. No PolyA
Cpg per yg total RNA)
1 0.00086
2 0.00068
3 0.00108
4 0,00154
5 0.00130
6 0.00100
7 0,00112
Mean 0.00108
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Nevertheless, it was of Interest to see whether during diabetes there was 
a change in the amount of skeletal muscle mRNA and, if so, whether it was 
similar to or different from that found for total RNA (Table 3.2.2.3) and 
hence for rRNA (cf. also the results of Wool, Stirewalt and Moyer, 1968). 
Therefore the polyA(+)RNA content of intact skeletal muscle was examined.
This was done by extracting the RI^ A from the intact tissue (see Experimental;
section 2.4.1) and determining the ratio of polyA(+)RNA (determined from 
3
the ( H) polyU hybridization assay) to total RNA (determined from measure­
ment of ultraviolet absorbance at 260 nm). Table 3,3.2.1 summarizes the 
results obtained from five separate experiments using skeletal muscle of 
normal, streptozotocin - diabetic and streptozotocin - diabetic rats after 
treatment with insulin for 60 min. It is clear that the polyA(+)RNA 
constitutes a similar proportion of the total muscle RNA in both normal and 
diabetic rats. Thus in diabetes it appears that the amount of muscle mRNA 
decreases to the same extent as does the total RNA (which has declined by 
about 25% with respect to DNA, 3 days after induction of diabetes by 
streptozotocin - Table 3.2,2.3).
Table 3.3.2.1 also shows that the ratio of polyA(+)RNA to total RNA is 
similar in both the diabetic rats and the diabetic rats treated with insulin 
for 60 min. This, then,was consistent with the idea of translational 
control. However it was possible that, in extracting the total tissue 
polyA(+)RNA, measurements of cytoplasmic mRNA were obscured by the polyA(+)RNA 
in heterogeneous nuclear RNA, also being extracted. Therefore the 
polyA(+)RNA content of the different subfractions of skeletal muscle 
(see Fig. 3.3.2.1) were examined (Table 3.3.2.2), Unfortunately the
Table 3,3.2.1 Proportion of polyA(+)RNA to total RNA in 
unfractionated skeletal muscle from 
normal and diabetic rats
Diabetic rats had received streptozotocin (50 mg/kg body weight)
2 days before death and, where indicated, 5 units of insulin
60 min before death. The RNA (extracted from the unfractionated
muscle as described in section 2.4.1) was determined by its
ultraviolet-absorbance at 260 nm, and its polyA content was
3measured by hybridization with ( H) polyU as described in 
section 2.6. Figures in parentheses indicate comparison with 
a normal value set at 100%.
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Fig. 3.3.2.1 Summary of different fractions obtained during 
preparation of skeletal muscle ribosomes
Rat skeletal muscle was homogenized and fractionated as 
described in section 2.3.1. (This figure is identical to 
Fig. 2.3.1.1).
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Fig. 3. 3.2.1.
SKELETAL MUSCLE
HOMOGENATE
,  1 ,
Mitochondrial Pellet Post-Mitochondrial S/T
Microsome Pellet Post-Microsomal S/T
I
Ribosome Pellet Post-Ribosomal S/T
Table 3.3.2.2 Distribution of total RNA and polyA(+)RNA
between different fractions of rat skeletal 
muscle
A part of the intact rat skeletal muscle was directly extracted
with phenol as described in section 2.4.1 and the rest of muscle
was homogenized at low ionic strength (80 mM KCl; section 2.3.1).
A portion of each fraction was used to determine the RNA content
in that fraction and the rest was used for further fractionation.
The RNA in each case was extracted with phenol as described in
section 2.4.2, and its ultraviolet-absorbance at 260 nm was
determined. The polyA content was measured by hybridization 
3with ( H) polyU as described in section 2.6. (In the case of 
supernatant fractions, a portion of each supernatant was pre­
cipitated with 95% ethanol in the presence of 100 mM NaCl at -20°C 
for 16 hr, and the precipitates were extracted with phenol there­
after) . The values of RNA content in different fractions were 
normalized to 100 yg RNA as the initial amount, and to 100% 
recovery at each stage.
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comparative values of polyAC+)RNA to total RNA for the intact tissue are 
atypical in this experiment Cthat from the diabetic being 137% of that 
from the normal), as can be seen by comparison with Table 3.3.2.1.
Moreover there were some inconsistencies between the total polyA(+)RNA 
in individual fractions and the subfractions derived from them (e.g. cf.
# f f
the ’microsomal pellet' with the sum of the ribosome pellet and post-
t
ribosomal supernatant). But despite these deficiencies, this experiment 
was important, for it indicated that there was no stage in the purification 
of ribosomes where the ribosome-containing fraction derived from the diabetic 
animal lost polyA(+)RNA relative to that from the normal, with the 
polyA(+)RNA appearing in a non-ribosomal fraction. Thus it appeared 
that the ribosome pellets derived from the muscles of the normal and diabetic 
rats contained similar proportions of polyA(+)RNA, although this conclusion 
was not completely unequivocal because the polyA(+)RNA content of the 
original intact muscle was higher in the diabetic rat than in the normal. 
However this conclusion was confirmed by the results of subsequent measure­
ments on the purified ribosome pellets (Table 3, 3.2,3). These results 
also showed a similar proportion of polyA(+)RNA for the diabetic rats and 
the diabetic rats after treatment with insulin, confirming the conclusion 
of translational control by insulin, suggested by Tables 3.3.2.1 and 
3.3.2.2.
The finding of similar proportion of polyA(+)RNA in ribosomes from normal 
and diabetic rats was of some significance, for the proportion of polysomes 
in the sucrose density gradient sedimentation profiles of ribosomes from 
normal and diabetic rats was different (Fig. 3.2.1.3), implying a different 
content of polysomal mRNA. This suggested that in the ribosome pellet 
from the diabetic rat there was non-polysomal mRNA co-sedimenting with the
Table 3.3.2.3 Comparison of polyA content of purified 
ribosomes from skeletal musclé of normal 
and diabetic rats
Diabetic rats had received streptozotocin (50 mg/kg body weight)
2 days before death and, where indicated, 5 units of insulin
60 min before death. The purified ribosomes prepared at low
ionic strength (section 2.3.1) were extracted with phenol as
described in section 2.4.2. The total RNA was determined by its
ultraviolet-absorbance at 260 nm and the polyA by hybridization 
3with ( H) polyU as described in section 2.6. Figures in 
parentheses indicate comparison with a normal value set at 100%.
N.D. = not determined.
Table 3.3.2.3
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PolyA Cpg per yg total RNA)
Expt. No.
Normal Diabetic
Diabetic
Insulin
1 0.00086(100)
0.00079
(92)
0.00110
(128)
2
0.00108
(100)
0.00104
(96)
0.00125
(116)
3
0.00112
(100)
0.0087
(78) N.D.
Mean 
(% of Normal)
0.00102
(100)
0.00090
(88)
0.00118
(116)
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ribosomes, perhaps as messenger ribonucleoprotein particles.
To determine whether this was the case, equal amounts of ribosomes (con­
taining similar amounts of polyA(+)RNA)from normal and diabetic rats were 
applied to sucrose density gradients,and fractions collected as shown in 
Fig. 3.3.2,2. In each fraction, the ribosomes were precipitated with 
95% ethanol in the presence of 100 mM NaCl, dissolved in sodium dodecyl 
sulphate-containing Medium E and extracted with phenol and chloroform as 
described in Experimental (section 2.4.2). The total RNA recovered was '
determined by its ultraviolet absorbance at 260 nm, and the polyA(+)RNA
3
by hybridization with ( H) polyU. It can be seen from Table 3.3.2,4 that, 
as expected, most of the polyA(+)RNA was within the polysome fraction (3) 
from the ribosomes of normal rats and diabetic rats treated with insulin.
This polyA(+)RNA disappeared from the diabetic fraction, in proportion to 
the decline in polysomes (Fig. 3.3.2.2). However, surprisingly, no other 
fraction of the gradient of the ribosomes from the diabetic rats contained 
an amount of polyA(+)RNA greater than in the fraction of the sucrose density 
gradient of the ribosomes from the normal rats; in contrast to what would 
have been expected from the fact that similar amounts of poIyA(+)RNA were 
applied to each gradient. This can be seen most easily from the bar diagram 
in the lower part of Fig. 3.3.2.2, which is taken from the more detailed 
analysis in Table 3.3.2.4. Inspection of the latter shows that incomplete 
recovery of polyA(+)RNA was obtained in all cases. However, whereas the 
recoveries for the RNA from normal rats and the diabetic rats treated with 
insulin were 56% and 61% respectively that for the RNA from the diabetic 
rats was only 25%
It was thought possible that these losses of polyA(+)RNA might be in the
Fig. 3.3.2.2. Summary of polyAC+)RNA in different fractions 
of normal arid diabetic rat skeletal muscle 
ribosomes analysed by sucrose density gradient 
centrifugation
Ribosomes (4 A^^q units) from (a) normal, (b) streptozotocin- 
diabetic rats and (c) streptozotocin-diabetic rats treated with 
insulin 60 min before death, were suspended in 0.2 ml of medium 
containing 50 mM Tris-HCl (pH 7.6), 200 mM KCl, 5 mM MgCl2» and 
applied to a 5.2 ml linear gradient of 15-45% (w/v) sucrose in 
the same medium. They were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C, and analysed as 
described in section 2.5.1. Three fractions were collected 
from each gradient as indicated by the dotted lines. The RNA in 
each fraction was precipitated with 95% ethanol in the presence of 
100 mM NaCl at -20°C for 16 hr, and the precipitates were extracted 
with phenol as described in section 2.4.2. The RNA was determined
by its ultraviolet absorbance at 260 nm and the polyA by hybridiza-
3tion with ( H) polyU as described in section 2.6.
The bar diagram in the lower panel represents the polyA recovered 
in the different fractions.
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Table 3.3.2.4 PolyA(+)RNA in different fractions of normal and 
diabetic rat skeletal muscle ribosomes analysed 
by sucrose density gradient centrifugation
This table presents the detailed figures for the experiment
described in the legend to Fig. 3.3.2.2.
"k
These values were corrected to 100% recoveries of the RNA 
applied to the gradients, this later being normalized to 100 ug.
The original amounts of ribosomal RNA applied to the sucrose 
gradients were 200 yg from normal, 200 yg from diabetic rats, 
and 181 yg from diabetic rats treated with insulin. The 
recoveries were 6 7.5%, 81.9% and 67.7% in RNA from normal, diabetic, 
and diabetic rats treated with insulin, respectively. The values 
for 'Total applied' RNA were obtained by direct extraction of a
portion of the same ribosome pellets.
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very high molecular weight material (probably aggregated) which was 
observed as small pellets at the bottom of the tubes after centrifugation. 
Because of the difficulty in recovering these pellets after piercing the 
bottom of the tubes for fractionation, it was decided to try to prevent 
the pelleting of the high molecular weight aggregates by layering a 
'cushion' of 70% sucrose at the bottom of the tubes.
It can be seen from Fig. 3.3.2.3 that a considerable amount of ultraviolet 
absorbing material was found on this sucrose 'cushion'. When the 
polyA(+)RNA of these sucrose'cushion'fractions (3) was analysed, it was 
found that that from the ribosomes of the diabetic rats was greater than 
that from the ribosomes of the normal rats. Moreover this excess approximately 
compensated for the extent to which the polyA(+)RNA was greater in polysome 
and subpolysome fractions from ribosomes derived from normal rats, com­
pared with those from ribosomes derived from diabetic rats (lower part of 
Fig. 3.3.2.3 and Table 3,3.2.5).
The recovery on this fractionated gradient of much of the polyA(+)RNA, 
previously lost from the ribosomes of diabetic rats, was a result of prime 
importance in this work. Because of the possibility of errors in analysis 
of Jthe subfractions from which the totals -were summed in Table 3.3.2.5, the 
total RNA from a similar, but unfractionated, gradient was also analysed 
in the same experiment, and similar values for the proportion of polyA(+)RNA 
in ribosomes from normal and diabetic rats were observed (Table 3.3.2,6).
Although the ultraviolet-absorbing material collected on the sucrose 
'cushion' (fraction 3 of Fig. 3.3.2,3) was relatively rich in polyA(+)RNA 
(Table 3.3.2.5), it contained predominantly non-polyA(+)RNA. Hence it
Fig. 3.3.2.3 Summary of polyA(+)RNA in different fractions 
of normal and diabetic rat skeletal muscle 
ribosomes analysed by sucrose density gradient 
centrifugation with a sucrose 'cushion'
Ribosomes (4 A^^q units) from (a) normal and (b) streptozotocin- 
diabetic rats were suspended in 0.2 ml of medium containing 50 nM 
Tris-HCl (pH 7.6), 200 mM KCl, 5 mM MgCl2, and applied to a 5.2 ml 
linear gradient of 15-45% (w/v) sucrose in the same medium with 
0.3 ml of 70% sucrose at the bottom. They were centrifuged for 
35 min at 50,000 rpm (234,000 g) in a Beckman SW 50.1 rotor at 
4°C, and analysed as described in section 2.5,1. Three fractions 
were collected from each gradient as indicated by the dotted lines, 
the RNA in each fraction was precipitated with 95% ethanol in the 
presence of 100 mM NaCl at -20^C for 16 hr, and extracted with 
phenol (section 2.4.2). In each fraction, the RNA was determined 
by its ultraviolet-absorbance at 260 nm and the polyA by hybridiza- 
tion with ( H) polyU. The bar diagram in the lower panel 
represents the polyA recovered in each fraction.
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Fig. 3.3 .2.3.
(b) Diabetic(a) Normal
0,06 0.06
0.050.05
Total
PolyA
(jug)
0.040.04
0.030.03
0.020.02
0 . 010.01
Table 3.3.2.5 PoIyA(+)RNA in different fractions of normal 
and diabetic rat skeletal muscle ribosomes 
analysed by sucrose density gradient centri­
fugation with a 70% sucrose 'cushion*
This table presents the detailed figures for the experiment 
described in the legend to Fig. 3.3.2,3.
A
These values were corrected to 100% recoveries of the RNA 
applied to the gradients, this later being normalized to 100 yg. 
The original amounts of ribosomal RNA applied to the sucrose 
gradients "were 200 yg from normal, and 148,8 yg from the diabetic 
rats. The recoveries were 46.9% and 62,2% in RNA from normal 
and diabetic rats respectively.
The values for ’Total applied’ RNA were obtained by direct 
extraction of a portion of the same ribosome pellets.
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Table 3.3.2.6 Comparison of different analyses of the
proportion of polyA(+)RNA in skeletal muscle 
ribosomes from normal and diabetic rats
The ratio of polyA(+)RNA to total RNA in a single preparation 
of ribosomes was determined either by direct extraction (cf. 
legend to Table 3.3.2.3); in the sucrose gradient fractions 
indicated in Fig. 3.3.2.3; or in a similar gradient to 
Fig. 3.3.2.3 that was not fractionated.
Table 3.3.2,6
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PolyA/Total RNA
Source of 
RNA Normal Diabetic
Diabetic 07 
Normal
Ribosome pellet 0.00112 0.00087 78%
Fractionated 
sucrose gradient 0.00123 0.00101 82%
Unfractionated 
sucrose gradient 0.00095 0.00075 79%
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seemed likely that this ultraviolet-absorbing material was predominantly 
ribosomes (presumably in an aggregated form). This would be consistent 
with the incomplete recovery of RNA applied to the gradient (Table 3.3.2,4).
To determine whether this was in fact so, the RNA extracted from this ' 
cushion fraction was subjected to sucrose density gradient centrifugation 
in sodium dodecyl sulphate-containing Medium G as described in Experimental 
(section 2,5,3). Fig. 3,3,2.4 shows that this RNA was predominantly 18S 
and 28S, which is consistent with the ultraviolet absorbing material of 
the sucrose * cushion' fraction being predominantly ribosomes.
It appeared that the extra polyA(+)RNA in the sucrose 'cushion* from 
ribosomes of diabetic rats (Fig, 3.3.2.3 - Table 3,3,2,5) might be in 
messenger ribonucleoprotein particles, trapped with the aggregated ribosomes. 
Attempts were therefore made to obtain conditions which would prevent the 
putative messenger ribonucleoprotein particles being precipitated in this 
way, allowing their true sedimentation value to be investigated.
Elevated temperature had been found to enhance the resolution of different 
polysome species on sucrose density gradient analysis (Fig. 3.1.2,0 and 
therefore it was thought that preincubating the ribosomeyat 37^C might 
possibly reduce the aggregation of ribosomes, and hence allow the polyA(+)RNA 
to sediment in its authentic form. However Fig. 3.3,2.5 shows that there 
was still a large amount of ultraviolet-absorbing material on the sucrose 
'cushion' when the gradients were performed under these modified conditions. 
Hence the problem of aggregation could not be overcome by these means.
The second approach to this problem was rather different. Most analyses of 
messenger ribonucleoprotein particles have been performed on 'post-mitochondrial
Fig. 3.3.2.4 Sucrose density gradient analysis of RNA 
extracted from the sucrose 'cushion'
The RNA in the sucrose 'cushion' fractions of Fig. 3,3.2,3 was 
precipitated by 95% ethanol in the presence of 100 mM NaCl at 
-20°C for 16 hr. The precipitates were extracted with phenol 
(section 2.4.2), reprecipitated, and 25 pg RNA from (a) normal 
and (b) diabetic rats was resuspended in 0.2 ml of medium con­
taining 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA and 
0.5% sodium dodecyl sulphate and applied to a 5 ml linear 
gradient of 7-25% (w/v) sucrose in the same medium. They were 
centrifuged for 2.5 hr at 45,000 rpm (189,000 g) in a Beckman SW 50.1 
rotor at 20°C, and analysed as described in section 2.5.3.
The first peak in (b) is probably machine 'noise'. The S values 
are nominal.
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Fig. 3,3.2.5 Sucrose density gradient analysis of rapidly 
sedimenting material from normal and 
diabetic rat skeletal muscle ribosomes pre- 
incubated at 4°C and 37‘^C
Ribosomes (1.5 units) from the skeletal muscle of normal
(a and b) and diabetic (c and d) rats were suspended in 0.2 ml 
of medium containing 50 mM Tris-HCl CpH 7.6), 200 mM KCl,
5 mM MgCl2> incubated for 15 min at 4°C (a and c) or 37°C 
(b and d), and applied to a 5.2 ml linear gradient of 15-45% 
(w/v) sucrose in the same medium with 0.3 ml of 70% sucrose at 
the bottom. They were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C, and analysed as 
described in section 2.5.1.
F ig .  3. 3 . 2 . 5 .
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supernatants^ rather than purified ribosomes (e.g. Jacobs-Lorena and 
Baglioni, 1972; Bester, Kennedy and Heywood, 1975). Towards the end of 
this work it was discovered that pelleting of messenger ribonucleoprotein 
particles can cause their aggregation (M.E, Buckingham, personal communication), 
although other reports do not indicate this (Huynh-Van-Tan and Schapira,
1978). Clearly it was desirable therefore to analyse the polyA(+)RNA in 
the 'post-mitochondrial supernatant' from rat skeletal muscle. However in 
initial studies when the 'post-mitochondrial supernatant’ (prepared as 
described in Experimental; section 2.3.1) was displayed on sucrose density 
gradients, little ultraviolet-absorbing material could be detected and most 
of the ribosomes were sedimented to the bottom of the centrifuge tube under 
the conditions used. The latter result was observed even when the con­
centration of KCl in the homogenizing medium was increased to the 250 mM 
used in the preparation of ribosomes in this work (section 2.3.2), or in 
the work of Chen and Young C1968) for the analysis of the 'post-mitochondrial 
supernatant' of rat skeletal muscle by sucrose density gradient centri­
fugation (Fig. 3.3.2.6 a). Indeed, it was for this reason that most of 
the studies already described in this work had been concentrated on the 
purified ribosome fraction. However at this stage it was felt important 
to make further attempts to display the 'post-mitochondrial supernatant’ on 
a sucrose density gradient. This was achieved using the procedure of 
Chen and Young (1968), modified so that the concentration of KCl, in the 
homogenizing medium was 350 mM (section 2.3.3). Even under these conditions, 
however, the majority of the ribosomes were still aggregated and sedimented 
to the bottom of the tubes. (Fig. 3,3.2,6 b).
Although this preparation of 'post-mitochondrial supernatant' did not 
prevent the aggregation of ribosomes, it did appear that in the case of the
Fig. 3.3.2.6 Sucrose density gradient centrifugation
of 'post-mitochondrial supernatants' from 
rat skeletal muscles extracted at different 
ionic strengths
A 'post-mitochondrial supernatant' (1.5 ml) prepared as 
described in section 2,3.3 either (a) in medium containing 
10 mM Tris-HCl (pH 7.6), 250 mM KCl, 10 mM MgCl^ or (b) in 
medium containing 10 mM Tris, 350 mM KCl, 10 mM MgCl^, was 
applied to a 37 ml linear gradient of 15-40% (w/v) sucrose 
made in the same medium. They were centrifuged' for 3 hr at 
2 7,000 rpm (94,500 g) in a Beckman SW 27 rotor at 4°C, and 
analysed as described in section 2.5.2.
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normal rat, there were relatively more large polysomes than had been 
observed in previous analyses of purified ribosomes (Fig, 3.3,2,6 b - 
cf. with Fig, 3,1.1.1), although the resolution of the individual peaks 
was poor. Because it was of interest to obtain larger polysomes, and as 
there was a clear difference between the ’post-mitochondrial supernatant' 
from normal and diabetic rats (Fig. 3,3,2.7) the ’post-mitochondrial 
supernatant' was pelleted and the ribosomes analysed by analytical sucrose 
density gradient centrifugation in the hope of getting better resolution 
of individual peaks. However this re-analysis gave profiles of polysomes 
no larger than those from purified ribosomes (Fig, 3.3,2,8 - cf. with 
Fig. 3,2.1,3),
Thus it has not been possible to determine whether or not the extra polyA(+) 
RNA, associated with the ribosomal aggregates from diabetic rats, derives 
from messenger ribonucleoprotein particles.
Fig. 3.3.2.7 Sucrose density gradient analysis of
'post-mitochondrial supernatants' from 
skeletal muscle of normal and diabetic 
rats prepared at 350 mM KCl
The 'post-mitochondrial supernatant' (1.5 ml) prepared as 
described in section 2.3.3 from (a) normal or (b) diabetic 
rats, in medium containing 10 mM Tris-HCl (pH 7.6), 350 mM 
KCl, 10 mM MgCl^j was applied to a 37 ml linear gradient of 
15-40% (w/v) sucrose made in the same medium. They were 
centrifuged for 3 hr at 27,000 rpm (94,500 g) in a Beckman 
SW 27 rotor at 4°C, and analysed as described in section 2.5.2
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Fig. 3.3.2.8 Sedimentation profiles of ribosomes from 
rat skeletal muscle extracted at 
350 mM KCl
The ’post-mitochondrial supernatant’ from (a) normal, or (b) 
diabetic rats, described in the legend to Fig. 3.3,2.7, was 
layered on 5 ml of 500 mM sucrose containing 50 mM Tris-HCl 
(pH 7.6), 80 mM KCl, 12.5 mM MgCl2> and centrifuged for 3 hr 
at 50,000 rpm (165,000 g) in a Beckman 50 Ti rotor at 4°C.
The ribosome pellets were suspended in 0.2 ml of medium 
containing 50 mM Tris-HCl (pH 7.6), 200 mM KCl, 5 mM MgCl2» and 
applied to a 5.2 ml linear gradient.of 15-45% (w/v) sucrose in 
the same medium. They were centrifuged for 35 min at 50,000 rpm 
(234,000 g) in a Beckman SW 50.1 rotor at 4°C, and analysed as 
described in section 2.5.1.
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3.4 QUALITATIVE COMPARISONS OF POLYA(+)RNA FROM THE SKELETAL MUSCLE 
OF NORMAL AND DIABETIC RATS
3.4.1 Comparison of the size of polyA sequences in skeletal muscle 
polyribosomal polyA(+)RNA
One important assumption in the quantitation of mRNA from the skeletal muscle
3of normal and diabetic rats by hybridization to ( H) polyU is that the size 
of the polyA sequences is the same under both physiological conditions.
However it has been found in mouse ascites cells (Mendecki, Lee and Brawerman, 
1972) and in HeLa cells (Sheiness and Darnell, 1973) that the size of the 
polyA sequence decreases with the age of the mRNA. Thus it was important 
to see whether the size of the polyA sequence was the same in the mRNA from 
the skeletal muscle of normal and diabetic rats, to determine whether the 
quantitation in section 3.3. was in fact valid.
Two different approaches to this problem were adopted. The first, which
was chosen for ease and simplicity, entailed hybridization of the polyribosomal
RNA to ( H) polyU, digestion with ribonuclease, fractionation by sucrose
density gradient centrifugation and measurement of the radioactivity of
different fractions (see section 2.5.3 and the legend to Fig. 3.4.1.1).
3Fig. 3.4.1,1 shows the sedimentation profiles of hybrids between ( H) polyU 
and polyA sequences from skeletal muscle polyribosomal RNA which were 
resistant to pancreatic ribonuclease digestion. It is evident that the 
polyA sequences from the mRNA of the skeletal muscle of the diabetic rat 
were similar :in size to those of the normal, with a peak at a sedimentation 
coefficient of about 5S.
3
Fig. 3.4.1.1 Sedimentation profiles of hybrids between ( H)
polyU and polyA tracts from rat skeletal muscle
polyribosomal RNA
Polyribosomal RNA (50 pg) from normal (#— •— •) or streotozotocin-
(specific activity 512 ^Ci/pmole P)
diabetic (0— 0— 0) rats was mixed with 0.01 ug ( H) polyU and 
the volume was adjusted to 0.2 ml in medium containing 50 mM Tris- 
HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA and 0.5% sodium dodecyl 
sulphate. The mixtures were incubated at 50°C for 14 hr, cooled 
to 20°C and digested with pancreatic ribonuclease (section 2.6).
Samples were then layered on a 5 ml linear gradient of 7-25% (w/v) 
sucrose in the medium mentioned above. The gradients were 
centrifuged for 4 hr at 45,000 rpm (189,000 g) in a Beckman SW 50.1 
rotor at 20°C, analysed, fractionated and the radioactivity was 
measured as described in section 2.5,3. E.coli tRNA (4S) and rat 
skeletal muscle ribosomal RNA (18S) were used as markers on a
parallel gradient. Limiting concentrâtions of,(^H) poly U were 
necessary in this and subsequent direct hybridization experiments 
to prevent the profiles being obscured by a large peak of 
unhybridized (^ Hi) polyU.
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As the experiments described above compared the sedimentation of hybrids of
3the polyA sequences and C H) polyU, the value of the sedimentation co­
efficient obtained would be expected to be larger than that for the polyA 
sequence alone. It was conceivable that this might obscure a difference 
in the sizes of the polyA sequences. Therefore a second approach was
adopted, in which the ENA was first digested, sedimented on sucrose density
3gradients and fractionated, before being hybridized with Q H) polyU,
Fig, 3,4.1.2 shows the sedimentation pattern of polyA sequences from normal 
and diabetic rats in two experiments. These experiments indicated that the 
sedimentation coefficient of the polyA sequence was about 4S in material 
from the mENA of the muscle of both normal and diabetic rats. This sedimentation 
value was slightly lower than that obtained in the experiment in Fig, 3,4.1,1, 
as had been anticipated. In one experiment, Ca), the polyA sequence from 
the diabetic rats appeared at a slightly higher sedimentation coefficient than 
that from the normal rats, the median value being displaced by about one 
fraction. However this difference was not seen in a second experiment, Cb), 
where the median sedimentation coefficient for polyA from the diabetic rats 
was, if anything, somewhat lower than that from the normal.
Thus it was concluded that diabetes does not cause any significant alteration 
in the size of the polyA sequence at the 3’^ end of skeletal muscle mRNA, 
and hence does not invalidate the basis of quantitation of mRNA used in this 
work.
3,4,2 Comparison of the size of polyA(+)RNA from the skeletal muscle of 
normal and diabetic rats
It was also of interest to compare the size of polyAC+)RNA extracted from
the ribosome pellets from skeletal muscle of normal and diabetic rats.
Fig. 3.4.1.2 Sucrose density gradient sedimentation profiles
of polyA tracts from rat skeletal muscle
polyribosomal RNA
Polyribosomal RNA (50 ug) from normal (f— •— #) or streptozotocin -
diabetic (0— 0— 0) rats was suspended in medium containing 10 mM
Tris-HCl (pH 7.4), 100 mM NaCl, 1 mM EDTA and 0.5% sodium dodecyl
sulphate and incübated with pancreatic ribonuclease CIO pg) and
T^ ribonuclease (10 pg) for 2 hr at 37°C. The mixtures were
then extracted with phenol (section 2.4.2), precipitated with 95%
ethanol at -20°C, resuspended in medium (0.2 ml) containing 50 mM
Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA and 0.5% sodium dodecyl
sulphate, and applied to a 5 ml linear gradient of 7-25% (w/v)
sucrose in the same medium. The gradients were centrifuged for
4 hr at 45,000 rpm (189,000 g) in a Beckman SW 50.1 rotor at 20°C,
3analysed and fractionated as described in section 2.5.3*( H) polyU 
(0.01 pg) was then added to each fraction, and the mixtures 
(0.5 ml in Medium H) were incubated at 50°C for 14 hr. The hybrids 
formed were digested with pancreatic ribonuclease, collected, and 
the radioactivity was measured as described in section 2.6.
(a) and (b) show the results of two separate experiments.
Fig. 3.4.1.2.
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This was done by analogous methods to those used in section 3.4.1.
3Fig. 3.4.2.1 shows the sedimentation profiles of hybrids of ( H) polyU 
with polyA(+)RNA from the skeletal muscle of normal and diabetic rats.
The size distribution was similar in the two cases, the range of sedimentation 
coefficients being from about 5S-18S. In this experiment there appear to 
be two distinct peaks at about 6S and 8S, although it is not clear whether 
these really represent separate species.
The presence of large polyA(+)RNA species sedimenting faster than 18S 
under the conditions used is unlikely, since when the centrifugation time 
was decreased, no substantial radioactivity above the background could be 
detected (Fig. 3.4.2.2).
Similar results were obtained when the polyA(+)MA was analysed by the 
second method, involving fractionation on sucrose density gradient 
followed by hybridization analysis of individual fractions (Fig. 3.4.2.3).
The sedimentation distribution of the polyA(+)RNA was again in the range 
4S-18S and was similar for RNA derived from the skeletal muscle of normal 
and diabetic rats with a median value around 9.58.
As the most predominant polyAC+)RNA species from the skeletal muscle
ribosomes of normal and diabetic rats were of small molecular size (Fig.3.4.
2.1), it was thought that this might possibly be due to degradation of
the mRNA during isolation of ribosomes. Therefore polyA(+)RNA extracted
from unfractionated skeletal muscle was subjected to sucrose density
3gradient analysis after having been hybridized to C H) polyU. However it 
is clear from Fig. 3.4.2.4 that the predominant polyA(+)RNA species were 
again of small molecular size.
Fig. 3.4.2.1 Sedimentation profiles of hybrids between
(bH) polyU and polyA(+)RNA from rat skeletal
muscle polyribosomal RNA
Polyribosomal RNA (50 pg) from normal (#— 9— #) or strepto- 
zotocin - diabetic (0— 0— 0) rats was mixed with 0.01 pg ( H) 
polyU. The volume was adjusted to 0.2 ml in medium containing 
50 mM Tris-HCl (pH 7\6), 150 mM NaCl, 1 mM EDTA and 0.5% 
sodium dodecyl sulphate, and applied to a 5 ml linear gradient 
of 7-25% (w/v) sucrose in the same medium. The gradients were 
centrifuged for 4 hr at 45,000 rpm (189,000 g) in a Beckman 
SW 50.1 rotor at 20°C, analysed, fractionated and the radioactivity 
was measured as described in section 2.5.3.
E.coli tRNA (4S) and rat skeletal muscle ribosomal RNA (18S) 
were used as markers on a parallel gradient.
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3Fig. 3.4,2.2. Sedimentation profiles of hybrids between Ç H) 
polyU and polyA(+)RNA from rat skeletal muscle 
polyribosomal RNA, analysed under conditions 
allowing detection of larger species
Polyribosomal RNA (25 ug) from normal (•— #— #) or streptozotoein-
3
diabetic (0— 0— 0) rats was mixed with 0.025 ug ( H) polyU. The 
volume was adjusted to 0.2 ml in medium containing 50 mM Tris- 
HCl (pH 7,6), 150 mM NaCl, 1 mM EDTA and 0.5% sodium dodecyl sulphate, 
and applied to a 5 ml linear gradient of 7-25% (w/v) sucrose in the 
same medium. The gradients were centrifuged for 3 hr at 45,000 rpm 
(189,000 g) in a Beckman SW 50.1 rotor at 20°C, analysed,
' fractionated, and the radioactivity was measured as described in 
section 2.5.3.
E.coli tRNA (4S) and rat skeletal muscle ribosomal RNA QSS and 
28S) were used as markers on a parallel gradient.
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Fig. 3.4.2.3 Sucrose density gradient sedimentation profiles
of polyA(+)RNA from rat skeletal muscle
polyribosomal RNA
Polyribosomal RNA (50 ug) from normal (#— # — #) or streptozotocin-
diabetic (0— 0— 0) rats was suspended in 0.2 ml of medium
containing 50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA and
0.5% sodium dodecyl sulphate, and applied to a 5 ml linear
gradient of 7-25% (w/v) sucrose in the same medium. The
gradients were centrifuged for 4 hr at 45,000 rpm (189,000 g)
in a Beckman SW 50.1 rotor at 20^0, analysed and fractionated .
3as described in section 2.5.3. ( H) polyU (0.01 ug) was then 
added to each fraction, and the mixtures (0.5 ml in Medium H) 
were incubated at 50°C for 14 hr. The hybrids formed were 
digested with pancreatic ribonuclease, collected, and the radio­
activity was measured as described in section 2.6.
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Fig. 3.4.2.4 Sedimentation profiles of hybrids between
(3h ) polyU and polyA(+)RNA from unfractionated
rat skeletal muscle
RNA (20 ug) was extracted from unfractionated muscle of normal 
(•— #— #) or strepto-zotocin-diabetic (0— 0— 0) rats as
3described in section 2.4.1., and mixed with 0.004 ug ( H) 
polyU. The volume was adjusted to 0.2 ml in medium containing
50 mM Tris-HCl (pH 7.6), 150 mM NaCl, 1 mM EDTA and 0.5%
■&
sodium dodecyl sulphate, and applied to a 5 ml linear gradient 
of 7-25% (w/v) sucrose in the same medium. The gradients 
were centrifuged for 4 hr at 45,000 rpm (189,000 g) in a 
Beckman SW 50.1 rotor at 20‘^C, analysed, fractionated, and the 
radioactivity was measured as described in section 2.5.3.
E.coli tRl^ A (4S) and rat skeletal muscle ribosomal RNA (IBS) 
were used as markers on a parallel gradient.
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3.4,3 Comparison of template activity of polyA(+)RNA from the skeletal 
muscle of normal and diabetic rats
It was of interest to know whether the mRNA from the skeletal muscle of
normal and diabetic rats had similar template activity. An attempt was
therefore made to isolate the polyA(+)RNA, free from ribosomal RNA and to
translate it in a cell-free system.
The mRNA was separated on polyU-Sepharose, as described in Experimental 
(section 2.4,3), and translated in a cell-free system from wheat germ 
(Experimental; section 2.7.2), It was found that polyA(+)RNA from the 
muscle of normal and diabetic rats exhibited a small but reproducible stim­
ulation above the endogenous level of incorporation of radioactivity 
(Table 3,4,3.1), As far as can be judged, this stimulation would appear 
to be similar for the RNA from the muscle of normal and diabetic rats, 
although because of its relatively small size compared to the endogenous 
incorporation, the values' obtained were not very consistent. Clearly it 
would be desirable to obtain better template activity of the polyA(+)RNA 
for valid comparison between that from normal and diabetic rats, and future work 
on this problem should include further experiments to optimize the con­
ditions for isolation and translation of polyA(+)RNA,
Table 3.4.3.1 Translation of rat skeletal muscle polyA(+)RNA 
in a cell-free system from wheat germ
Reaction mixtures contained: 0,5 pg of polyA(+)RNA isolated as
described in section 2,4.3, 15 pi of wheat germ S-30 fraction,
20 mM HEPES (pH 7,6), 2 mM dithiothreitol, 1 mM ATP (neutralized), 
20 M GTP, 8 mM creatine phosphate, 0,5 pg creatine phospho- 
kinase, 0,4 mM spermidine, 75 mM KCl, 1,5 mM pg acetate, 25 pCi 
of (^^S) methionine (1080 Ci/mmole), and water to 50 pi.
Incubation was at 25°C for 2 hr, then 5 pi aliquots were removed 
for determination of radioactivity incorporated into protein as 
described in detail in section 2,7,2'’,
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4.1 CHARACTERIZATION OF mRNA FROM ADULT RAT SKELETAL MUSCLE
One original feature of the work described in this thesis is that it 
provides information concerning mRNA from the skeletal muscle of adult 
rats; previous studies on muscle mRNA having been almost exclusively 
concerned with embryonic tissue (see Introduction). The characteristics 
of this mRNA will therefore be considered before proceeding to a 
discussion of the effect of diabetes on the metabolism of the mRNA.
One aspect of the skeletal muscle mRNA described in this work is that 
it appears to be relatively small in size. Thus, sucrose density 
gradient analyses revealed polyA(+)RNA species with sedimentation 
coefficients in the approximate range 5-T8S, the median value being 
9.5S (calculated from data in Fig. 3.4.2,3). These values are small 
compared to those of the polyA(+)RNA of myoblasts, where a range of 
sedimentation coefficients of 6-32S has been observed (Buckingham, Cohen 
and Gros, 1976).
It is possible that the small size of this isolated mRNA does not 
represent the actual size of the mRNA in the cell. For example, it 
might have resulted from shearing during homogenization by the rapidly 
rotating blades of the Virtis "23" homogenizer. However, when the RNA 
was extracted directly from muscle that had not been homogenized, but 
frozen in liquid nitrogen and pulverized, the polyA(+)RNA species 
obtained had a similar range of sedimentation coefficients (Fig. 3,4.2.4), 
suggesting that shearing was not responsible for the small size of mRNA. 
Alternatively, the small size of mRNA could be due to nuclease action,
- 150 -
despite the precautions taken to avoid this (see section 3.1.3).
Indeed, that portion of the polyA(+)RNA sedimenting at about 5S in 
Fig. 3.4.2.3 could well be mainly nuclease-resistant polyA tracts; 
for these latter sediment at only a slightly lower value of about 4S 
(Fig. 3.4.1.2). Nevertheless other results are consistent with a 
predominance of relatively small mRNAs,
Thus the polysomes from which muscle mRNA was extracted were of 
relatively small size (Fig. 3.1.1.1), the most predominant species 
being those containing three, four and five ribosomes respectively; 
although smaller peaks corresponding to polysomes bearing up to perhaps 
15 ribosomes could sometimes be detected (Fig. 3,1,2.1). The size 
of these predominant polysome species is small compared to that in 
embryonic chick leg muscle (Heyvzood, and Rich, 1968), where
polysomes containing 5-60 ribosomes were seen; those containing 
15-25 ribosomes being most prevalent. The polysomes with 5-9 ribo­
somes were shown to be active in the synthesis of tropomyosin 
(molecular weight ca. 35,000), those with 15-25 ribosomes were shown to 
be active in the synthesis of actin (molecular weight ca, 43,000), and 
those with 50-60 ribosomes were shown to be active in the synthesis of 
the myosin heavy chain (molecular weight ca, 200,000). Further studies 
of embryonic chick skeletal muscle showed polysomes containing 4-6 
ribosomes synthesizing myoglobin - molecular weight ca. 17,000 - 
(Thompson, Buzash and Heywood, 1973), and some with 4-9 ribosomes 
synthesizing the myosin light chains - molecular weight range ca. 
17,000-30,000 - (Low, Vournakis and Rich, 1971),
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The small size of polysomes could however be an artifact, perhaps 
due to limited ribonuclease activity. This could occur during 
isolation of ribosomes, either by the liberation of intracellular 
nucleases during homogenization, or by accidental exposure to ribo­
nuclease from contaminated glassware during the preparation. However, 
isolation of ribosomes under sterile conditions, with heparin added 
to all solutions to inhibit ribonuclease (Palmiter, Christensen and 
Schimke, 1970), did not result in any increase in the size of polysomes
(Fig. 3.1.3.4). Another possibility is that the small size of poly­
somes could be due to "run-off" of ribosomes from the mRNA. Inclusion 
of cycloheximide, however, did not increase the polysome size (Fig. 3.1.
3.1 and 3,1.3,3). It is worth mentioning, however, that some heavy 
polysomes, might have sedimented to the bottom of the tube during
centrifugation. The absence of large species of polyA(+)RNA (see
Fig. 3,4.2.2 above) argues against this, but it is difficult to exclude 
the possibility that such hypothetical heavy polysomes carry exclusively 
polyA(-)mRNA, which would have escaped detection here.
The foregoing discussion has assumed that the size of the mRNA will be 
the main determinant of the size of the polysomes. However a changed 
rate of initiation of protein synthesis can alter the size of polysomes 
on a single mRNA (Lodish, 1971); thus the polysomes in skeletal muscle 
of adult rats might code for proteins larger than those of corresponding 
size in embryonic muscle; if the rate of initiation were slower in the
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case of the adult muscle. This might allow for the synthesis of 
somewhat larger proteins (see below), but would hardly be expected to 
be of major significance, especially as no very large mRNA was detected,
IVhen rat muscle polysomes were translated in a cell-free system in this 
investigation, the major products were polypeptides of 15,500 and, to 
a lesser extent, of 17,500 molecular weight; although' others of larger 
size were detected after prolonged exposure of the autoradiograph 
(Fig. 3.2.1.5). Published values of sedimentation coefficients of 
mRNA species show a fairly good linear relationship to the logarithm 
of the molecular weight of the protein product (Fig. 4,1,1), allowing 
one to estimate that mRNA species of about lOS and IIS would be required 
to code for the major polypeptides described above. Although the 
median value of the muscle mRNA was only about 9.5S (corresponding to 
a protein of molecular weight 12,500), these sizes of lOS and IIS for 
the mRNA can be accommodated within the range of sizes of polyA(+)RNA 
observed (Fig. 3.4.2,3), Again, it is possible to use published data 
to estimate that proteins of molecular weight 15,500-17,500 would be 
made on polysomes containing 5-7 ribosomes and hence could be made on 
the polysomes observed here (Fig. 4.1.2).
Although this predominantly low molecular weight exhibited by the cell- 
free products of translation would support the other two lines of 
evidence suggesting that the muscle mRNA is, in fact, small, this piece 
of evidence, like those discussed above, is unfortunately equivocal. 
While the cell-free translation system from wheat-germ is efficient in 
synthesizing proteins of small molecular weight, it has been shown with
Fig. 4.1,1 Comparison of the molecular weights of some proteins
with the sedimentation coefficients of their mRNAs
This graph includes published data for the sedimentation coefficients 
of some mRNAs and the molecular weights of their protein products.
(1) Histone H4 from sea urchin embryos (Grunstein et al.,1973).
(2) g-globin from rabbit reticulocyte (Gould and Hamlyn, 1973).
(3) 8-globin from rabbit reticulocyte (Gould and Hamlyn, 1973),
(4) Immunoglobulin light chain from mouse myeloma (Brownlee
et al., 1973).
(5) aA^-crystallin from calf lens (Berns, Janssen and Bloemendal,
1974).
(6) Ovalbumin from chick oviduct (Haines, Carey and Palmiter,
1974).
(7) 6-crystallin from calf lens (Zelenka and Piatigorsky, 1974).
(8) Immunoglobulin heavy chain from mouse myeloma (Stevens and
Williamson, 1973).
(9) Collagen from embryonic chick tendons (Harwood et al., 1974).
(10) Myosin heavy chain from embryonic chick muscle (Heyvzood and
Nwagwu, 1969).
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Fig. 4.1.2 Comparison of the molecular weights of some proteins
with the number of ribosomes comprising their polysomes
This graph includes published data for the molecular weights of 
some proteins and the number of ribosomes comprising their polysomes.
(1) Haemoglobin from rabbit reticulocyte (Warner, Rich and Hall, 1962)
(2) Myoglobin from embryonic chick muscle (Thompson, Buzash and
Heywood, 19 73).
(3) Immunoglobulin light chain from mouse myeloma (Becker, Ralph
and Rich, 1970)
(4) Tropomyosin from embryonic chick muscle (Heywood, and '
Rich, 1968).
(5) Immunoglobulin heavy chain from mouse myeloma (Becker, Ralph
and Rich, 19 70).
(6) Actin from embryonic chick muscle (Heywood, and Rich,
1968).
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other mRNAs to synthesize fewer higher molecular weight proteins than 
the intact cells (see for example, Prives et al., 1974). Thus the 
cell-free products of low molecular weight in this study might be due 
to premature termination of nascent polypeptide chains.
Nevertheless, if it is assumed that the adult muscle mRNA really is 
small, can one reconcile such an apparent small mRNA with the large 
proteins-which characterize the skeletal muscle? This is possible, in 
the context of the proposal (Zak, Ratkitzis and Rabinowitz, 1971) that 
in the muscle of adult rats the rate of turnover of the structural 
proteins of the myofibrils (which include most of the large proteins) 
is slower than that of the soluble proteins, which tend to be small, 
Consistent with this idea, Velick (.1956) reported that in rabbit 
skeletal muscle the half-life of the structural protein, myosin, was 
80 days, while that of the soluble protein, aldolase, was 50 days; 
and Swick and Song (1974) found a similar difference in rat skeletal 
muscle, although they obtained different absolute values (myosin:
35 ± 10 days; and aldolase: 18 ± 3 days). However measurements on 
a much wider range of other proteins (especially the soluble proteins) 
are clearly required before one can accept this idea. In fact recent 
investigations indicate that in skeletal muscle the various myofibrillar 
proteins may not be synthesized and degraded as a unit, but that they 
may turn over separately (Millward, 1970; Funabiki and Cassens, 19 72; 
Koizumi, 1974; Zak et al., 1977). However it is still possible that 
the larger proteins are more stable (and would have less mRNA), as the 
large myosin heavy chain (molecular weight ca. 200,000) appears quite 
stable by comparison with the much smaller tropomyosin chain (molecular 
weight ca, 35,000) or the even smaller myosin light chain - molecular
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weight about 20,000 (Low and Goldberg, 1973). However Dice et al (1978) 
have found large proteins to he generally less stable (i.e. to turn 
over more rapidly) than small proteins.
Assuming that the mRNA of adult skeletal muscle codes predominantly 
for soluble proteins, it is of interest to compare the size of the 
subunits of such proteins with that of the cell-free products of the 
polysomes, as seen in Fig. 3.2.1.5. Some of the proteins which are 
most abundant in skeletal muscle (depending, to some extent, on the 
proportion of red and white muscle fibres) are aldolase (molecular 
weight of the subunits ca, 40,000), a-glycerophosphate dehydrogenase 
(molecular weight of the subunits ca. 40,000), glyceraldehyde-3- 
phosphate dehydrogenase (molecular weight of the subunits ca. 37,000), 
enolase (molecular weight of the subunits ca. 41,000), pyruvate kinase 
(molecular weight of the subunits ca. 57,000), lactate dehydrogenase
(molecular weight of the subunits ca. 35,000) and creatine kinase
(molecular weight of the subunits ca. 40,000). Some of these protein
subunits might clearly correspond to the well-defined bands at molecular
weights of about 41,000 and 34,000 (Fig. 3.2,1.5). Also from Fig.4.1.1, 
it can be seen that the molecular weight 40,000 corresponds to a value 
of about 158, which is not inconsistent with the range of sizes of 
polyA(+)RNA observed (Fig. 3.4.2.3). As myoglobin has a molecular 
weight of about 17,000, and as the major proteins synthesized in the 
cell-free system have molecular weights of about 15,500 and 17,500 
(Fig. 3.2.1.5), it is possible that one of these proteins is myoglobin. 
This is feasible as the rat gastrocnemius muscle is composed of, 
approximately, 50% fast white, 40% fast red (rich in myoglobin), and 
10% slow red .fibres (Baldwin et al,, 1972). However further more accurate 
determination of the molecular weights are required (see legend
to Fig. 277:3.1.).
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It was of interest in this study to estimate the percentage of
skeletal muscle RNA that is mRNA. To do this it was necessary to
estimate the size of the mRNA and that of the polyA tract. It has
been shown that, under non-denaturing conditions, there is no accurate
relationship between the sedimentation coefficients and the molecular
weights of RNA species (Boedtker, 1968), and that mRNAs exhibit
anomalous sedimentation coefficients relative to ribosomal RNA on
aqueous sucrose gradients (Macleod, 1975). It was not, however,
possible during the course of this study to analyse the skeletal muscle 
mRNA under the denaturing conditions of 70% formamide sucrose gradients
(Suzuki, Gage and Brown, 1972), as this would have interfered with the
3hybridization ^ of the polyA tract of the mRNA to ( H) polyU. Therefore 
it was necessary to use the results obtained in non-denaturing sucrose 
density gradients and compare these with published values for other 
mRNAs, the size of which had also been determined by independent means 
(Fig. 4.1.3). When the median value (9.58) of the sedimentation co­
efficient of rat skeletal muscle mRNA (Fig. 3.4,2.3) is compared with 
that of other classes of well characterized mRNAs, it is found that 
this sedimentation coefficient corresponds to a size of about six 
hundred nucleotides.
The polyA tracts obtained from skeletal muscle mRNA by ribonuclease 
digestion (see legend to Fig. 3.4.1.2) had, on average, a slightly 
lower sedimentation coefficient than that of E.coli tRNA (known to be 
48). Although the average size of E. coli tElNA corresponds to about 
80 nucleotides (Dayhoff, 1969), one can not conclude that the polyA 
tracts contain less than 80 nucleotides because of differences in the
Fig. 4.1.3 Comparison of the number of nucleotides of some 
mRNAs with the sedimentation coefficients of 
the mRNAs
This graph includes published data for the number of nucleotides of 
some mRNAs and the sedimentation coefficients of their mRNAs.
(1
(2
(3
(4
(5
C6
(7
(8
(9
(10
Histone H4 mRNA from sea urchin embryos (Grunstein et al.,
1973).
a-globin mRNA from rabbit reticulocyte (Gould and Hamlyn,
1973).
g-globin mRNA from rabbit reticulocyte (Gould and Hamlyn,
1973).
Immunoglobulin light chain mRNA from mouse myeloma (Brownlee
et al., 1973).
gA^-crystallin mRNA from calf lens (Berns, Janssen and
Bloemendal, 1974).
Immunoglobulin heavy chain from mouse myeloma (Stevens and
Williamson, 1973).
6-crystallin mRNA from calf lens (Zelenka and Piatigorsky,
1974).
Ovalbumin. mRNA from chick oviduct (McReynolds, et al.,
1978).
Collagen mRNA from embryonic chick tendons (Harwood et al.,
1974).
et al., 1974)
(11) 16S rRNA from E.coli (Spohr et al., 1976).
(12) 238 rRNA from E . coli (Spohr et al., 1976).
(13) 288 rRNA from HeLa cells (Spohr et al., 1976).
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sedimentation properties of homo- and heteropolynucleotides, and in 
molecules with different degrees of secondary structures. The average 
sedimentation coefficient of total cytoplasmic polyA from mouse 
sarcoma ascites cells was rather similar to that described here, at 
3 .4s  (Brawerman, 1976),  and when converted into nucleotide size using 
the data of Fresco and Doty (1 9 5 7 ), a value of about 120 nucleotides was 
obtained. This value is consistent with that reported for myoblast 
polyadenylated mRNA, where the polyA moiety comprises 90-110 nucleotides 
(Paterson and Bishop, 1977).  Therefore it seems more reasonable to 
assume a value of 120 nucleotides for the polyA tract in the present 
work.
Thus using the value of 120 nucleotides for the average length of 
polyA tracts in rat skeletal muscle, and 600 nucleotides for the average 
length of the mRNA, one can conclude that the polyA tract accounts for 
20% of the length of skeletal muscle mRNA of adult rats. From the 
hybridization assay described in section 3.3.1, it was found that about 
0*100% of the muscle polyribosomal RNA consists of regions of polyA - 
seven experiments giving an average value of 0.108% (Table 3.3.1,1) - 
and hence the proportion of mRNA to polyribosomal RNA in rat skeletal 
muscle is 0.54%. This value appears to be relatively small compared 
with that of 3% reported by Rudland et al.(1975) for BALB/c 3T3 
cultured mouse fibroblasts (where it was assumed that 10% of the length 
of mRNA is polyA), or that of 3% reported by Whalen and Gros (1978) for 
cytoplasmic polyAC+)RNA in calf myoblasts. However, it should be 
pointed out that, if the size of mRNA determined in this study is 
smaller than the actual size (as discussed above), then this would
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decrease the proportion of polyA to mRNA and accordingly the percentage 
of mRNA would be increased. Another possible source of underestimation 
of the proportion of mRNA could arise if the skeletal muscle of adult 
rats contained an unusually large proportion of mRNA lacking polyA, 
which would not have been detected in this work.
The proportion of polyA(+)RNA may also be estimated from the results 
of the polyU-Sepharose affinity chromatography described in Experimental 
(section 2,4.3), The amount of RNA eluted as polyA(+)RNA was on 
average 4% of the total applied. This value is higher than that 
obtained above, but it is possible that the eluted polyA(+)RNA still 
contains some ribosomal RNA, non-specifically bound to the polyU- 
Sepharose.
Implicit in the foregoing discussion is the assumption that polyA(+)RNA 
is mRNA. There is every reason to think that this assumption is valid 
(see Introduction), but ultimate proof that an RNA is a mRNA rests on 
its translation in a cell-free system. Thus, attempts were made to 
translate the skeletal muscle polyA(+)RNA (isolated from polyribosomal 
RNA by polyU-Sepharose affinity chromatography) in a cell-free system 
from wheat germ. However only a small stimulation above the endogenous 
level of incorporation of radioactivity was obtained (Table 3.4.3.1).
This might, again, be due to degradation of mRNA. However the optimum 
conditions adopted for translation vary with different mRNAs and 
systematic experiments are required to try to find the correct conditions in 
this case. Such experiments would be of high priority in any future 
development of this work. Another possible .explanation for the poor
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translation in the wheat germ cell-free system is that specific muscle 
initiation factors are required to translate muscle mRNA. However the 
bulk of evidence does not favour this idea (see Introduction).
The supposition that the skeletal muscle polyA(+)RNA is mRNA is 
supported by its distribution during cell fractionation (Fig. 3.3.2.1; 
Table 3.3.2.2), which will now be considered in a little more detail.
First it should be pointed out that the ’mitochondrial pellet' fraction 
contains much more of the total RNA and polyA(+)RNA than would be at 
first expected. However this is due to the fact that at 80 mM KCl 
(Medium A), this fraction contains a large amount of trapped ribosomes, 
which can be partially recovered (Table 3.1,1.1) at 250 mM KCl (Medium C). 
It is also striking that the percentage of polyA in this fraction is 
higher than in purified ribosomes. This can be explained by the presence 
in this fraction of the nuclei which are rich in heterogeneous polyA(+)RNA 
species, but contain relatively little rRNA and tRNA precursor species.
The majority of the remainder of the polyA(+)RNA (ca. 70%) is in the 
’ribosome pellet’ fraction, as expected. However some polyA(+)RNA 
(ca. 15%) is present in the ’post-microsomal supernatant’. This might 
represent free mRNA, similar to that found in the ’post-ribosomal 
supernatant’ by Bonanou-Tzedaki, Pragnell and Arnstein (1972); or 
mRNA in the form of mRNP particles of sedimentation coefficient less than 
408, as found by Jacobs-Lorena and Baglioni (1972) in the ’post- 
ribosomal supernatant' of rabbit reticulocyte lysates. The proportion 
of polyA to total RNA is low in this fraction (compared to other 
fractions) and this is consistent with the expectation that the major 
species of RNA here would be tRNA. Finally it should be noted that some 
polyA(+)RNA (ca, 15%) is found in the ’post-ribosomal supernatant'.
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This is presumably released from the polysomes during resedimentatioh, 
and a similar occurrence may explain the high proportion of polyA in 
the slowest sedimenting fraction of sucrose density gradients on which 
the purified polysomes were analysed, (Fig. 3.3.2.3; Table 3.3,2,5).
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4.2. METABOLISM OF SKELETAL MUSCLE mRNA IN DIABETES
The main objective of this investigation was to determine the quantitative 
and qualitative effects of diabetes on mRNA metabolism; in particular 
to see whether insulin modulates protein synthesis by stimulating the 
translation of pre-existing mRNA.
In the present work it was found that diabetes decreased the total amount 
of RNA in skeletal muscle, as others had found previously (Pain and 
Garlick, 1974). The new finding however, was that there was a similar 
reduction in the amount of polyA(+)RNA. Thus the concentrations of 
different RNA species were decreased in concert. This extends earlier 
work, in heart muscle, showing that the concentrations of rRNA and tRNA 
were reduced to the same extent during diabetes (Wool, Stirewalt and 
Moyer, 1968), and implies that in diabetes there is a co-ordinated decrease 
in the concentrations of all the RNA species involved in muscle protein 
synthesis. It would be of interest to know whether the concentration of 
the various protein species involved in protein synthesis (e.g. initiation 
and elongation factors) are also reduced proportionally in diabetes.
The major result of this study was that the relative proportion of 
polyA(+)RNA in muscle from diabetic rats is similar to that in muscle 
from diabetic rats treated with insulin. This implies that insulin 
stimulates protein synthesis in these circumstances by causing the 
recruitment of pre-existing mRNA into polysomes, and not by inducing the 
synthesis of new mRNA. Thus insulin would appear to regulate protein 
synthesis in the skeletal muscle of diabetic rats through translational 
control. In the light of this finding it is worth referring to the two
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models for the polysomes from the skeletal muscle of diabetic rats, 
put forward in the Introduction (Fig, 1,2,1), Model Ci) implied less 
mRNA in the polysomes, whereas Model Ciil implied an equal amount of 
mRNA, the number of ribosomes being decreased. It is clear from the 
analysis,of the ratio of polyAC+IRNA to total RNA in the different 
regions of the sucrose density gradients [Fig, 3,3,2,3; Table 3.3.2,5), 
that Model Cii) is not tenable, and that the results are more consistent 
with Model Ci),
Both these foregoing conclusions rely on one assumption which, though 
reasonable, lacks experimental basis. That is that the polyA(+)RNA is 
representative of the total muscle mRNA (polyAC+lRNA and polyAC"IRNA) 
in normal and in diabetic rats, Clearly, if the concentration of 
polyAC-)RNA were affected by diabetes in a different way to other RNA 
species, the conclusion above regarding co-ordinated changes in RNA 
concentrations would need modifying. It is probable, however, that most 
muscle mRNA is polyAC+)RNA, as Wahlen and Gros (19781 found that the 
great majority of mRNA from either prefusion or postfusion cultures of 
calf myoblasts was polyA(+)RNA. Of course, this situation need not 
necessarily be similar in the skeletal muscle of adult rats, especially 
given the different size distribution of mRNA species (see section 4,1). 
Even if the proportion of polyA(+)mRNA to polyA(-)mRNA did alter in 
diabetes, the results still show that insulin controls the translation 
of polyA(+)RNA.
These results imply that there is in the skeletal muscle of the 
diabetic rats a pool of potentially active 'masked’ mRNA. There is a
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precedent for inactive mRNA in muscle during development of myoblasts, 
and in this case it is found in messenger ribonucleoprotein particles 
of sedimentation coefficients 70-90S (Heywood, Kennedy and Bester, 1975). 
It was therefore .of interest to try to determine whether the mRNA stored 
in the skeletal muscle of diabetic rats was also in the form of mRNP 
particles, as might be anticipated. Unfortunately this problem could 
not be solved due to the aggregated form in which the polyA(+)RNA was 
found in ribosomes during the sucrose gradient analyses. Further attempts 
are clearly required to overcome this problem of aggregation.
It is important to know whether the structure of mRNA in the muscle of 
diabetic rats differs from that of mRNA in the muscle of normal rats.
For example, differences in the non-coding sequences of the mRNA might 
be related to the control of the translation of muscle mRNA. If the 
skeletal muscle mRNA is stored in an inactive form in the muscle of 
diabetic rats, one might expect that this mRNA would have a longer half- 
life than that in polysomes, and thus than the majority of the mRNA in 
the skeletal muscle of normal rats. As the polyA tract in mRNA becomes 
gradually shorter as the RNA ages in the cytoplasm (see Introduction), 
one would anticipate that the longer half-life might be reflected in 
a decrease in the length of the polyA tract. Moreover, it has been 
found that the decrease in polyA size with age occurs whether or not the 
mRNA is associated with polysomes (Brawerman, 1973), and that it is 
independent of the translation process (Sheiness and Darnell, 1973).
In this study, the sedimentation coefficient of the polyA tract was 
found to be similar in muscle from normal and diabetic rats (section 
3.4.1). This may mean that - contrary to expectation - the stored mRNA
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is turning over at a similar rate to that mRNA which is being translated.
Another possible difference in the non-coding sequences of the mRNA 
might be in the ’cap’ at the 5’-end (see Introduction). The ’cap' 
structure might be eliminated in mRNA from the muscle of diabetic 
animals resulting in the inactivation of the mRNA and its transfer to 
the stored pool. Alternatively, a difference in the number of penul­
timate 2’-0-methylated nucleotides in the two types of mRNAs might exist. 
Such a difference as this latter was found for g-and g-globin mRNA 
(Lockard, 1978), and may possibly explain the fact that each molecule 
of g-globin mRNA initiates protein synthesis at a rate 30% faster than 
3&-globin mRNA (Lodish and Jacobsen, 1972; Lodish, 1974).
More subtle chemical modifications of the structure of the muscle mRNA 
during diabetes can not be ruled out. These might be, for example, in 
the internal methyl^adenine or methyl^cytosine that is present in some 
eukaryotic cellular mRNAs (see Introduction). It would be of interest 
to know whether there is a change in the proportion of such modified 
residues.
Another question of interest is whether there is a qualitative difference 
between the proteins coded by the mRNAs stored during diabetes and the 
mRNAs which are translated. Such a difference would be expected to be 
reflected in different products synthesized by ribosomes of normal and 
diabetic rats; but from Fig. 3.2.1.5 it appears that the polypeptides 
synthesized in a cell-free system by the ribosomes from diabetic rats 
were similar to those synthesized by ribosomes from normal rats. Although 
some polypeptides of higher molecular weight are visible in the products
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of ribosomes from normal rats, this difference was not reproducible.
This similarity between the proteins synthesized by the muscle of normal 
and diabetic rats is consistent with earlier observations using dis­
continuous electrophoresis on polyacrylamide gels (Kurihara and Wool, 
1968), but more extensive investigations are required on this point. 
Further analysis using the improved resolution of two-dimensional gel 
electrophoresis (O'Farrell, 1975; Whalen, Butler-Browne and Gros, 1976) 
would be desirable. It would also be interesting to analyse the mRNA 
from skeletal muscle of normal and diabetic rats for possible differences 
by preparing complementary DNAs from these and comparing their hybrid­
ization to the two populations of mRNAs.
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4.3 NUCLEASE ACTIVITIES IN THE MUSCLES OF DIABETIC RATS
One minor and unexpected observation in this study was that insulin 
administered to rats, made diabetic with alloxan, did not lead to the 
reformation of polysomes when ribosomes were isolated in a medium of 
high ionic strength (section 2.3,2). Reformation of polysomes did 
occur if the rats had been made diabetic with streptozotocin, or if 
the ribosomes were isolated at low ionic strength, and it was concluded 
that alloxan - but not streptozotocin - causes the induction or 
activation of a nuclease, which is only extracted into the ’post- 
mitochondrial supernatant’ at high ionic strength. This causes the 
breakdown of polysomes which have been reassembled in vivo in response 
to insulin.
Although this interpretation of the results seems virtually inescapable,
no independent evidence was obtained for the existence of the putative
ribonuclease. The assays used in the unsuccessful attempts to detect
the nuclease relied on measurements of the acid-soluble degradation
products of RNA, Thus it is possible that the putative nuclease
induced by alloxan is a relatively specific endonuclease releasing large
oligonucleotides which are insoluble in acid. One could perhaps detect
32such an activity by analysing the products of hydrolysis of ( P)-
labelled rRNA using gel electrophoresis.
These results imply that alloxan-diabetes is more severe, and produces 
more side effects than streptozotocin-diabetes, This is consistent
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with, previous claims that streptozotocin-diabetic rats —  unlike 
alloxan^diabetic rats-r-have normal levels of blood ketones and plasma 
free fatty acids, and of heart glycogen (Mansford and Opie, 1968), It 
is also consistent with the observation that insulin did not restore 
normal blood glucose concentrations In alloxan-diabetes, although it 
did so in streptozotocin-diabetes (Table 2,2,2.11,
The results of the present work emphasize the need for careful assessment 
of studies on protein synthesis in rats made diabetic with alloxan. 
Specifically, where such studies have used a high ionic strength for 
preparation of ribosomes, their results should not be accepted unless 
control experiments with insulin indicate otherwise. Most of the 
experiments from Wool’s laboratory cited in the Introduction (Chapter 1) 
are immune for this criticism, as ribosomes were prepared at low ionic 
strength. However two late pieces of work were performed with extraction 
at high ionic strength, and without such insulin controls. Thus one must 
have strong reservation whether there is a defect in the 60S subunits of 
ribosomes from alloxan-diabetic rats which affects their ability to form 
80S couples and to allow 80S ribosomes to be dissociated by initiation 
factor-3 (Wettenhall, Nakaya and Wool, 19.74; Nakaya, Ranu and Wool,
1974),
In view of the net breakdown of RNA during diabetes it might have been 
expected that the measurements of ribonuclease made in this work (for 
the reasons indicated above) would have detected an increase in the 
activity of acid ribonuclease during diabetes, similar to that seen in 
dystrophic muscle (Abdullah and Pennington, 19681, However, no increase 
was found in the activity of acid ribonuclease present in unfractionated
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homogenates of skeletal muscle (Table 3,2.2,4). However the measure­
ments made were probably of total nuclease activity, some of which is 
’latent' in lysosomes of the intact cells (Rannels, Kao and Morgan,
1975). Careful measurements of ’free' ribonuclease would be required 
to determine whether there is an increase in ribonuclease responsible 
for the decreased concentration of RNA in rat skeletal muscle during 
diabetes. Only if such experiments gave negative results could one 
conclude that the loss of skeletal muscle RNA during diabetes is caused 
solely by a decrease in the rate of RNA synthesis, rather than an increase 
in the rate of RNA degradation. If this were the case, the situation 
would be analogous to that established for the control of the total 
protein of skeletal muscle under a variety of conditions. (Millward 
et al., 1976).
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